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The ureter is a complex organ with unique characteristics, and it responds to the continuous 
changes in its internal and external environment. The initiation and propagation of ureteric 
peristalsis along the different ureteric segments and its adaptability to various flow conditions 
are not clearly understood. The hypothesis of this thesis postulates that the ureter can adapt 
to various physiological and pathological conditions due to the difference in the contractile 
and pharmacological properties of its segments. 
To investigate this hypothesis; the ureter was divided into five segments, and the basal 
contractile properties of these segments were investigated and compared. 
The effect of cholinergic pharmacological manipulation on the ureter was investigated in the 
upper, middle and lower ureteric segments.  Also, the effect of ureteric obstruction caused 
by kidney stones was investigated in the upper and lower ureteric segments. 
 
Methods: 
The investigation of ureteric basal and pharmacologically modulated contractility and 
obstruction by stones were conducted in organ bath experiments using ureteric segments 
from freshly slaughtered pigs.  
 
Results & Conclusion:   
The different ureteric segments demonstrated variability in their contractile behaviour. The 
ureter demonstrated a spasmodic response to obstruction caused by the stone passage. The 
difference in ureteric segment contractility and response to pharmacological manipulation 
has provided further insight into the complexity and adaptability of the ureter to various 
conditions and further targetted investigations to explore a new approach to medical 
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Introduction & overview 
 
1.1 Introduction   
Ureteric peristalsis represents a complex physiological phenomenon and exhibits some 
unique properties and some that are shared with other organs. The ureter shares a few 
pharmacological and anatomical similarities with the Fallopian tube and vas deferens, 
respectively. The fallopian tube shows rhythmic contractions and is responsive to 
prostaglandins as the ureter and the vas deferens resembles the ureter in its uniformity of 
structure over its length (Boyarsky & Labay, 1971). No other organ in the body, except the 
urethra, transports urine. The ureter has the ability to alter readily dimensions of the lumen 
in response to the amount of urine produced by the kidney and in pathological conditions. It 
propels small boluses of urine during dehydration but can dilate and still enable a wide 
column of fluid to flow in diuresis (Boyarsky & Labay 1971). Also, in conditions where there is 
an intrinsic (e.g. stone, tumour) or extrinsic (e.g. retroperitoneal fibrosis, pregnancy) cause of 
obstruction, the ureter can respond to these challenges and maintain a flow of urine, that will 
preserve renal function, unless the obstruction is severe.  
To develop a conceptual understanding of ureteric dynamics it is necessary to consider the 
ureter as more than just a simple conduit that contracts repetitively to maintain peristalsis. 
Overall function is integrated by the presence of typical smooth muscle cells, atypical 
pacemaker cells and coordination by the autonomic nervous system (Constantinou & 
Djurhuus, 1981).  A better understanding of how the ureter functions under different 
physiological and pathological constraints is therefore essential. A focus of research has been 
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to understand how the ureter functions in pathological conditions such as obstructive stone 
disease to better understand how it may expel renal stones.  However, less research has been 
spent on how the ureter may adapt to maintain near-normal function under a range of 
pathological constraints and has been the focus of the work in this thesis.  
1.2 Ureteric anatomy 
The ureter is a hollow organ which arises from the collecting system of the kidney and 
terminates at the bladder. In humans and pigs the kidney is multicalyceal and minor calyces 
combine to form several major calyces that open into the renal pelvis. In small mammals such 
as the rat, guinea pig and the rabbit, the kidney is unicalyceal. A detailed understanding of 
the renal anatomy further elucidates the origin of the collecting system. The kidney structure 
is divided into the cortex and medulla; the functioning unit of the kidney is the nephron. 
medulla is subdivided into eight to eighteen striated well-defined, conically shaped regions 
that is referred to as renal pyramids. These are separated by sections of renal cortex 
called columns of Bertin. Each renal pyramid terminates centrally in a papilla. 
Microscopically, the renal collecting system originates in the renal cortex at the glomerulus 
as filtrate enters Bowman’s capsule. Collectively the glomerular capillary network and 
Bowman’s capsule form the renal corpuscle. The filtrate is initially collected in Bowman’s 
capsule and then moves to the proximal convoluted tubule. The proximal tubule is located 
more profound into the cortical tissue where it becomes the loop of Henle. Within the renal 
medulla, the loop of Henle reverses course and moves back toward the periphery of the 
kidney, becoming the distal convoluted tubule; which ultimately returns to a position 
adjacent to the originating glomerulus and proximal convoluted tubule. The distal convoluted 
tubule turns once again towards the interior of the kidney, becoming a collecting tubule. 
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Collecting tubules from multiple nephrons join into a collecting duct that reaches inward 
through the renal medulla and ultimately empties into the apex of the medullary pyramid; 
the renal papilla, which is the first gross structure of the renal collecting system. Usually there 
are seven to nine papillae per kidney, but this number is variable and can range from four to 
eighteen. Each papilla is cupped by a minor calyx. Groups of minor calyces join to form a major 
calyx and the major calyces combine to form the renal pelvis (Elkoushy & Andonian, 2015). 
The ureters are situated in the retroperitoneum, lateral to the tips of the transverse processes 
of the lumbar vertebrae and extends down to the bladder crossing the abdominal and pelvic 
structures . 
In the abdomen; the ureter originates at the level of the renal artery and vein and is located 
posteriorly. The pelviureteric junction usually corresponds with the second lumbar vertebra 
on the left side, and the right is situated marginally lower. 
The course of the ureter continues anteriorly over the psoas major muscle, traversing inferior 
to the gonadal vein at the level of the lower pole of the kidney. The ureters subsequently 
course medial to the sacroiliac joint and then course laterally in the pelvis. The colon and its 
mesentery are located anteriorly to the ureters. Precisely, the cecum, appendix, and 
ascending colon are situated over the right ureter; the descending and sigmoid colon lie over 
the left ureter. 
As the ureter enters the pelvis, it crosses anterior to the iliac vessels, usually at the bifurcation 
of the common iliac artery. At this level, the ureters are within 5 cm of one another before 
they separate laterally. The ovarian vessels are located in the suspensory ligament of the 
ovary; the infundibulopelvic ligament and traverse anteriorly to the ureter and lateral to the 
iliac vessels. The ureters then course lateral to the ischial spines before coursing medially to 
enter the bladder at the base. The anteromedial aspect of the ureter is covered by 
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peritoneum, and the vas deferens runs anteriorly to it. The ureter proceeds with the inferior 
vesical neurovascular pedicle into the bladder. In females, the ureter continues posterior to 
the ovary and then under the broad ligament and within the cardinal ligament as the uterine 
artery crosses anteriorly in the rectouterine fold of peritoneum. 
The international anatomical terminology has divided the ureter into an abdominal segment, 
pelvic segment and an intramural segment. Also, a different nomenclature of the ureter has 
been described based on its anatomic relationship to the surrounding structures. The ureter 
is divided into upper, middle, and lower segments. The upper ureter extends from the renal 
pelvis to the upper border of the sacrum. The middle ureter continues from the upper to 
lower borders of the sacrum. The distal ureter continues from the lower border of the sacrum 
to the bladder (Lescay and Tuma, 2019; Soriano and Leslie, 2019).  
 
In humans the length of the ureter in adults is between 25–30 cm and in new-born infants it 
is between 6.5–7.0 cm long (Anderson & Kabalin 2007). The diameter of the ureter is between 
1.5–6 mm; this will depend on the segment of the ureter; other studies show that the average 
diameter of the ureter is between 2-4mm in humans (Zelenko et al., 2004).  The renal pelvis 
is funnel shaped and is a wider diameter ranging between 7mm to 10mm in adults (Emamian 
et al., 1993). In the upper ureter the diameter is larger than the middle and lower ureteric 
segments. The study by Carugo et al., (2013) demonstrated the size difference between the 
ureteric segments in the pig model; the upper ureter mean diameter of 6.0±1.3mm and tapers 
down to 2.4±0.6mm in the middle ureter and the lower ureter 2.2±0.6mm; these figures 
represent the average diameter of each segment in that study.  
As the ureter enters the bladder, it runs obliquely through the bladder wall, and is enveloped 
by the muscular layer of Waldeyer. Here the ureter merges with bundles of detrusor muscle 
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of the bladder wall to form thicker longitudinally arranged muscle bundles. This oblique entry 
through the bladder wall forms an anti-reflux mechanism that prevents retrograde flow of 
urine from the bladder back into the ureter. This intramural segment of the ureter is about 
0.5 – 0.8 cm in neonates and 1.2 to 2.5 cm in adults (Fröber, 2007). 
The blood supply to the ureter originates from the renal arteries, the testicular/ ovarian 
arteries, but also direct branches from the aorta and common and internal iliac arteries. 
Branches of the renal artery supply the renal pelvis and the upper ureter. The middle part of 
the ureter is supplied by branches from the testicular or ovarian artery. The aorta and the 
common iliac arteries play a role in supplying vascular branches to the ureter.  
The pelvic or distal  segment of the ureter is supplied mainly by branches of the internal iliac 
artery. It is important to recognise the direction of the nutrient blood supply of the ureter as 
this may affect the surgical approach; hence, not to compromise the blood supply to a 
particular segment. These nutrient arteries tend to approach the ureteric wall from one 
direction. In the upper segment of the ureter, i.e. above the pelvic brim, these arteries come 
from a medial direction. Below the pelvic brim, the ureteric segment is supplied by branches 
that come from the lateral aspect.  The distal segment of the ureter is occasionally supplied 
by the middle rectal artery. In males, the internal iliac artery or the umbilical artery may give 
rise to the artery of the vas deferens which gives a branch to the lower segment of the ureter. 
In females, the distal part of the ureter is supplied by the uterine artery (Fröber, 2007).  
The anatomical division of the ureteric segments implies that there is a functional difference 
between the segments, but there is no clear evidence from the literature about possible 
functional variability between the three segments has been investigated.  
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1.3 Innervation of the ureters 
Ureteric innervation originates from both divisions of the autonomic nervous system. The 
thoracolumbar innervation from T10-L1 provides sympathetic innervation via the renal plexus 
and ganglia. The renal and upper ureteric branches from the inter-mesenteric plexus 
proximally and the middle ureteric branch of the inter-mesenteric plexus in the middle 
segment of the ureter. In the pelvis, the ureter receives parasympathetic innervation from 
the pelvic splanchnic nerves and the inferior hypogastric plexus.  
The ureter smooth muscle cells are a syncytial type of without discrete neuromuscular 
junctions (Burnstock, 1970). Ureteric peristalsis may persist after transplantation (O’Conor & 
Dawson-Edwards, 1959) or denervation (Wharton, 1932), as the spontaneous ureteric activity 
may occur in isolated in-vitro segments (Finberg and Peart, 1970). The evidence from the 
literature denotes that ureteric peristalsis can occur without innervation, although, the 
nervous system provides a modulating role in ureteric peristalsis. Morita et al. (1987) describe 
the autonomic nervous system may affect urine transport by altering both the frequency of 
peristalsis and the volume of the urine bolus.  
 
1.4 Ureteric Histology 




The adventitia completely envelops the whole ureter. It is composed of areolar and fibro-
elastic connective tissue with variable thickness. The ureteric blood supply runs longitudinally 
under this layer. It provides a cover for the ureter which allows it to slide freely and change 
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its calibre during peristalsis. The adventitia starting at the renal pelvis is continuous with the 
pelvic fascial sheath. The structure of the adventitia is altered at the distal end of the ureter 
as it becomes thicker and more prominent; this fibromuscular layer forms a cover around the 
terminal 3 to 5 cm of the ureter - Waldeyer’s sheath described in 1892 (Scheuerlein et al. 
2017). The space between the ureteric wall and Waldeyer's sheath contains loose connective 
tissue that aid the movement of the ureter into the bladder during peristalsis.  This sheath 
has an important functional role for the lower ureteric segment and the vesicoureteric 
junction as it serves as part of the anti-reflux mechanism described by Wood Jones 1953 
(Radmayr et al., 2009). It also forms a connection between the mesodermal-derived ureter 
and the detrusor muscle, derived from endoderm.  
 
1.4.2 Muscle layer 
 
The ureter is a muscular tube which starts at the renal pelvis; the upper third has a thin 
muscular layer that consists of smooth muscle fibres that are arranged in small bundles and 
separated by connective tissue. The pelviureteric junction has a gradual change in calibre 
from the renal pelvis to the upper part of the ureter. During embryonic development, the 
cranial end of the ureteric bud grows to form the renal pelvis, and the rest of the tube 
continues to lengthen caudally. In the early developmental stages, a mesenchymal cell 
arrangement has a circular orientation around the ureter, and as it extends, the muscle fibres 
develop a more longitudinal orientation.  The growth of the ureter in both directions results 
in a mixed orientation of fibres throughout the collecting system; with a preponderance of 
either circular or longitudinal fibres at different locations along the ureter: the renal pelvis 
(Fig 1) tends to have more circular oriented fibres because its growth was along a transverse 
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axis.  The pelviureteric junction and upper ureter (Fig.2) has more circular fibres than 
longitudinal and as the ureter grows longitudinally, it has an equal distribution of fibre 
orientation (Spronck et al., 2014).  
The lower ureter (Fig.3) has longitudinal fibres and some smaller circular bundles. This 
segment has a longitudinal orientation of fibres as it approaches the ureteric orifice where 
the ureter continues into the trigone. 
 
 
                                                        Chapter 1 – Fig 1. Renal Pelvis (Mag:4x0) 
 
 
Chapter 1 – Fig 2. Upper ureter (Mag:4x0) 
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Chapter 1 – Fig 3. Lower ureter (Mag:4x0) 
 
 
1.4.3 Mucosa  
The mucosa of the ureter is composed of transitional epithelium. The ureteric urothelium lies 
over the lamina propria, which itself is composed of loose tissue and fibrous bands that attach 
the basal epithelial cells to the muscle layer. As this sub-urothelial layer is not rigid and loosely 
attached, in the resting state it forms longitudinal folds that can distend easily and stretch the 
urothelium to allow for a potential space that  that may undergo gross structural changes of 
the ureter during peristalsis. The transitional epithelium also provides a barrier against urine 
diffusion into the interstitial space and will layer serves as a protection against the acidity of 
urine (Le Gros Clark, 1958).  
 
1.5 Ureteric pathology  
The kidney, ureter and renal pelvis can be affected by many pathological conditions which 
range from congenital, neoplastic and inflammatory.  
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1.5.1 Congenital conditions  
There are various congenital abnormalities of the upper tracts that may manifest in reflux or 
urinary stasis that may lead to stone formation and infection. The ureteric duct can be 
affected by growth failure that can cause renal agenesis; duplication; or positional 
abnormalities of the upper urinary tract. These result from abnormal development of the 
ureteric duct which originates from the mesonephric duct.   
Agenesis 
Renal agenesis is total failure of the ureteric duct to develop, when the ureteric bud does not 
fuse with the metanephros or when the ureteric duct forms a blind-ending diverticulum. 
Bilateral renal agenesis is a rare condition, however unilateral renal agenesis is more common 
(Magee, Lucey & Fried, 1979), about 1/1200 of screened children (Sheih et al., 1990).  
 
Duplication 
A duplex collecting system develops when the ureteric duct elongates, the renal unit ascends 
and splitting of the ampullary bud.  If splitting occurs in the early phase of nephrogenesis or 
along the mesonephric duct, two ampullary buds form and a second renal pelvis and ureters 
develop (Lenaghan, 1963). This condition is usually asymptomatic but may present with 
recurrent abdominal pain.  
 
Ectopia  
Two events occur to fuse the end of the ureter to the bladder: the ureteric duct migrates 
caudally along the mesonephric duct to attach to the bladder; and the vesicoureteric orifice 
migrates to its normal position at the trigone. However, if the ureteric duct develops close to 
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the bladder, then the vesicoureteric orifice may extend beyond the trigone laterally and 
caudally. The ectopic ureter is often inserted directly into the bladder wall with subsequent 
loss of the antireflux mechanism that results in vesicoureteric reflux (Pope et al., 1999). In 
severe cases, the ureteric orifice extends beyond the bladder, and the ureter may can attach 
to the genital organs that develop from the mesonephric duct or attach to the urethra 
(Fernbach et al., 1997). 
Ureteric ectopia in males manifests with a single ureteric outflow, however, in females, there 
is a duplex system in about 80% of cases (Pope et al., 1999). As the mesonephric duct provides 
the origin for the ureteric duct, abnormalities of the upper urinary tract can be associated 
with malformations of the genitourinary system such as prune belly syndrome, VATER 
syndrome and trisomy (Dewan et al. 1998).  
 
Pelviureteric Junction Obstruction (PUJO) 
This condition manifests in significant impairment of urinary flow from the renal pelvis to the 
ureter leading to hydronephrosis; it is mainly congenital and occurs in the paediatric 
population. However, this obstruction can also be due to other conditions such as 
inflammatory strictures, kidney stones, postoperative strictures and neoplastic growth 
(Karaca et al., 1997; Lam, Breda & Schulam, 2007).  There is manifestation of agenesis and 
cystic renal dysplasia in the contralateral kidney (Aslam, 2006). An increased risk of PUJ 
obstruction is also present in 15-20% of cases in congenital renal abnormalities (Dewan, 
Penington &  Jeyaseelan, 1998). In paediatric patients, PUJ obstruction is frequently bilateral, 
whereas in adults it is usually unilateral.  PUJ obstruction has also been reported in 16-20% of 
the population with extrinsic compression of this ureteric segment due to an aberrant lower 
pole vessel. Although the majority of PUJ obstruction cases could be due to a physical cause, 
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impairment of urine transport could also be functional as no obstructing lesion is always 
identified. (Ylinen et al. 2004). 
Many studies have shown cellular and ultrastructural with increased interstitial collagen 
concentration. However, this finding may be secondary to the obstructive process (Gosling 
and Dixon 1978).  In addition, reorientation of smooth muscle fibres and folds in the muscle 
or the mucosa layer have been proposed to occur with obstruction (Kaneto et al., 1991; Starr 
et al., 1992). Furthermore, innervation defects of the PUJ during obstruction has been found 
by immunohistochemistry (Harish et al., 2003; Kuvel et al., 2011), along with increased 
transforming growth factor beta 1 (TGF-β1) levels that indicate increased connective tissue 
deposition(Yang et al., 2003). 
 
Ureteric or Para-ureteric Diverticula and ureterocele 
Ureteral diverticula are rare and can be congenital or acquired. They are sites of weakness in 
the ureteric wall and are located near the pelviureteric and vesicoureteric junctions (Rank et 
al. 1960). The acquired type can be secondary to obstruction or prolonged infection (Scarcello 
& Kumar, 1971; Summers, Keitzer & Hathaway, 1972). A ureterocele is a cystic dilatation of 
the distal segment of the ureter as it enters the bladder. This condition is more common in 
females and frequently associated with a duplex system (Rickwood et al., 1992).  
 
Megaureters 
Large ureteric dilatation can be primary or secondary.  Primary megaureters, when there is 
intrinsic smooth muscle defect, is characterised by a ureteric diameter of >7 mm and seen in 
the paediatric patients.  It can be associated with ureteric obstruction or reflux, but many 
individuals have no reflux and non-obstructed ureters (King, 1980).  
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Ureteric Dysplasia 
In ureteric dysplasia, the muscular layer has poorly structured myocytes with poor fibre 
organisation or absent muscle bundles. There is significant interstitial fibrosis with infiltrate 
of plasma cells and lymphocytes. 
Ureteric Stricture 
Ureteral strictures can be congenital or acquired secondary to trauma or inflammation. The 
aetiology of congenital strictures is unclear and could be associated with failure of ureteric 
recanalisation as the ureter is temporarily obliterated during foetal development (Ruano-Gil 
& Tejedo-Mateu, 1975; Cauchi & Chandran, 2005). Also, external compression of the ureter 
by foetal vessels can lead to poor development of the smooth muscles (Allen, 1970). 
Acquired or secondary ureteric strictures can be due to trauma, ureteric inflammation due to 
infections, tuberculosis, radiation ureteric stones, vasculitis, ischemia and amyloidosis and 
endometriosis. Also, endoscopic procedures and pelvic surgery have an incidence rate for this 
complication ranging between 0.5-3% (Kubo et al., 1996; Carl & Stark, 1997; Cholkeri-Singh, 
Narepalem & Miller, 2007). 
Ureteric tumours  
Primary tumours of the ureter such as transitional cell carcinoma, squamous cell carcinoma 
and adenocarcinoma, although rare, usually present with obstruction and stricture of the 
ureter. Also, extra-ureteric tumours may impinge on the ureter and obstruct by infiltration or 
metastatic spread (Chaudhary et al., 2016). 
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Renal Pelvis and Ureteric Infection 
One of the major causes of upper urinary tract infection is infection of the lower urinary tract, 
for example due to urinary tract obstruction and voiding dysfunction.  Catheterisation, 
instrumentation and kidney stones also predispose to urinary tract infections. Escherichia coli 
is the most common pathogen of the urinary tract followed by species of Proteus, 
Enterococcus, Klebsiella, Pseudomonas and Serratia. Struvite stones are caused 
predominantly by Proteus infection (Stamm & Hooton, 1993). Mycobacterial infection of the 
ureter is usually secondary to an infected kidney which may result in the development of a 
ureteric stricture, obstruction and hydronephrosis. Candidal infection is the most commonly 
seen fungal pathogen and usually encountered in immune-compromised patients. Reports 
confirm that Aspergillus and Coccidiosis, may result in ureteral stricture formation (Wise, 
Talluri & Marella, 1999; Modi & Goel, 2007) 
Kidney stones 
Urolithiasis is a common disease that affects a large number of the population worldwide.  It 
causes significant morbidity and in acute presentation, if not managed promptly, may lead to 
sepsis and risk of mortality. Kidney stones can affect all age groups with a prevalence rate of 
4%-7% in women and 5%-12% in men. The rate of stone formation is associated with gender, 
age and geographical location (Romero, Akpinar & Assimos, 2010). It has frequently been 
reported that men have a higher ratio of forming stones in comparison with women. In 
children, kidney stones represent 1% of patients and have an almost 100% risk of urinary 
stone recurrence during their lifetime (Edvardsson et al., 2013).  
Dietary habits and environmental conditions play a significant role in urinary stone formation 
as well as medical conditions such as diabetes mellitus, gout and obesity (Chung, Chen & Lin, 
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2011; Marchini et al., 2013). There are many consequences of kidney stones on the renal 
pelvis and the ureter, including obstruction, ureteric wall injury and stricture formation. 
Management of kidney and ureteric stones is influenced by stone size, location and stone 
composition and renal anatomy can influence the outcome of different treatment modalities 
(Mendez Probst, Denstedt & Razvi, 2009; Srisubat et al., 2009; Straub, Gschwend & Zorn, 
2010). 
 
1.6 Ureteric physiology 
Ureteric behaviour is dynamic and changes according to urine volume produced by the kidney 
and to the flow along its length (Constantinou, 1974). Pacemaker cells in the pelvicalyceal 
system depolarise spontaneously to generate action potentials that can conduct to adjacent 
smooth muscle to initiate contraction and the peristaltic wave to impel the urine bolus along 
the ureter to the bladder. The average number of ureteric contractions per minute in humans 
ranges between two to six contractions per minute (Ross et al. 1967). The urine production 
rate has a positive  impact on the frequency and magnitude of contractions by the ureter. 
When diuresis is significant, the ureter may not have identifiable separate contractions and 
conducts urine in a continuous column of fluid (Boyarsky et al. 1981). 
Ureteric smooth muscle has a broad length-tension relationship. Factors such as obstruction, 
diuresis and vesicoureteric reflux can affect ureteric smooth muscle fibre length and may 
influence the ability of the ureter to generate a propulsive force during peristalsis. The length-
tension relationship is a primary property of skeletal, cardiac and smooth muscle. It expresses 
the relation between the force developed by the muscle when it is stimulated under isometric 
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conditions and the resting length of the muscle at the time of stimulation. Mild degrees of 
dilatation is relatively well tolerated. 
After severe and prolonged dilatation, ureteric function may remain permanently impaired 
even after correction of the causative factor. The ureter can compensate for muscle stretch 
over the peak of its length-tension; (Weiss et al. (1972) describe that stress relaxation in cat 
ureteric smooth muscle is exponential with the significant drop in tension occurring during 
the period immediately after stretch. Stress relaxation was associated with an increase in 
developed force (Weiss et al., 1972).  
In the rabbit model Biancani et al. (1982) describe the effect of obstruction on ureteric 
circumferential force-length relation and show that after two weeks of obstruction; there is 
an increase in ureteric length by 24%, the outer diameter of the ureter by 100%, and the 
cross-section of the muscle region by 248%.  
Also, the obstructed ureters show larger circumferential contractile forces than the control 
ureters. The peak active force of obstructed ureteric segments were approximately twice that 
of the control. The increase in the force generated was associated with a corresponding 
doubling of active circumferential stress (force/unit area) which implies that the force 
increment resulted from an increase in contractility and not a representation of muscle 
hypertrophy due to obstruction and reorientation of the muscle fibres. In this model, the 
ureter is not mechanically decompensated but instead undergoes alterations that increase 
contractility. Despite muscle hypertrophy and increased contractility, there is a decrease in 
the obstructed ureter's ability to generate the intraluminal pressures required for urine 
transport. The increase in ureteric diameter decreases the intraluminal pressure despite an 
increase in contractility following obstruction according to the Laplace relationship (Biancani 
et al., 1982). 
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In the upper urinary tract of many species, including humans and pigs, pacemaker cells – so-
called atypical smooth muscle cells - located near the pelvicalyceal system can initiate ureteric 
peristalsis in the absence of an external stimulus (Lang et al., 2006).  These pacemaker 
spontaneously depolarise to threshold and initiate an action potential (Fig.4).  
 
       
Chapter 1 - Fig 4. Action potentials recorded from proximal and distal renal pelvis of guinea 
pig ureter. (Adapted from Lang et al.1998).  
 
In the ureteropelvic junction of the mouse, c-KIT–positive ICC-like cells have also been 
identified and showed high-frequency spontaneous transient inward currents that can act 
also as pacemaker potentials (Lang & Zoltkowski, et al., 2007). It was hypothesised that in the 
absence of the above pacemaker drive these ICC-like cells could fulfil such a function and 
trigger contractions in adjacent smooth muscle cells in the ureteropelvic junction. Hence both 
atypical smooth muscle cells and ICC-like cells may play a pacemaker role in the initiation and 
propagation of pyeloureteric peristalsis (Richard J Lang et al., 2006) (Lang & Hashitani, et al., 
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2007). Whether such ICC-like cells are also present in larger animals and humans in not 
known. 
The ureteric smooth muscle cell is the functional contractile unit of the ureter; they range 
between 250-400 micrometres (µm) in length and 5-7 µm in diameter. The generation of an 
action potential is the primary event in conduction of an electrical signal along the ureter, 
that in turn initiates a peristaltic wave of contraction. Conduction occurs at a velocity of 2-6 
cm/sec (Ross 1972) and the electrical signal is transmitted from one smooth muscle cell to 
another via gap junctions.  
   
1.7 Contractile activity 
Contractile activity is determined by formation of cross-bridges between actin and myosin 
and is dependent on a transient increase of the intracellular Ca2+ concentration, [Ca2+]i, from 
less than 0.1 µM to 0.1-1.0 µM.  Calmodulin (CaM) is a Ca2+-binding protein which forms a 
Ca2+4-CaM complex to activate myosin light chain kinase (MLCK). MLCK catalyses the 
phosphorylation of the myosin light-chain (MLC) and permits contraction to occur (Yoshimura 
& Yamaguchi, 1997).  Adenosine triphosphate (ATP) provides the energy for this process as it 
undergoes hydrolysis. Relaxation in phasic smooth muscles such as in the ureter is achieved 
by reduction of the [Ca2+]i, as described below.  However, with smooth muscle, including 
ureteric smooth muscle dephosphorylation of MLC can also regulate the rate of relaxation 
through Rho-kinase-mediated and cyclic nucleotide-dependent intracellular pathways. 
 
A rise of [Ca2+]i for contraction comes from two sources: i) influx through L-type Ca2+ channels 
during the action potential (Brading et al., 1983; Hertle & Nawrath, 1989; Floyd et al., 2008) 
 30 
and release from intracellular Ca2+ stores, such as the sarcoplasmic reticulum (Burdyga et al., 
1998; Lang et al., 2002).  An additional source of Ca2+ influx may also be via Na+-Ca2+ exchange 
(Lamont, Burdyga & Wray, 1998).  
Ca2+ is released from the sarcoplasmic reticulum (SR) of smooth muscle cells by an inositol 
1,4,5-trisphosphate (IP3)–induced release mechanism or by Ca2+-induced Ca2+ release (CICR) 
(Somlyo & Somlyo, 1994). In addition to providing a source of Ca2+ for contraction, such an SR 
release can activate Ca2+–sensitive K+ channels to modulate membrane excitability (Imaizumi 
et al., 1989; Carl et al., 1996). Relaxation results from a decrease of [Ca2+]i, in the region of 
the contractile proteins and can result from the uptake of Ca2+ into intracellular stores (Maggi, 
Giuliani & Santicioli, 1994) or extrusion of Ca2+ from the cell through Na+-Ca2+ exchange 
(Burdyga & Magura, 1988). 
 
1.8 The role of the nervous system 
Contraction of ureteric smooth muscle depends on transmitter release from efferent nerves, 
augmented by subsequent impulse conduction between muscle cells.  Ureteric peristalsis can 
also occur without neuronal stimulation via the pacemaker cells; this is seen in cases of renal 
transplantation when the ureter still exhibits peristaltic contractions (O’Conor, 1959). Also 
when denervation of the ureter  occurs (Wharton, 1932), spontaneous activity in isolated in 
vitro segments has been observed (Finberg & Peart 1970) and regular antegrade peristalsis 
following reversal of a segment of the ureter in situ (Melick, et al. 1961). However, the 
literature indicates that the nervous system plays a modulating role in ureteric contractility.   
The ureter is supplied by both noradrenergic-sympathetic and cholinergic-parasympathetic 
nerves (Duarte-Escalante 1969). Adrenergic and cholinergic nerve terminals have been 
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identified using electron microscopy within the adventitia, smooth muscle and submucosa of 
the human ureter (Schulman, 1975). With histochemical techniques, a more extensive 
cholinergic innervation was found at the pelvi-ureteric and vesicoureteric junctions in 
comparison with an adrenergic innervation (Duarte-Escalante 1969). 
 
1.8.1 Sympathetic Nerves 
Adrenergic receptors are present along the length of the ureter with a higher density in the 
intramural region (Weiss, Bassett and Hoffman, 1978; Morita et al., 1994). The response to 
catecholamine release depends on the receptor that is activated; a-adrenergic receptors 
increase function, whilst b-adrenergic receptors reduce function.  
In ureteric smooth muscle, a-adrenergic receptors predominate over b-adrenergic receptors, 
and for both receptor classes, subclasses a1, a2 as well as b1, b2 are found. Noradrenaline 
from sympathetic nerve terminals or adrenaline released from the adrenal medulla activates 
these receptors. Both alpha-adrenoceptor subtypes result in smooth muscle contraction, a1 
by activation of phospholipase C and a2 by inhibition of adenylyl cyclase. In turn, a1-
adrenoceptors predominate in the human ureter and are further subdivided 
pharmacologically into a1A, a1B and alpha-1D-adrenoceptors (Sigala et al., 2005). The 
density of a1-adrenoceptors is highest in the distal ureter as compared to the middle and 
proximal sections,  and a1A, a1D receptors predominate over a1B at all levels.  
The a1-adrenoceptors subtypes mediate their response via G-protein (Gq) coupled pathways, 
through phospholipase C (PLC).  PLC activation results in the production of Inositol 
trisphosphate (IP3) and diacylglycerol (DAG). These second messengers together release Ca2+ 
from intracellular stores and activate both voltage-dependent and voltage-independent Ca2+ 
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channels, as well as mediate activation of protein kinase C and phospholipase A2 and D, with 
arachidonic acid release and cAMP formation, that leads to muscle contraction. a-agonists 
will therefore increase the force of ureteric smooth muscle contraction; phentolamine, an a-
adrenoceptor antagonist, reduces the force of contraction (Weiss, Bassett and Hoffman, 
1978; Morita, Wada, Suzuki, et al., 1987).  
b1- adrenoceptors are predominant in the heart and adipose tissue and display an equal 
affinity for adrenaline and noradrenaline. b2-adrenoceptors are found in vascular, uterine 
and airway smooth muscle and exhibit a higher affinity for noradrenaline than adrenaline. 
b1, b2 & b3-adrenoceptors were found to be expressed in the normal ureter but lower 
expression in the dilated ureter (Shen et al., 2017). The b-adrenoceptors are also coupled to 
G-proteins and subsequent intracellular second messenger systems. The b1-adrenoceptor is 
coupled to adenylyl cyclase via activation of stimulatory G-proteins (Gs). There is also 
evidence to suggest b-adrenoceptors form a link via a stimulatory G-protein to voltage-gated 
Ca2+ channels (Hieble et al., 1995). Propranolol, a nonselective b-antagonist, increases the 
force of contraction by blocking b-adrenoceptors and promoting the stimulant effect of 
noradrenaline at a-receptors (Weiss, Bassett and Hoffman, 1978). Isoprenaline, a b-
adrenoceptor agonist, decreases contractility in the ureter (Morita et al., 1994; Danuser et 
al., 2001). Salbutamol, a b2-adrenoceptor agonist, reduces the amplitude of ureteric 
contractions (Yamamoto 2000).  
β-Adrenoreceptor agonists such as salbutamol is a selective β2-agonist used commonly as a 
treatment for acute exacerbations of asthma. β2-agonist induces smooth muscle relaxation 
and reduces bronchospasm. Salbutamol is also used for tocolysis in premature labour 
(Caughey & Parer, 2001) . 
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There is plausible evidence that the use of β-agonists in renal colic may have a relaxing effect 
on the ureter. Jung et al., (2008) demonstrated the effect of isopreterenol on relaxing the 
ureter during ureteroscopy. 
Cocaine inhibits the neuronal uptake of noradrenaline and therefore potentiates the effect 
of noradrenaline with a resultant increase in the force of contraction through a-
adrenoceptors. b-agonists, such as adrenaline and isoprenaline, also facilitate Ca2+ influx 
through voltage-gated Ca2+channels which may limit their relaxing effect on the smooth 
muscle. 
a-blockers can relax the ureter in the presence of adrenaline, an endogenous ligand of b and 
a receptors; this finding led to an investigation of the role of b-adrenergic receptors in 
ureteric relaxation. Matsumoto et al. demonstrated the transcription of β1, β2 and β3-
adrenoceptors mRNA acid in the human ureter and human ureteric relaxation is mediated by 
both β2 and β3 -adrenoceptor stimulation (Matsumoto et al., 2013). β3-adrenoceptor 
agonists can potentially induce relaxation of the human ureter and they may have a role in 
the management of ureteric stones as medical expulsive therapy. 
 
1.8.2 Parasympathetic Nerves 
Ureteric smooth muscle cells do not exhibit discrete neuromuscular junctions and depend on 
the diffuse release of the neurotransmitter that may activate several cells.. Muscarinic 
receptors and acetylcholinesterase-containing neurons have been identified in the ureter 
(Prieto et al., 1994) . Five muscarinic receptor subtypes (M1 –M5) have been demonstrated 
by immunohistochemistry in the human ureter, but polymerase chain reaction analysis has 
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identified only M2, M3 and M5 receptor subtypes (Sakamoto, Suri and Rajasekaran, 2006c): 
the predominant subtype is M3. 
Thus ureteric contractions occur by activation of M3 receptors via PLC activation and 
generation of IP3 and DAG (Berridge, 1984). As with a1-adrenoceptors IP3 will mobilise Ca2+ 
from the sarcoplasmic reticulum (Streb et al. 1983) and one action of DAG will be to increase 
Ca2+ influx across the cell membrane through a PKC-dependent pathway (Nishizuka et al. 
1984) .An additional presence of muscarinic M1, M2 and M4 receptors in the porcine ureter 
has also been recorded (Londos, Cooper and Rodbell, 1981), but their role is less clear.  
 
Overall muscarinic receptors do have a functional role.  Carbachol, a non-selective muscarinic 
receptor agonist,  has been used with isolated pig ureter (Hernández, García-Sacristán and 
Orensanz, 1995).  Tomiyama et al. (2003) suggested that the contractions induced by 
carbachol in the isolated canine ureter were mediated by the M3 receptor. However, Roshani 
et al. (2003) demonstrated that mid and distal ureteric contractions were not modulated by 
muscarinic receptors in the porcine model. Furthermore, Tomiyama et al. (2004) 
demonstrated that carbachol reduced ureteric pressure and peristalsis in obstructed ureters 
of the anaesthetised dogs.  The contractile response to carbachol thus varies between studies 
and one aim of this thesis it to clarify its action of pig ureter. 
ATP is co-released from sympathetic and parasympathetic fibres and will act via a P2X1 
receptor to cause Ca2+ influx and muscle contraction (Kennedy, 2015). ATP is present on the 
subepithelial sensory nerve fibres and stimulates purinoceptors (P2X and P2Y) in pigs and 
humans; it sends a stimulus to the pain centres located in the brain and initiates local reflexes 
(Burnstock, 2006). 
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Hence, ATP is considered to be a significant NANC component. ATP activates P2X1 receptors; 
ligand-gated cation channels that promote the influx of extracellular Ca2+  into muscle cells. 
The activation of P2Y2 or P2Y4 purinoceptors induces smooth muscle contractions via a 
PLC/IP 3 signalling pathway and causes release of intracellular Ca2+  (Burnstock, 2013). ATP is 
released due to mechanical stretch and also electrical field stimulation. The contribution of 
ATP release from neuronal sources is lower compared to non-neuronal origin. In the guinea 
pig ureter; ATP is  released from the epithelium in a pressure-dependent manner which 
activates P2X 3 purinoceptors on the subepithelial sensory nerves causing pain and 
contraction (Knight et al., 2002). A summary of autonomic responses, and the receptors 
mediating these responses are shown in fig.5. 
 
Chapter 1 - Fig 5. Second messenger systems in the ureter.  
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Ach = Acetylcholine; ATP = adenosine triphosphate; NE = noradrenaline;  
PLC = phospholipase C; IP 3 /DAG = inositol trisphosphate/diacylglycerol;  
cAMP = cyclic adenosine monophosphate; PKA = protein kinase A;  
AC = adenylate cyclase; MLC = myosin light chain; MLCP = myosin light chain phosphate; MLC 
= myosin light chain phosphatase, M2 -, M3 - and -receptors are coupled to G proteins, + = 
activation, – = inhibition. (Adapted from Canda et al. (2007). 
1.9 The effect of the urothelium on ureteric contractility 
Mastrangelo et al. (2003) demonstrated that the urothelium of the rat ureter produced nitric 
oxide (NO) which had an inhibitory effect on ureteric contractility. Furthermore, Mastrangelo 
& Iselin (2007) showed that the urothelium inhibited spontaneous contractions of isolated 
segments of the rat ureter and removal of the urothelium increased the stimulatory effect of 
carbachol, neurokinin A, vasopressin, bradykinin and angiotensin II.  With ureteric segments 
where the urothelium is intact, cyclooxygenase inhibitors increased the stimulatory effects of 
neurokinin A, carbachol, vasopressin, bradykinin, and angiotensin II. Cyclooxygenase 
inhibitors did not exert any effect on the response to these agents in the ureteric segments 
with the urothelium removed. These findings may suggest that the inhibitory effect of the 
urothelium on ureteric contractility may be due to a urothelial cyclooxygenase agent such as 
prostacyclin.  A similar reduction of bladder spontaneous contractions by the mucosa has also 
been recorded, but the mode of action in either tissue is not clear (Hawthorn et al., 2000) . 
1.10 Ureteric pharmacology 
The investigation of ureteric physiology has always been closely related to pharmacology. 
Multiple agents have been used to investigate and manipulate the physiological response of 
the ureter. Ureteric colic had a significant focus due to the its clinical implications and painful 
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symptoms experienced by patients. The aim to develop a targeted therapy for ureteric 
spasms and contractions during colic has been sought since Laird et al. (1997) demonstrated 
that ureteric spasm causes pain. 
The effect of nonsteroidal anti-inflammatory (NSAIDS) drugs has been extensively 
investigated due to their effect on prostaglandin production, which themselves are potent 
stimulators of ureteric smooth muscle contraction. NSAIDs have been successful in inhibiting 
ureteric contractility in many studies (Davidson and Lang, 2000). Both nonselective COX 
inhibitors and selective COX-2 inhibitors have an inhibitory effect on ureteric contractions 
(Chaignat et al., 2008).  In the clinical setting, patients who present with ureteric obstruction 
and inflammation, show up-regulation of  COX-2 activity, and inhibition of COX-2 may relax 
the ureter in these conditions. Drugs such as indomethacin and Celecoxib can inhibit 
prostaglandin release in the ureter, even when COX-2 is upregulated (Davenport et al. 2010).  
These agents have a significant role in ureteric relaxation in obstructed and inflammatory 
conditions, but their clinical use can occasionally be limited due to their effect on renal 
function.  When one kidney is obstructed, there is vasodilatation of the contralateral kidney 
to maintain glomerular filtration to some extent, and is driven by prostacyclin which is 
dependent on COX-2 activity. Blockade of this pathway by NSAIDs may therefore cause 
further deterioration in overall renal function (Hörl, 2010). 
 
Ca2+ channel blockers and  -adrenergic blocking agents have been used in ureteric colic as a 
therapeutic modality, called medical expulsive therapy, to facilitate the passage of ureteric 
stones.  These agents inhibit ureteric contraction and may reduce pain. Ca2+ channel blockers 
nifedipine and verapamil do not inhibit peristalsis but they can prevent ureteric spasm by 
inhibiting fast phasic contractions. Hertle & Nawrath (1984) showed that nifedipine increases 
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stone passage rate from 65% to 87%. Caravati et al. (1989) investigated the effect of 
nifedipine on pain control in patients with renal colic in a double-blind, placebo-controlled 
clinical trial. They evaluated the effect of nifedipine versus placebo in thirty patients but found 
no significant difference. 
 
There is significant evidence that a-antagonists can relax the ureter and aid in the stone 
passage. a-adrenoceptor antagonists, selective or nonselective depending on their affinity 
for a1A and a1D receptors reduce ureteric spasm.  Several randomised placebo-controlled 
trials have investigated the effect of Tamsulosin as a selective a-adrenoceptor blocker in 
comparison to nifedipine. The Tamsulosin group has shown a statistically significant  
(p <0.0001) increase in stone passage rate in comparison with nifedipine (Dellabella et al. 
2005). 
Thus, a-blockers are currently favoured over Ca2+ channel blockers due to their efficacy and 
a low side effect profile. A meta-analysis by Hollingsworth et al. (2006) studied nine 
randomized controlled trials investigating the use of a-blockers and Ca2+ channel blockers. In 
comparison with the control group which are the patients who were not given these 
treatments; patients treated with nifedipine or Tamsulosin had an overall 65% increase in 
stone passage. Yilmaz et al. (2005) studied the difference in efficacy between Tamsulosin, 
Terazosin, and Doxazosin which are all a-blockers and found that they increased stone 
passage rate and all three agents were equally effective.  
The SUSPEND trial which is a large UK clinical trial investigated the effectiveness of medical 
expulsive therapy in adults with ureteric colic in a multicentre, randomised, placebo-
controlled trial.  
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Patients were randomised to tamsulosin 400 μg, nifedipine 30 mg, or placebo. The medication 
was taken daily for up to 4 weeks. The trial concluded that Tamsulosin 400 μg and nifedipine 
30mg are not effective at decreasing the need for further treatment to achieve stone 
clearance in 4 weeks, for patients with expectantly managed ureteric colic (Pickard et al., 
2015). The SUSPEND trial has further supported the concept that medical expulsive therapy 
(MET) is not effective, but other clinical trials and metanalysis have shown favourable 
Hollingsworth et al. ( 2006) & Ye et al.(2018) and unfavourable results for MET , De Coninck 
et al. (2019). Further discussion about MET and the SUSPEND trial in chapter 4- section 4.1.9. 
 
The effect of steroids on stone passage has also been investigated; as corticosteroids have an 
anti-inflammatory action and hence, may reduce the mucosal oedema in the ureter caused 
by an impacted stone and therefore may facilitate stone passage (Barnes, 2006). In a 
randomised clinical trial, 60 patients were randomised to a-blockers plus steroids, or steroids 
alone. However, the study did not show any difference in the overall stone passage rate. 
However, in the steroid group there was a more rapid rate of passage (72 vs 120 hr). Thus, 
Steroids may provide some benefit as expulsive therapy when combined with other 
medications, but not as a single agent (Dellabella, Milanese & Muzzonigro, 2005).  
Many clinical trials investigating the benefit of ablockers have shown evidence they 
contribute to pain control in cases of obstruction and ureteric colic.  Tamsulosin decreased 
discomfort and facilitated stone passage after treatment with shockwave lithotripsy, as well 
as reduced pain and colic in patients who developed persistent stone fragments (steinstrasse) 
after treatment (Gravina et al., 2005; Resim, & Ciftci, 2005). 
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Another category of medication considered for a role in medical expulsive therapy is 
phosphodiesterase (PDE) inhibitors, as they have a significant effect on ureteric contractility 
(Stief et al., 1995). Phosphodiesterase enzymes degrade cAMP and cGMP and blocking this 
process with PDE inhibitors leads to their accumulation, with subsequent smooth muscle 
relaxation. Relaxation occurs by activation of protein kinase A or protein kinase G and 
dephosphorylation of myosin light chain kinase. There are seven isoforms of PDE inhibitors 
and  PDE 4 inhibitor - rolipram has the most significant effect on ureteric relaxation (Becker 
et al., 1998).  Nitric oxide (NO) is an inhibitory neurotransmitter in the ureter and may have a 
role in ureteric relaxation in humans (Stief et al., 1996). In vitro, NO inhibited ureteric 
contractions in rats (Iselin et al., 1997). NO may play a specific role at the ureterovesical 
junction, where it has been proposed that NO has a regulatory role on the anti-reflux 
mechanism of this ureteric segment (Yucel and Baskin, 2003). Multiple agents are being 
investigated to aid in ureteric relaxation; histamine antagonists, 5-HT receptor antagonists, 
Vasoactive intestinal polypeptide, neuropeptides, Calcitonin gene-related peptide, 
Neuropeptide Y, and agents which affect the Rho Kinase pathway (Venkatesh et al., 2005).  
Carbachol has been used in several investigations involving the ureter and it is a synthetic 
choline ester, a positively charged quaternary ammonium compound and a Para-
sympathomimetic; It mimics the effect of acetylcholine on muscarinic and nicotinic receptors. 
Carbachol has also been used to stimulate micturition by contracting the detrusor muscle; 
this drug may cause hypotension, bradycardia, nausea, vomiting, bronchospasm, and 
abdominal cramps. Carbachol induces ureteric contraction during investigation on human, 
pig and sheep ureters in vitro (Hernández, García-Sacristán & Orensanz, 1995; Nyirády, 
Cuckow and Fry, 2008). 
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Atropine is a naturally-occurring alkaloid isolated from the plant Atropa belladonna. Atropine 
functions as a sympathetic competitive antagonist of muscarinic cholinergic receptors. It 
thereby abolishes the effects of parasympathetic stimulation. This agent may induce 
tachycardia, inhibit secretions, and relax smooth muscles. The effect of atropine on ureteric 
contractions has been described as inhibitory in pigs and dogs (Tomiyama et al. 2004; 
Tomiyama et al. 2003). 
 
1.11 The pig urinary tract  
The pig urinary tract provides a good experimental model for the human tract with  much 
resemblance in terms of morphology and physiological function (Sampaio, Pereira-Sampaio 
& Favorito, 1998). 
The adult domestic pig kidney weighs between 98-280 grams with a length of 12-13 cm, 
including the cranial and caudal poles (Sisson, 1975; Sampaio and Mandarim-de-Lacerda, 
1989). One study (Sampaio, Pereira-Sampaio & Favorito, 1998) reported two different 
structure of the pig renal system; the first type is characterised by major cranial and caudal 
pole calyces (40%) and the second is mainly comprised of calyces in the midpart of the kidney 
that drain directly into the renal pelvis (60%).  The human kidney mainly (62%) is formed of 
major superior and inferior calyces (Sampaio and Mandarim-de-Lacerda, 1989). Wolf et al. 
(1996) studied the comparative micro-anatomy of the domestic pig, mini-pig, human ureter 
and other animals including rat, rabbit, dog and sheep. Of interest, the sheep ureter was most 
similar to the human ureter but was 45% smaller. The domestic pig and the mini-pig had a 
similar ureteric cross-sectional thickness of the human ureter but only the domestic pig had 
the same cross sectional area. Overall, to study methods that assist in the expulsion of 
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ureteric stones the domestic pig ureter was  considered most suitable. 
 
1.12 Methods of investigating the ureter  
1.12.1 In Vitro Methods 
Investigation of different animal and human ureteric segments has been useful to develop a 
conceptual and functional understanding of ureteric physiology in general and the effect of 
multiple medications that may manage ureteric conditions. One of the most painful and 
common conditions is ureteric stones, and a significant number of publications have 
investigated the effect of drugs on stone passage. These have been carried out on pig, rabbit, 
sheep, guinea pig, rat and dog tissues; with pig and sheep ureters histologically more similar 
to human ureter (Wolf et al., 1996).  Ureteric segments are placed in a buffered solution 
maintained at 4°C until the time of experimentation, to maintain the tissue function.  During 
experiments segments are suspended in a jacketed organ bath maintained at 37°C and tied 
to an isometric force transducer, whilst irrigated with a buffered physiological solution, 
usually gassed with a 95% O2/5% CO2 mixture. At the outset of the experiment, a resting 
tension is applied to the preparation and allowed for 30-60 minutes. Spontaneous phasic 
contractions represent a healthy, functional preparation. These phasic contractions allow two 
main variables to be measured,  amplitude and frequency of contraction (Lang et al., 2006). 
In addition, drugs added to the superfusate may also generate tonic contractions or 
relaxation. Overall, concentration-response curves to drugs may be compiled by 
measurement of their effects on the above contractile responses.  Useful drug interventions 
include the muscarinic agonist carbachol and the high-K solution to depolarise the muscle 
(Van Mastrigt, 1985). 
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1.12.2 In Vivo Methods 
 
Many studies have investigated ureteric physiology in vivo using animal and humans models 
describing the peristaltic process and the response to physiological and pharmacological 
changes.  Intraluminal methods include intra-ureteric pressure measurement and 
endoluminal ultrasound, but extraluminal ultrasound has been used during laparoscopy 
(Bagley et al. 1994). The contraction amplitude generated by the ureter during in vivo 
investigations is more difficult to record accurately, whereas contraction frequency is easier. 
However, intraluminal methods have numerous limitations: such as antegrade or retrograde 
ureteric may affect the normal physiology of ureteric contractions. (Kondo 1970).  The choice 
between animal species and humans comes at the price of convenience versus accuracy. 
Human tissue is more difficult to acquire, but animal tissue is not always representative of 
human ureteric function.  
Many extra-luminal investigations have been done using dogs and pigs, but these methods 
are quite invasive and require a surgical procedure, either through an open or laparoscopic 
approach. Moreover, extraluminal methods are expensive, more complicated and may not 
always be possible in humans.  Ureteric contractions in vivo have been recorded for a short 
period but functional changes over a significant period were not found (Tillig et al., 2004).  
Moreover, other factors such as anaesthetic medications and analgesia, and the state of 
hydration can affect ureteric contractile activity (Osman et al., 2009).  Overall the in  vitro 
approach is useful to establish fundamental aspects of ureteric physiology and will be 
adopted in this thesis. 
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1.13 Hypothesis, aims and experimental objectives 
The dynamic contractile properties of the ureter allow it to maintain a continuous conduction 
of urine from the kidney to the bladder. The changes exhibited by the ureter to obstruction 
and various perturbations present a complex and poorly-characterised adaptation.  
Several  studies have investigated the compensatory and adaptive behaviour of the kidney 
during ureteric obstruction.  Moreover, the ureter has been characterised in terms of its 
response to several drugs.   However, the response of the ureter to external  stimuli, such as 
the presence of a stone in the lumen, are not well-characterised.  
 
The hypothesis to be tested in this thesis is that:  
The ureter adapts its functional behaviour to obstruction of its lumen.  
 
The aims of this thesis are; 
1. To compare the behaviour of the basal and pharmacologically manipulated ureteric 
contractions of different segments of the ureter.  
2. To describe histological variations of the different segments of the ureter.  
3. To determine the ureteric response to obstruction in an in-vitro model.  
 
The experimental objectives were carried out with an in vitro approach with pig ureter: 
1 Describe the basal contractile activity of different segments of the pig ureter 
2 Characterise the effects of carbachol and high-K solutions of contractile activity 
3 Describe the histological structure of different segments of the pig ureter 
4 Measure the functional activity of different segments of the obstructed pig ureter 
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Chapter 2 
Investigation of the basal spontaneous activity of the pelvicalyceal system, 
renal pelvis, upper, middle and lower ureteric segments in a porcine model. 
 
2.1 Introduction 
The contraction of the ureter along its length and the propagation of peristalsis presents an 
interesting phenomenon.  The initiation and propagation of the peristaltic wave along the 
different ureteric segments has not been sequentially and completely described. The 
continuity of peristaltic propagation poses an essential question; is there a specific role for 
each of the ureteric segments during peristalsis? The ureter has been previously described as 
an organ which contracts as a syncytium (Aragona et al., 1988). If that is true, then each 
segment would behave in a similar fashion to all the other segments regardless of its position 
in the upper urinary tract.  
As mentioned earlier in chapter one of this thesis, the ureter is not merely a tube or conduit 
that simply vermiculates, it rather demonstrates complex and changing behavior. In order to 
understand the degree of ureteric physiological complexity, various inferences can be 
deducted from the relationship between its morphological structure and contractile 
behaviour in ex-vivo, in-vivo or in-vitro studies.  
In order to further understand the dynamics of peristalsis; the aim of this study was to 
evaluate the following objective which is: 
To measure and compare the non-stimulated basal contractile behaviour of the different 
segments of the ureter.  
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2.1.1 Ureteric peristalsis  
As urine flows from the upper urinary tract to the lower segments of the ureter, the peristaltic 
wave goes through different stages that is influenced by ureteric frequency and amplitude of 
contraction. Morita et al. show that the frequency of contraction at the pelvicalyceal system 
(PCS) and the renal pelvis (RP) is greater than that in the upper ureter and there is a subtle 
electric block at the pelviureteric junction (PUJ) (Morita, Ishizuka & Tsuchida, 1981). Urine 
accumulates in the renal pelvis and as the pressure increases in the collecting system, the 
urine is expelled into the upper ureter which is believed to be in a collapsed state (Griffiths & 
Notschaele, 1983). The pressure generated by the ureter propagates the urine to flow 
forwards; the kidney is protected by the PUJ by preventing the back flow of urine. As the rate 
of flow increases, the PUJ dilates and there is a constant flow ratio with 1: 1 between the PCS, 
renal pelvis and the upper ureter.(Constantinou and Hrynczuk, 1976) (Yamaguchi & 
Constantinou, 1989) 
In pelviureteric junction obstruction, the areas of narrowing due to mucosal folds (Takeyama 
& Sakai, 2007) or a valve like structure (Maizels & Stephens, 1980) may hinder this 
propagation and obstruction develops. The PUJ may not be obstructed anatomically, but an 
abnormal peristaltic propagation may occur, leading to functional obstruction as the urine 
flow from the kidney may be greater than the ability of the PUJ to allow the effective passage 
of urine. In this situation, a ureteric catheter can be introduced through the PUJ or during 
ureteroscopic examination of the ureter in patients with signs and symptoms of PUJ 





2.1.2 PUJ obstruction 
There are multiple possible aetiologies for PUJ obstruction but intrinsic obstruction due to 
fibrotic and adynamic stenotic segment of the ureter is the most common aetiology in about 
75% of cases (Woodward & Frank, 2002), that results in failure of peristalsis producing an 
incomplete, functional obstruction. Other causes include crossing vessels (20%), peripelvic 
fibrosis, abnormal ureteric insertion, fibroepithelial polyps and anatomical variants, such as 
retrocaval ureter, horseshoe and duplex kidneys (Hashim and Woodhouse, 2012). 
Alternatively, crossing lower-pole vessel/s cause entrapment of the ureter and hence 
obstruction to urine flow. The abnormal high insertion of the ureter into the renal pelvis may 
alter the configuration of the ureter and impair the drainage of urine. Renal ectopy or 
malrotation of the kidney can be potential causes for intermittent obstruction of urine flow 
(Hindryckx & De Catte, 2011). 
A secondary cause of PUJ obstruction can be due to failed prior surgical intervention for PUJ 
obstruction or an impacted ureteric stone that has caused intrinsic ureteric and or 
periureteric fibrosis and scarring. These abnormalities impair urine drainage and result in 
elevated intrarenal pressure, dilatation of the collecting system, and hydronephrosis (Rogers 
& Hasan, 2013). 
There is evidence confirming smooth muscle apoptosis and defective neural development in 
the pathogenesis of congenital ureteropelvic junction obstruction which may affect peristalsis 
through the PUJ (Kajbafzadeh et al., 2006). Murnaghan (1958) attributes the functional 
obstruction or abnormality to an altered configuration in the layout of the muscle bundles. 
Also, Foote et al. (1970) describes a decrease in the muscle bundles at the PUJ.  
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In an electron microscopy study, Hanna (1978) found a decrease in the muscle fibres in severe 
PUJ obstruction, and also abnormalities in the muscle layout of the renal pelvis and 
disruptions between the intercellular relations at the PUJ.  
The effect of mechanical obstruction caused by a crossing vessel at the PUJ may lead to 
subsequent histological changes and ischemic related fibrosis of smooth muscle as shown in 
the specimens obtained during Pyeloplasty. The stenotic segments demonstrated severely 
impaired contractility in comparison with pre and post stenotic segments. (Portincasa et al. 
2006) 
The Pelviureteric junction provides a reflective example of how a ureteric segment may 
contribute to the overall success of the peristaltic process. If that is the case with one 
segment, then the next question would be; how do other segments contribute to peristalsis 
and the propagation of urine? 
2.1.3   Peristaltic propulsion 
The propagation of the peristaltic wave has been described by many authors and a depiction 
of how the process may occur is described by Griffiths & Notschaele (1983); During normal 
physiological flow, urine accumulates in the renal pelvis; with the rise in the renal pelvic 
pressure, urine is then passed onto the upper ureter which is believed to be in a collapsed 
state and that the urine bolus is propelled through the coaptation of the ureteric wall. A 
ureteric contraction is described to be originating in the most proximal portion of the ureter 
and propels urine forward towards the distal ureter. (Woodburne & Lapides, 1972). 
 
Yin & Fung (1971) & Weinberg (1974) described that the bolus of urine is propelled forward 
by ureteric contraction that creates intraluminal pressure that aids in the propelling process. 
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The resting pressure in the ureter is approximately 0 to 5 cm H2O and the ureteric contractions 
raise the pressure to a level between 20 to 80 cm H2O. The number of ureteric contractions 
per minute ranges from two to six times Kiil F. (1973) Ross et al. (1972).  At the level of the 
Vesicoureteric junction (VUJ), urine enters the bladder and is prevented from retrograde 
reflux back into the ureter. The urine bolus creates enough pressure to traverse the VUJ and 
the force of that contraction dissipates where the ureter joins the bladder.  
During regular flow conditions, the maximum transport capacity of the ureter is more than 
the bolus of urine being conducted from the upper to the lower segments. As the ureter is a 
tubular structure, it can transport a set volume of fluid per unit time.  
Whitaker (1973) in his standard perfusion studies described the flow characteristics in the 
ureter.  At extremely high flow rates, the ureteric walls do not coapt and a fluid column is 
formed to transport the urine rather than regular boluses of urine being propelled. Urinary 
stasis occurs when there is inadequate transport which could be due to high inflow per unit 
time or low outflow per unit time. Ureteric dilatation can be the result of this phenomenon.  
The ureter has the ability to adapt to the different rates of inflow by changing its dimensions 
to accommodate the varying volumes of urine.  
Pathologic conditions can affect this adaptability of the ureter and may result in delayed urine 
transport. Intraluminal obstruction leads to increased intraluminal pressure, the ureter 
compensates by increasing its diameter to partly reduce the intraluminal pressure and 
perhaps to protect the kidney, if this condition persists, it may result in inefficient urine 
transport with potentially deleterious effects on the kidney. (Griffiths & Notschaele, 1983) 
The ureter can also be affected by extraluminal compression or conditions that may increase 
the wall tension as in retroperitoneal fibrosis. The Laplace equation (Boyarsky, S., Tanagho, E. 
A., Zimskind 1971) demonstrates the relationship between the factors that may affect the 
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intraluminal pressure which is related to the wall tension and tubular diameter by the 
relationship: 
 
                            Pressure = tension x wall thickness  
                                                          Radius 
 
Laplace's law shows that as the radius of a vessel increases, the intraluminal pressure declines 
for a given wall tension. In ureteric obstruction, either due to intraluminal or extraluminal 
causes; there is a change in the flow dynamics of urine. In the pre-obstructed segment of the 
ureter; there may be a dilatory adaptation of the ureteric wall causing 
hydroureteronephrosis. The change in the ureteric wall caused by the dilatation and 
obstruction will affect the flow dynamics of the urine and ureteric contractility. As the change 
in the ureteric wall tension may change from one ureteric segment to the next, i.e. from the 
segment above the obstruction to the obstructed segment, there is an expected change in 
flow characteristics. There may be a transient compensatory ureteric contraction (spasm) to 
overcome the obstruction, but then gradual muscle fatigue will ensue. The resultant change 
in the flow of urine and especially in segments with partial obstruction over time may 
gradually affect renal function (Basile, Anderson & Sutton, 2012). Understanding the 
contractile characteristics of the different ureteric segments may provide an insight into 
ureteric adaptability and compensatory mechanisms. 
Lee et al. (1998) demonstrate that the histological composition dilated ureters that occur in 
obstruction and megaureters have different amounts of type I and type III collagen. As the 
peristaltic wave propagates to the VUJ, the bolus of urine under normal flow conditions exerts 
the pressure necessary to overcome the intravesical pressure and the bolus of urine traverses 
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the VUJ into the bladder. (Griffiths & Notschaele, 1983). The mechanism of urine transfer 
across the VUJ involves the creation of pressure and thrust of the urinary bolus to traverse 
the VU junction which does not relax to allow the passage of urine (Weiss & Biancani, 1983).  
During the ejection of the urine bolus into the bladder, the distal ureteric segment moves 
within its sheath in a projectile and retractile fashion, which decreases the resistance to flow 
at the VUJ and facilitates the process of emptying the urinary bolus into the bladder. (Blok et 
al., 1985). During obstruction at the VUJ and raised intravesical pressure or excessively high 
flow rates that exceed the ability of the VUJ to allow efficient fluid transport, there is an 
impediment of the transfer of the urinary bolus into the bladder. In this instant the urinary 
bolus cannot traverse freely into the bladder and there is rise in the pressure exerted by the 
bolus which may exceed the pressure in the contractile wave. The contractile wave usually 
encircles the ureter but during these changes in pressure of the urine bolus, the contractile 
wave loses the ability to occlude the ureter and there is retrograde flow of urine so that only 
a fraction of the bolus of urine passes into the bladder.  
In the event of ureteric lack of contraction or weak contractions, Griffiths & Notschaele (1983) 
demonstrate theoretical evidence that this phenomenon would lead to impaired transport of 
the bolus of urine across the VUJ. Inherent defect in the ureteric contraction may lead to a 
wider, weakly contracting ureter that may become less effective to deliver the urine bolus to 
go across the VUJ which should have low resistance in order to allow urine transport. Tanagho 
(1968) describe that at the VUJ, the resistance to flow may be affected by the forces of muscle 
contractions at the trigone. Other authors attribute this flow resistance to the detrusor 
pressure (van Duyl & Coolsaet, 1982). 
Schick and Tanagho (1973) demonstrate that gravity may aid in the transport of urine through 
the VUJ when the ureter is in the erect position, especially in patients with dilated upper 
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tracts. Also, an interesting notion has been described in patients with wide upper tracts and 
urinary retention, bed rest may be deleterious to renal function (Holden et al., 1984). 
The anatomy and function of the VUJ have been debated for a long time. Three schools of 
thought propose their ideas about the antireflux mechanism at the VUJ. The first theory 
suggests that the VUJ is thought to be governed by an inactive valve mechanism dependent 
on the oblique direction of the terminal ureter as it enters the bladder and the length of the 
intravesical ureter. length (Paquin, 1959; Juskiewenski et al., 1984). The second theory 
proposes that the VUJ possess mixed active and passive valvular action. Also, in addition to 
the anatomical factors, the distal ureter displays antireflux ureteric peristaltic activity so that 
contraction of the ureter can prevent the retrograde passage of urine (Hutch et al. 1961; 
Roshani, et al., 2000; Roshani, Dabhoiwala, et al., 2000). The third theory affirms that the VUJ 
is thought to be acting as a sphincter. Noordzij and Dabhoiwala, (1993) proposed a sphincteric 
function for the VUJ, which could be enhanced by the intrinsic musculature of the trigonal 
region of the bladder, which complements a merely passive antireflux mechanism. 
Multiple studies investigated the flow characteristics through the VUJ using doppler 
ultrasound and delineating the flow wave and characteristics. Considering all the features 
observed in multiple Doppler US studies of the ureteric jet, it is proposed that the human VUJ 
tends to can act as a functional sphincter (Leung & Metreweli et al.,2002). There is a 
monophasic ureteric peristaltic wave demonstrated by M-mode study of the ureter while the 
waveform of the ureteric jet originating from the VUJ demonstrates a more complex pattern. 
As there is an alteration of the flow pattern as the waveform of the ureteric jet is modified, it 
is proposed that an active sphincter mechanism is probably present at the VUJ (Leung & 
Metreweli et al., 2002). As the VUJ shows sphincteric activity, different patterns of the 
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ureteric jet can be identified under various physiological and pathological conditions with 
infrequent modifications (Leung et al., 2007). 
2.1.4 The investigation of peristaltic propulsion 
Ureteric peristalsis has been described in different contexts but the process of peristaltic 
initiation and propagation has not been clearly described in a sequential manner along the 
different parts of the ureter and the upper urinary tract. 
Constantinou (1974) described the initiation of the peristaltic wave from the renal pelvis, 
Hannappel et al. (1982) & Tsuchida et al. (1981) describe the role of the pelvicalyceal system 
in the initiation and propagation of peristalsis. 
As the urine passes from the kidney into the pelvicalyceal system (PCS) and the renal pelvis 
(RP), it has been described as mentioned earlier that the urine accumulates in the upper 
segments and creates pressure and through that pressure it is expelled into the upper ureter. 
This may demonstrate an explanation of the process but it is a passive process of urine 
transport. There is a discrepancy in understanding how the process occurs as the upper 
segments i.e. the PCS and RP are contracting segments and may have an active role in the 
propelling urine through the PUJ. The same concept applies to the rest of the ureter and 
whether other segments along the length of the ureter contributes to the peristaltic wave. In 
the literature, there is no description of how each segment contributes to the peristaltic 
process and how each segment may play a role in the delivery of urine to the next segment. 
The description of the PUJ obstruction or in instances when the PUJ may not be physically 
obstructed but may be functionally obstructed as during surgery or intervention, the PUJ may 
be open but still the urine transport is inadequate. This segmental failure may not be the only 
part of the ureter that is not contracting and leading to urinary stasis but rather a cumulative 
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effect of other parts or the rest of the ureter. The flow of urine through the two junctions at 
each end of the ureter, the PUJ and the VUJ, are interesting phenomena, in trying to 
understand the relationship between flow and pressure. Also, the contractile force created 
by the ureter to deliver the urine bolus through both junctions may reflect an intricate 
interaction between different physiological phenomena. The ureter is not a uniform structure 
as demonstrated earlier in chapter one, it has the ability to coordinate variable degrees of 
pressure and flow along its different segments and in response to different conditions. In this 
chapter, a detailed investigation of the ureter will demonstrate the different functional 
characteristics of each segment and allude to the initiation of the peristaltic wave. 
2.1.5 Hypothesis 
The peristaltic process starts at the pelvicalyceal system and the renal pelvis and continues 
along the length of the ureter to propel the urine bolus into the bladder. We hypothesize that 
there are physiological differences in the contractile properties of each segment that allows 
it to contribute to the peristaltic process. 
 
2.1.6  Aims 
The aim of this study was to investigate the basal spontaneous activity of the different 




2.1.7  Objectives 
To examine the basal spontaneous activity of the upper tract and ureteric segments; the 
Pelvicalyceal system (PCS), Renal pelvis (RP), Upper ureter (UU), Middle ureter (MU) and to 
the Lower ureter (LU) and evaluate the differences and similarities in the contractile behavior 
of each segment in terms of the amplitude and frequency of contraction. 
 
2.2 Methods  
The methods described here refer to the experiments described in Chapters 2-4.  Experiments 
in Chapters 2 and 3 measure spontaneous contractions and the influence of the cholinergic 
receptor agonist carbachol.  Chapter 4 describes experiments in which the influence of an 
artificial obstruction placed in the ureteric lumen affects spontaneous contractile function. 
 
2.2.1 Tissue retrieval 
The pelvicalyceal system, renal pelvis, upper, middle and lower ureteric segments were 
retrieved from the urinary tract of freshly slaughtered female pigs aged between 6 and 8 
months. The urinary tract was collected intact in its entirety. This was to ensure the integrity 
of the tissue and for dissecting the specimens in the lab. 
The abdomen of the animal was dissected open and the intestines were retracted to one side 
and the posterior peritoneum was approached. The kidney and ureter were identified and 
protected. The kidney was dissected free and the renal artery and vein were dissected. The 
ureter was separated from the retroperitoneal attachment and followed down to the bladder. 
The bladder was cut at the urethra and then dissected from its attachments making sure the 
ureter was protected. The specimens, once free were kept in cold, buffered Krebs bicarbonate 
solution for transport in sealed containers on ice. 
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The Krebs buffer included 118.4 mM NaCl, 11.7 mM glucose, 24.9 mM NaHCO3, 4.7 mM KCl, 
1.9 mM CaCl2, 1.15 mM MgSO4 and 1.15 mM KH2PO4.  
 
2.2.2 Tissue preparation 
In the lab, the specimens were gently dissected as per the following protocol.  
The upper urinary tract was divided into five segments; the pelvicalyceal system (PCS), renal 
pelvis (RP), upper ureter (UU), middle ureter (MU) and lower ureter (LU). based on its 
morphological aspects, anatomical location and length. The pelvicalyceal system and the 
renal pelvis were obtained through the dissection of the kidney from the lateral aspect to 
evenly expose the pelvicalyceal system PCS and the RP.  
Segments of the PCS were dissected from the region of the renal calyces, the tissue at this 
level is thin and quite adherent to the underlying renal tissue and it converges towards the 
renal pelvis. At this point, the tissue is separated to make sure the renal pelvis is not part of 
this specimen. The renal pelvis segment is taken from the part of the intrarenal pelvis with a 
cutoff point at the exit from the kidney to avoid taking part of the upper ureter. At this level 
the tissue is thicker, with less visible blood vessels and has a white creamy color and there 
are fine converging lines towards the ureter with a clear demarcation between the PCS and 
the renal pelvis. The upper ureteric segment is taken below the renal pelvis after it converges 
into the UU, to ensure that tissue from the renal pelvis is not incorporated into the UU 
segments, the tissue is transected about a centimeter below the renal pelvis. The caliber of 
the ureter changes along its length with wider renal pelvis, narrower upper ureter and further 
smaller caliber of the middle ureter. The middle ureteric (MU) segments were taken about 
10cm below the upper ureter to make sure that the UU has ended and the MU segment began 
and the caliber delineation of the MU was taken into consideration as it became narrower 
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and with less muscle mass in comparison with the upper ureter. The lower ureteric segments 
were taken one centimeter above the intravesical segment of the ureter above the 
vesicoureteric junction, this is to make sure there is no bladder muscle fibers involved in the 
specimen.  
The dissection method described above for tissue retrieval was applied to ensure consistency 
and practicality of obtaining the specimens, not only considering the length of the ureter but 
also the morphological differences between the segments. All segments were dissected 
gently to preserve the morphological and the physiological integrity of the tissue. The 
segments were then cut into longitudinal strips of tissue ranging between 2.5 to 3 cm to have 
a uniform tissue setup for all segments except for the PCS segments as they were smaller in 
size due to its anatomical and morphological nature and the segment length ranged between 
1 to 1.5 cm – Fig 1. 
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2.2.3 In vitro experiments – measurement of spontaneous activity 
The ureteric segments were mounted in of water-jacketed glass organ baths by attaching the 
lower end of the segment to an anchor at the bottom of the organ bath.  The upper end of 
the preparation was attached via a silk suture that was introduced through the tissue and tied 
to an isometric force transducer.  The segments were perfused with Krebs bicarbonate 
solution (section 2.2.1), maintained at 36±1°C, and gassed with 95% O2 / 5% CO2 to maintain 
adequate oxygenation and maintain pH at 7.40±0.05.  Segments were equilibrated under a 
resting tension of 1.5–2.0 g for 60 min. Tension was monitored via isometric force transducers 
(Pioden Controls Ltd, UK) and a Powerlab data acquisition system using LabChart software 
(ADInstruments, UK). The Krebs solution was changed every 15 to 20 minutes during an 
Chapter 2 - Fig 1 - Pig urinary tract. 
The ureteric segments are dissected and the 
anterior bladder wall is partly exposed.  








Segment between upper 
and middle ureter –  
not used in experiment 
Segment between middle 
and lower ureter -   
Not used in the experiment. 
PCS  location– Not dissected 
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equilibration period and separately warmed before addition to avoid fluctuations of 
temperature.  
When contractile activity was consistent for basal spontaneous activity was recorded without 
any addition to the superfusate.  The frequency and amplitude of contractions were recorded 
for subsequent analysis without any additions to the superfusate.  Spontaneous activity of all 
the segments, i.e. the pelvicalyceal system (PCS), renal pelvis (RP), upper ureter (UU), middle 
ureter (MU) and lower ureter (LU) were recorded for 60 to 90 minutes.  
Subsequently, Interventions with carbachol when required were by addition to the 
superfusate from an aqueous 10mM stock solution to achieve the required final 
concentration (10 µM).  The concentration was chosen from the literature as that which 
achieved a maximum effect but allowed recovery of contractile changes on its removal 
(Nyirády, Cuckow and Fry, 2008).  
 
2.2.4 In vitro experiments – measurements with artificial obstruction 
An artificial obstruction, to mimic a ureteric stone, was introduced into ureteric segments as 
a rounded ball of aluminium foil. The obstruction was uniformly, 6 mm diameter that would 
prevent irritation of the mucosa.  The size was chosen to fit comfortably into the lumen and 
obstruct it without causing excessive dilation.  The size was also guided by a literature review 
of stone sizes that had a 25% to 50% possibility of spontaneous passage in humans 
(Hollingsworth et al., 2006).  The similarity of human and pig ureteric dimensions was another 
factor that made this choice of animal model particularly suitable.  The preparation was 
mounted in the organ bath a little differently to allow potentially passage of the obstruction.  
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In his case the lower end of the ureteric segment was attached at one side to the anchoring 
needle to allow the lumen to remain patent. 
With these experiments, the ureter was divided from the kidney below the level of the renal 
pelvis based on the morphology and its anatomical location where the funnel-shaped renal 
pelvis converged to form the upper ureter. This dissection ensured that the specimen is a 
segment of the upper ureter and did not incorporate any part of the renal pelvis. Upper and 
lower segments (3cm) taken just distal to the renal pelvis and proximal to the VUJ were used. 
This dissection method described ensured consistency and practicality of obtaining 
specimens. All segments were dissected gently to preserve the morphological and the 
physiological integrity of the tissue. 
 
The stone was introduced into the ureteric segment, after control recordings had been made, 
at the top end using surgical forceps. Maximum care was taken when introducing the stone 
to prevent ureteric irritation or an effect on contractility. After a 15-30 minute period of 
recovery recordings were re-commenced, In control experiments, obstructions into the 
ureteric segments were not made but forceps was inserted at the top end to resemble the 
artificial procedure.  In no cases was contractile function altered by this control procedure 
after the recovery period. 
 
There is a possibility that aluminium salts that leach from the surface of the artificial 
obstruction might affect ureteric spontaneous contractions.  Evidence from intestinal and 
gastric smooth muscle showed Al3+ affected that muscle motility but at high (millimolar) 
concentrations that would not have occurred by leaching from the surface of an aluminium 
foil ball (Nasu & Suzuki, 1998).  
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2.2.5 Data presentation and analysis 
 
The amplitude of contractions was measured as the force generated by the tissue in grams, 
and the frequency of contraction was measured as the number of contractile events per 5 
minutes.  
Group data are presented as mean values ± SEM, and n refers to the number of preparations 
from which data were gathered. 
Differences between data sets was tested by ANOVA with Tukey post hoc tests.  The null 
hypothesis was rejected at p<0.05. 
 
2.3 Results  
 
Multiple specimens from each segment were investigated as shown in table 1. The 
pelvicalyceal system, renal pelvis and the upper ureter have demonstrated basal spontaneous 
activity in 100% of the specimens. The middle and lower ureteric segments demonstrated 
spontaneous activity in 67% and 65% respectively. 
Also, in order to ascertain the average length of the pig ureter, the ureteric length was 
measured in 8 pigs, and the measurement of the mean length have been consistent with an 






Segment  Number  of segments Spontaneous activity  
Pelvicalyceal system  32 100% 
Renal Pelvis  26 100% 
Upper ureter  38 100% 
Middle ureter  18 67% 
Lower ureter 26 65% 
Chapter 2 - Table 1 - The number of ureteric segments of each type investigated and the 
percentage of basal spontaneous activity that each segment demonstrated.  
 
Segment  Amplitude  
g/mg tissue 
Frequency 
Pelvicalyceal system  0.0046±0.0009 38.9±2.71 (p<0.001) 
Renal Pelvis  0.0182±0.0046 35.9±2.51 (p<0.001) 
Upper ureter  0.0065±0.0012 21.3±1.56 (p<0.001) 
Middle ureter  0.0147±0.0015 5.3±0.71 
Lower ureter 0.0262±0.0021 (p<0.001) 5.5±0.63 
Chapter 2 - Table 2 - The amplitude and frequency of contraction of each segment. The 
amplitude of contraction  presented as gram per milligram of tissue and frequency is 




Chapter 2 – Figure 2. 
Fig.2 (a) - Bar chart demonstrating the amplitude of contraction of all the ureteric segments. 
The amplitude of contraction is represented in grams per milligrams of tissue. The stars sign 
(***) above the chart indicates a statistically significant result (P<0.001). The renal pelvis and 
the lower ureter both show a significantly higher amplitude of contraction.  
Fig.2 (b) - Bar chart demonstrating the frequency of contraction of all the ureteric segments. 
The frequency of contraction is represented as the number of events in 5 minutes. The stars 
sign (***) above the chart indicates a statistically significant result (P<0.001). The 
pelvicalyceal system and the renal pelvis show a significantly higher frequency of contraction 
than the upper, middle and lower ureteric segments. The upper ureter demonstrates higher 
























Chapter 2 - Fig 3   -   The difference between the contractile pattern of all the segments of 
the upper urinary tract.  
Fig 3a- pelvicalyceal system, Fig3b-renal pelvis, Fig3c-upper ureter, Fig3d- middle ureter 
and Fig3e- lower ureter. 
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The Pelvicalyceal system - PCS 
All the segments from the pelvicalyceal system demonstrated basal spontaneous activity. This 
segment had the lowest amplitude (0.0046±0.0009) of contraction but significantly (p<0.001) 
higher frequency (38.9±2.71) than the upper, middle and lower ureteric segments.  Fig (2) 
The Renal Pelvis - RP 
The renal pelvis also demonstrated basal spontaneous activity in all segments, with 
significantly (p<0.001) higher amplitude (0.0182±0.0046) of contraction than the pelvicalyceal 
system (0.0046±0.0009), upper (0.0065±0.0012) and middle (0.0147±0.0015) ureteric 
segments but lower than (0.0262±0.0021- p<0.001) the lower ureteric segment . It also 
demonstrated lower contractile frequency (35.9±2.51) than the segments of the pelvicalyceal 
system but significantly(p<0.001) higher contractile frequency than the upper, middle and 
lower ureteric segments – table 2. 
The upper ureter - UU 
The amplitude of the spontaneous activity in the UU segments (0.0065±0.0012) was 
lower than the renal pelvis, middle and lower ureteric segments – table 2. The contractile 
amplitude in the upper ureter was slightly higher than the pelvicalyceal system. The frequency 
(21.3±1.56) of contraction in the upper ureter was lower than the pelvicalyceal system and 
the renal pelvis but significantly higher (p<0.001) than the Middle (5.3±0.71) and lower 
(5.5±0.63) ureteric segments.  
The Middle ureter - MU 
The middle ureteric segments demonstrated basal spontaneous activity in 12/18 strips (67%). 
The amplitude (0.0147±0.0015) of contraction in the middle ureter was higher than the upper 
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ureter (0.0065±0.0012) and the pelvicalyceal system (0.0046±0.0009) but lower than the 
renal pelvis and the lower ureteric segments – table 2.  
The frequency (5.28±0.71) of contraction in the middle ureter was significantly (p<0.001) 
lower than the pelvicalyceal system, renal pelvis and the upper ureteric segments but 
comparable to the segments from the lower ureter.  
The Lower ureter - LU 
In the lower ureteric segments, 17/26 (65%) of the strips demonstrated basal spontaneous 
activity. The lower ureteric segment had significantly (p<0.001) higher amplitude 
(0.0262±0.0021) than the pelvicalyceal system, renal pelvis, upper and middle ureter but 
lower frequency (5.5±0.63) than the pelvicalyceal system (38.9±2.71 (p<0.001), the renal 
pelvis and the upper ureteric segments. The lower ureter contractile frequency was 
comparable with the segments from the middle ureter (5.3±0.71) - table  2.   
 
2.4  Discussion 
Spontaneous ureteric contractions play an important role in the propulsion of urine from the 
kidney to the bladder and is dependent on the pacemaker activity that has been reported to 
originate from the proximal renal pelvis, upper, middle and lower part of the human ureter 
(Metzger et al. 2004). In pathological conditions such as the passage of kidney stones through 
the ureter, spontaneous activity plays an active role in the expulsion of ureteric stones (Nuss 
et al. 2005). Also, in the case of ureteric denervation after kidney transplantation, 
spontaneous contractions maintain ureteric peristalsis and the propulsion of urine (P 
Santicioli & Maggi, 1998). 
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In our current investigation of the spontaneous activity in the pelvicalyceal system, renal 
pelvis, upper, middle and lower ureteric segments; the porcine upper urinary tract 
demonstrated spontaneous activity in all the segments.  
This study shows a progression of frequency and force characteristics which transition along 
the length of the upper urinary tract i.e. from the pelvicalyceal system to the lower ureter. 
The rhythmic pattern of contraction in the pelvicalyceal system with high frequency 
demonstrates the possibility of this segment initiating the peristaltic wave. This pyelo-ureteric 
autorythmicity has been demonstrated by (Lang et al. 2006; Gosling & Dixon 1978). The 
accumulation of urine in the renal pelvis along with receiving the peristaltic wave from the 
pelvicalyceal system can explain the higher amplitude of contraction in this segment in 
comparison with the upper ureter; the renal pelvis contracts with higher amplitude in order 
to overcome the pelviureteric junction and propel the urine forward to the upper ureter, this 
finding and interpretation was also described by Morita et al. (1981). 
The amplitude of contraction gradually increases from the upper ureteric segment to the 
middle and then the lower ureter; this increase in contractile amplitude of the smooth 
muscles can be due to an intrinsic property of the lower ureteric segment. Our study has 
shown that the pelvicalyceal system had significantly higher frequency of contraction in 
comparison with the other segments. The frequency of contraction gradually decreases from 
the pelvicalyceal system onwards. The renal pelvis and the upper ureter demonstrated 
significantly higher frequency of contraction in comparison with the middle and lower 
ureteric segments. Fig (2) demonstrates the amplitude and frequency of contractions in all 
segments, and it is possible to comment on the inverse relationship between both the 
frequency and amplitude of contraction. As the frequency increases in a segment, the 
amplitude decreases, this is observed in all segments except the renal pelvis. The segments 
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that have demonstrated higher frequency like the pelvicalyceal system, renal pelvis and upper 
ureter, do not need to have a high amplitude as the urine volume is not large and frequency 
seem to be of higher importance to continue the propelling action and also to transmit the 
electrical impulse to the rest of the ureter in order to maintain the peristaltic wave. There is 
a gradual decrease in ureteric diameter from the upper to the lower segments and as the  
urine bolus traverses the ureter; although the volume of urine could be constant, the 
decrease in diameter may cause the lower segments  may require a higher amplitude to 
propel the bolus of urine forward towards the bladder.  
The renal pelvis seems to play a pivotal role in the conduction of the peristaltic wave and in 
the mechanics of moving the urine bolus through the pelviureteric junction and subsequently 
along the ureter. It is the only segment that demonstrated high frequency and amplitude of 
contraction. The significance of this finding has been discussed earlier in light of the findings 
by Morita et al. (1981) 
The contractile behavior of the ureteric segments seems to be demonstrating a pattern of 
contraction based on amplitude and frequency; this contractile pattern seems to be 
coordinated along all segments as the urine bolus traverses from the kidney to the bladder. 
Perhaps through these behavioral patterns, an analysis of the individual role of each segment 
can be proposed. The pelvicalyceal system seems to have the highest frequency but with low 
amplitude, the role of this segment can be the transfer of small volumes of urine from the 
calyces and to initiate peristalsis. The upper ureter receives the urine bolus from the renal 
pelvis after passage through the pelviureteric junction; this segment has high frequency of 
contraction comparable with the renal pelvis but a much lower amplitude. As the urine bolus 
has passed through the PUJ, there is no need for high amplitude muscle contraction and only 
the peristaltic action potential is required to pass on to the lower segments. The upper ureter 
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seems to have a more significant function in conducting the action potential of contraction 
and just augmenting the bolus of urine to pass forward into the middle ureter. The middle 
ureteric segment has low frequency and high amplitude of contraction; this is also true for 
the lower ureter. As urine passes through these segments, there is a gradual increase in the 
amplitude of contraction as the volume of urine may exert pressure on the ureteric wall. The 
middle ureter seems to add an augmentation to the amplitude of contraction to the lower 
ureter along with simply traversing the urine bolus. The lower ureteric segment interestingly 
has the highest amplitude of contraction yet with a low frequency. As described for the renal 
pelvis and the PUJ, the lower ureter has to also contract against a physiological junction; the 
vesicoureteric junction. Both the bolus of urine and the contractile wave generated in the 
upper segments and then the middle ureter, seem to conglomerate in creating this significant 
contraction.  
The difference in the contractile behaviour of the pelvicalyceal system, renal pelvis, upper, 
middle and lower ureter may indicate that each segment plays a different role in mediating 
the peristaltic wave. Understanding the difference in the basal contractile behaviour of the 
upper urinary tract may provide insight into the development of a targeted approach in the 
management of ureteric conditions.  
To further elucidate the relationship between the amplitude and frequency of contraction 
measured as the contractile effort (amplitude*frequency). There seems to be a constant 
relationship between the effort exerted by the ureter  and the contractile behaviour of each 
segment and the effort required to propel the bolus of urine. The PCS, UU, MU and LU 
segments demonstrated a balanced of contractile effort at each of those segments that are 
consistent with the flow dynamics of urine through each segment and the frequency and 
amplitude demonstrated above. The RP is the segment with the highest contractile effort that 
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further demonstrates the importance of the renal pelvis as the ureteric segment that may be 
playing a significant role in ureteric peristalsis and conditions like PUJ obstruction and renal 
pelvis obstructing stones should be carefully addressed. 
 




0.0046 38.9 0.17894 
Renal Pelvis  0.0182 35.9 0.65338 
Upper 
ureter  
0.0065 21.3 0.13845 
Middle 
ureter  
0.0147 5.3 0.07791 
Lower 
ureter 
0.0262 5.5 0.1441 
                                  Chapter 2 – Table 3: Contractile effort of all segments. 
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Contractile effort of all the segments
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Chapter 3 
The effect of cholinergic receptor modulators on upper, middle and lower 
ureteric segments. 
3.1 Introduction: 
Electron microscopy has demonstrated that adrenergic and cholinergic nerve terminals are in 
close proximity in the human ureter (Schulman, 1975). Ganglion cells in the ureter were 
described by Langley et al. as early as 1894. The two divisions of the autonomic nervous 
system, sympathetic and parasympathetic, play an active role in modulation of ureteric 
activity by affecting the frequency and amplitude of peristalsis and hence the volume of urine 
transported (Morita, Wada, Suzuki, et al., 1987). The upper ureteric segment receives 
sympathetic innervation from spinal cord segments T10-12 and parasympathetic innervation 
from the dorsal efferent nucleus of the vagus nerve (Langley & Anderson 1896; Mitchell 1935; 
Kuntz et al. 1957). The sympathetic innervation of the lower segment of the ureter is from 
the L1,2, and the parasympathetic component from S2,3 (Langley and Anderson, 1894; 
Swenson et al., 1952).  
Cholinergic agonists stimulate ureteric contractions in vitro in numerous animal preparations 
including cats, horses, dogs and pigs (Deane, 1967; Yano et al., 1984; Theobald, 1986; Prieto 
et al., 1994).  Moreover, effects have also been shown in vivo in anaesthetised animals (Rose 
and Gillenwater, 1974; Theobald, 1986; Latifpour et al., 1989; Prieto et al., 1994).  α-
adrenoceptors modulate ureteric contractions and relaxation is mediated by β-adrenoceptors 
(Deane, 1967). The effect of α-adrenoceptors has been widely studied in the ureter with 
emphasis on the role of α-adrenoceptor blockers in management of ureteric stones. However, 
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the role of cholinergic receptors modulators requires further investigation, especially their 
role in modulating ureteric contraction and their potential role in the management of ureteric 
stones.  
The density of muscarinic receptors and cholinergic nerves varies along the ureter;  smaller 
in the proximal ureteric segments and denser in the lower and intravesical segment of the 
ureter (Del Tacca, 1978; Hernández, García-Sacristán & Orensanz, 1995).  Conventional 
neuromuscular junctions are absent on ureteric smooth muscle, hence activation depends on 
a diffuse release of a neurotransmitter from nerves and subsequent spread of electrical 
activity by conduction between ureteric myocytes (Uehara & Burnstock, 1970). Moreover, 
the ureter has the ability to spontaneously contract and exhibit peristalsis even if it has been 
denervated; demonstrated by in vitro experiments and in humans after kidney 
transplantation (O’Conor, Dawson-Edwards 1959). 
 
Five muscarinic receptor subtypes (M1–M5) have been demonstrated in the human ureter 
with immunohistochemistry studies; however, RT-PCR analysis identified only M2, M3- and 
M5-receptor subtypes (Sakamoto, Suri & Rajasekaran, 2006c). Acetylcholine is a cholinergic 
agonist and functions both as a neurotransmitter at preganglionic parasympathetic 
neuroeffector junctions (nicotinic sites) and postganglionic parasympathetic neuroeffector 
junctions (muscarinic sites). The presence of M2 receptors in the porcine intravesical ureter 
and M1, M3 and/or M4 subtypes seems to be responsible for the cholinergic innervation of 
the ureter in the porcine model. Stimulation of muscarinic receptors by carbachol produces 
contraction of the pig isolated intravesical ureter.   
Hernandez et al. demonstrated that both M1 and M3 muscarinic receptor subtypes mediate 
the increases in the basal tone. At the same time, M2-receptors are involved in the increase 
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in the frequency of phasic contractions in the isolated porcine intravesical ureter in response 
to cholinoceptor agonists. (Hernández et al., 1993; Hernández, García-Sacristán & Orensanz, 
1995). However, Roshani et al 2003 showed that smooth muscle activity in the mid and the 
distal pig ureter was not modulated by muscarinic receptors (Roshani et al., 2003).  However, 
in the latter study insertion of the ureteric catheter, as part of the experimental procedure, 
caused reduction of peristalsis, as subsequently described elsewhere (Venkatesh et al., 2005).  
Thus, although the influence of the parasympathetic nervous system to modulate ureteric 
contractility has been described the effect on different ureteric segments is less clear, 
although the different density of innervation along the ureter may suggest regional variation 
(Paolo Santicioli & Maggi, 1998).  
3.2 Hypothesis 
Cholinergic receptor activation has varying effects on different segments of the ureter. 
Aim: To investigate the effect of carbachol, a muscarinic and nicotinic receptor agonist and 
atropine, a muscarinic receptor antagonist on the contractile activity of different segments of 
the pig ureter.  
Objectives:  In vitro experiments with pig ureter measured the amplitude and frequency of 
spontaneous contractions in the upper, middle and lower segments of the pig ureter. 
3.3 Methods:  
The methods for this chapter are explained in chapter 2.  
 
3.4 Results: 
The ureteric specimens were collected from different pigs and each ureteric segment was 
investigated in a separate experimental setup.  
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All the upper ureteric segments (n=23), demonstrated basal spontaneous activity (BSA) 
(100%). The middle (n=24) and lower ureteric segments (n=24) demonstrated lower 
percentage of spontaneous activity; (n=13) 54.2% and (n=17) 70.8% respectively. For the 
experiments comparing basal and carbachol stimulated spontaneous activity; (n=16) UU 
segments, (n=13) MU segments and (n=17) LU segments were investigated. 
The amplitude of BSA in the lower ureter (0.02±0.004 g tension/mg tissue) was significantly 
(P<0.001) higher than the middle (0.013±0.002 g tension/mg tissue) and the upper ureteric 
segments (0.009±0.002 g tension/mg tissue). However, the frequency of BSA was significantly 
(p<0.001) higher in the upper ureter (26.38±2.77 events in 5min) versus the middle 
(4.92±0.92 events in 5 min) and lower ureteric segments (4.18±0.94 events in 5min). 
The basal amplitude in the UU was the lowest in comparison with the MU and LU segments. 
The frequency of basal contractions in the UU segments were higher than the MU and LU 
segments. The MU and LU segments basal contractile frequency were comparable.  
MU basal amplitude was not significantly different from UU segments (0.013±0.002 g/mg) 
but the frequency was significantly lower (4.92±0.92 per 5-min).  LU basal amplitude was 
significantly greater than in the other two segments (0.02±0.004 g/mg) with a frequency 
similar to that in MU segments (4.18±0.94 per 5-min).  Thus, all three segments showed 
different amplitude and frequency characteristics of spontaneous contraction. 
In the Carbachol stimulated segments; the drug had no impact on the amplitude and 
frequency of contraction in the UU segments. In the MU segments; Carbachol significantly 
increased the amplitude and frequency of contraction. The LU segments have also shown a 





Effect of carbachol on the upper ureter.  Carbachol (10 µM) had no effect on the amplitude or 

















Chapter 3 – Fig .1. The effect of carbachol on upper ureter (UU) spontaneous contractions.  A: 
contration amplitude.  B: contraction frequency.  Data mean±SEM (n=16). 
 
Effect of carbachol on the middle ureter.  Carbachol (10 µM) significantly increased both the 
amplitude and frequency of spontaneous activity in middle ureteric segments (Fig 2).   














































Chapter 3 - Fig 2. The effect of carbachol on middle ureter (MU) spontaneous contractions.  A: 
contraction amplitude. B: contraction frequency. Data mean±SEM (n=13),**p<0.01, 
***p<0.001 
 
Effect of carbachol on the lower ureter.  Carbachol (10 µM) significantly increased both the 
amplitude and frequency of spontaneous activity in lower ureteric segments (Fig.3). 
Proportionately the effect on frequency was particularly great, more so than on the middle 
ureter.   














































Chapter 3 - Fig 3 The effect of carbachol on lower ureter (LU) spontaneous contractions.  A: 
contraction amplitude.  B: contraction frequency.  Data mean±SEM (n=17), ***p<0.001 
 
Atropine 1μM had no effect on the amplitude and frequency of contraction on the upper 
ureteric (n=12), middle (n=13), and lower ureteric segments (n=14). 
A summary of the data is shown in Fig. 4 for amplitude (part A) and frequency (part B).  The 
data shows basal activity values and any action of carbachol.  Shown is the variation of 
amplitude in the three segments of the ureter, as well as  augmentation of amplitude by 
carbachol in middle and lower ureter segments. 











































Chapter 3 – Fig 4.  Summary of amplitude data in the upper, middle and lower ureteric 
segments.  The effects of 10 µM carbachol and 1μM atropine added separately are shown.  
Mean±SEM (see Figs 1-3 for n-values); **p<0.01; ***p<0.001 
 
Fig. 5 shows similar data for frequency, variation of the basal frequency and augmentation of 











































































Chapter 3 - Fig 5.  Summary of frequency data in the upper, middle and lower ureteric 
segments.  The effects of 10 µM carbachol and 1μM atropine added separately are shown.  
Mean±SEM (see Figs 1-3 for n-values); ***p<0.001 
 
3.5  Discussion: 
This study demonstrated a difference between the basal and carbachol-dependent 
contractile behaviour of the upper, middle and lower segments of the pig ureter.  The 
frequency of basal spontaneous activity was significantly higher in the upper ureter compared 
to the middle and lower ureteric segments. In contrast, the amplitude of basal activity was 
significantly higher in the lower segment compared to the upper and middle ureter.   
 
These data corroborate a previous study whereby carbachol generated contractions if 






























































(Hernández et al., 1995).  The abolition of carbachol-mediated responses by atropine 
indicates that it acts on muscarinic receptors.  Tomiyama et al. (2003) demonstrated that 
carbachol altered ureteric contraction by increasing the contractile frequency in isolated 
canine ureter, possibly mediated by the M3 receptor. Morita et al. (1987) showed in dog 
ureter that atropine alone had no significant effect on contractile function, indicating little 
basal acetylcholine release. However, a study in anesthetised dogs study (Tomiyama et al., 
2004) showed cholinergic receptor stimulation by carbachol had a suppressive effect on 
ureteric pressure and peristalsis in obstructed ureters.  
 
The nature of the muscarinic receptor subtype is of interest and all five (M1-M5) have been 
demonstrated in ureter (Sakamoto, Suri & Rajasekaran, 2006).  Detrusor smooth muscle 
contains M2 and M3 receptors, with M3 as the functionally relevant subtype (Uchiyama & 
Chess-Williams, 2004), whereas M1 receptors are largely found on nerves. The M4 receptor 
is primarily found in the CNS (Weiner, Levey & Brann, 1990)], its distribution largely 
overlapping with that of M1 and M3 subtypes. M4 receptors are inhibitory auto-receptors for 
acetylcholine (activation will inhibit acetylcholine release) and this has been observed in 
human detrusor. The role of the M5 receptor is unclear.  A further study is therefore required 
to determine the effect of different muscarinic receptor subtype inhibitors to shed light on 
the prominent subtype that regulates ureteric contraction. 
 
This study has shown a complex relationship between contractile frequency and amplitude in 
modulating ureteric contractile function. As carbachol had no discernible effect on upper 
ureteric segments, but both agents affected the frequency and amplitude of the middle and 
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lower ureteric contractility this implies that parasympathetic modulation of activity is 
primarily in the middle and distal regions of the ureter.   
 
A comparison of the contractile properties of the upper, middle and lower segments of the 
pig ureter is novel. This suggests that cholinergic modulation does not primarily modulate 
initiation of contractile activity but modulates downstream peristalsis. Whether such a 
differentiation of action in the human ureter is present would be interesting to evaluate.  A 






The effect of obstruction on ureteric contractility; comparison between the 
upper and lower ureteric segments. 
 
4.1 Introduction 
Ureteric obstruction can have a deleterious effect on the kidney and may present in various 
ways.  The notion of obstruction implies that there is a discrepancy or imbalance between 
urine production and drainage from the kidney to the bladder. Ureteric pathology or 
obstruction can affect both the paediatric and adult age groups. The degree of renal injury 
depends on the severity of obstruction, baseline renal function, whether the obstruction is 
acute or chronic and the presence of other mitigating factors such as urinary tract infection 
or anatomical abnormalities of the urinary tract. The impact of obstruction on renal function 
can be significant with resultant physiologic and histologic changes that may result in 
permanent renal damage. 
4.1.1 Clinical presentation of ureteric obstruction 
The acute presentation of renal colic usually occurs with the passage of a kidney stone. The 
classic symptoms are flank pain accompanied by nausea and vomiting due to distension of 
renal pelvis and visceral response. The pain radiates to the lower abdomen, testicles, or labia. 
In cases of chronic obstruction, the patient is relatively asymptomatic or complains of 
occasional discomfort. The obstruction to urinary flow can occur anywhere along the urinary 
tract, which can be from the kidney to the urethral meatus. The upper urinary tract, which is 
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the kidney and the ureter and the lower urinary tract which is the bladder and urethra up to 
the level of the urethral meatus. This division allows for the delineation and description of 
the aetiology and impact of obstruction. In the upper urinary tract, three specific regions are 
more prone to obstruction; these include the pelviureteric junction, the crossing of the ureter 
over the area of the common iliac vessels- the pelvic brim and the ureterovesical junction. 
The area of ureteric narrowing at the pelvic brim is unique due to two reasons; which is the 
extrinsic compression by the iliac vessels and the anterior angulation of the ureter as it crosses 
the vessels to enter the pelvis. There is no actual intrinsic change in the ureteric calibre in this 
part of the ureter (Wein et al., 2016).  
 
Obstruction can either be due to intrinsic or extrinsic aetiologies which can induce 
compressive or restrictive forces on the urinary tract. Calculi, blood clots, sloughed papilla 
and tumours can cause intraluminal obstruction. The acute onset of intraluminal obstruction 
may lead to renal colic with flank pain, haematuria, nausea, vomiting, and fever. Another 
cause of intraluminal obstruction which can affect the renal function over time is ureteric 
strictures which can be caused by stone disease, malignancy, or iatrogenic causes such as 
ureteroscopy. Ureteric strictures tend to develop over a period and may cause a chronic 
obstruction which may ultimately lead to renal atrophy. In females, the distal ureter crosses 
the posterior aspect of the pelvic blood vessels and the broad ligament. The ureters can 
become externally compressed by pelvic tumours such as advanced gynaecologic 
malignancies. Also in women, prolapse of the pelvic structures such as the uterus can lead to 
urinary outflow obstruction. In pregnancy, the gravid uterus can lead to ureteric obstruction. 
(Carey et al., 1989) In males, benign prostatic enlargement and urethral strictures can affect 
the urine flow and can cause urinary outflow obstruction (Lepor, 2004). 
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There are other less common causes of ureteric obstruction such as inhibition of ureteric 
peristalsis, or an aberrant lower pole crossing artery that is oriented anterior to the ureter 
and can exert pressure at the level of the pelviureteric junction or the upper ureter and cause 
obstruction. Other vascular causes include abdominal aortic aneurysms and common iliac 
artery aneurysms which can externally compress the ureter. Vascular grafts placed for 
aneurysm repair can cause hydronephrosis in up to 10-20% of patients from mechanical 
obstruction of the ureter, they may spontaneously resolve  Retroperitoneal fibrosis can cause 
constriction around the ureter and prevent peristalsis of one or both ureters, in 8% to 10% of 
cases there is a coexistent malignancy. Retrocaval ureter which is an embryologic anomaly 
develops in utero due to the persistence of the posterior sub-cardinal vein which may lead to 
obstruction as the ureter passes posterior to the inferior vena cava, this occurs on the right 
side with male predominance. Ureteric obstruction becomes symptomatic in the third to 
fourth decade of life (Daune et al. 1991). 
In the paediatric population, the leading causes of ureteric obstruction are a pelviureteric 
junction or vesicoureteric junction obstruction, ectopic ureter, ureterocele, and megaureter 
(Shalaby-Rana et al. 1997).  
Unilateral ureteric obstruction  
In unilateral ureteric obstruction, there are three main phases; in phase one there is a rise in 
ureteric pressure and renal blood flow which lasts for one to two hours.  The Vasodilation of 
the afferent arterioles increases RBF which offsets the fall in GFR. The tubule-glomerular 
feedback mechanism, prostaglandin E2 and nitric oxide mediate this response (Rajasekaran, 
Maxvold and Bunchman, 2011). The decline in glomerular filtration rate is gradual, and the 
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decrease occurs over few hours. There is a drop in GFR by 50% in four hours, 75% in twelve 
hours and a further drop by 95% within twenty-four hours (Pickering & Endre, 2014). 
In the second phase, there is a persistent rise in ureteric pressure as this phase lasts for three 
to four hours. During this period, the renal blood flow begins to decrease as vasoconstrictors 
such as angiotensin II and thromboxane A2 play a vital role during this phase. In the 
experimental model, the administration of angiotensin-converting enzyme (ACE) inhibitor will 
mitigate the decline in GFR and renal blood flow, which provides evidence that angiotensin II 
plays a vital role in this process (Rajasekaran, Maxvold & Bunchman, 2011). 
The third phase begins after five hours of the obstruction. The ureteric pressure and the renal 
blood flow both start to decline at this stage as the afferent arteriolar resistance decreases. 
During this phase, the renal blood flow perfuses mainly the medullary regions as the blood 
shifts from the outer cortex. This shift in blood flow results in a lack of perfusion to a large 
number of glomeruli, and further reducing the  GFR 1. The decline in renal blood flow over 
time becomes significant as it decreases to 70% at 24 hours, 50% at 72 hours, 20% at two 
weeks and 12% at eight weeks (Pickering & Endre, 2014).  
Bilateral ureteric obstruction 
During the early phase of bilateral ureteric obstruction, the renal blood flow may slightly 
increase for approximately 90 minutes as nitric oxide is thought to mediate this mechanism. 
The renal blood flow then remarkably declines and is much more significant than in unilateral 
obstruction, and there is a significant decrease in medullary blood flow in bilateral 
obstruction.  The vasoconstrictors thromboxane A2, endothelin and angiotensin II mediate 
this phase. Ureteric pressure is much higher in the case of bilateral obstruction and remains 
elevated for at least 24 hours. The hypothesis behind this notion is that there is an 
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accumulation of vasoactive substances such as atrial natriuretic peptide (ANP) that do not 
usually accumulate in unilateral obstruction as the contralateral kidney would excrete these 
substances (Klahr & Morrissey 2002).  
 
4.1.2 Role of ANP in ureteric obstruction: 
Atrial natriuretic peptide (ANP) accumulates in bilateral ureteric obstruction (Purkerson et al., 
1989). Bilateral ureteric obstruction leads to an increase in the intravascular fluid volume that 
manifests in an increase in pulmonary capillary wedge pressure and body weight; these 
changes stimulate the secretion of ANP. ANP increases afferent arteriolar dilation and 
efferent arteriolar vasoconstriction, thus increasing the glomerular capillary pressure. It also 
decreases the sensitivity of tubule-glomerular feedback, inhibits the release of renin, and 
increases glomerular ultrafiltration coefficient (Fried, 1987; Cogan, 1990). 
 
4.1.3 Cellular and Molecular Changes 
The effect of ureteric obstruction on the kidney starts to have an impact on the renal tubules 
as these cells start to atrophy and die by apoptosis. The glomerular cells appear to be resistant 
to the deleterious manifestations of obstruction. Caspases which are cysteine aspartate-
specific proteinases mediates the apoptosis of tubular cells. These caspases generate 
significant inflammatory responses and the release of cytokines. An essential cytotoxic 
cytokine that plays a significant role in the apoptotic process is TNF-α (Ortiz, 2000). 
Continued urinary tract obstruction leads to the development of tubulointerstitial fibrosis and 
interstitial inflammation which results eventually in permanent changes to the structure of 
the kidney. In addition to TNF-α, other essential cytokines and growth factors that a play a 
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role in these changes are TGF-β, angiotensin II and NFκB. Obstruction also causes 
accumulation of extracellular matrix which further contributes to fibrosis (Schnaper, 2017).  
 
4.1.4 Initiation of fibrosis due to cellular and molecular changes 
The obstruction of the urinary tract eventually commences progressive and potentially 
permanent changes in the structure of the kidney, which including the development of 
tubulointerstitial fibrosis, interstitial inflammation, apoptosis and tubular atrophy.  
Various cytokines and growth factors play a role in the inflammatory changes that occur in 
the kidney; the most notable is the transforming growth factor-beta TGF-β, angiotensin II, 
NFκB, and TNF-α. Some are produced directly from the renal tubular and interstitial cells and 
some cytokines are produced by infiltrating macrophages.  
The extracellular matrix is synthesised and deposited at a rate higher than its degradation and 
consequently leads to the development of tubulointerstitial fibrosis. Also, the collapse of the 
parenchymal volume leads to an increase in the matrix as nephrons damaged (Hewitson, 
2009).  
Obstruction increases the synthesis of metalloproteinase inhibitors. Matrix 
metalloproteinases and collagenase are a group of enzymes that cleave and degrade the 
collagenous and non-collagenous components of the extracellular matrix. Hence it reduces 
metalloproteinase activity and results in the accumulation of extracellular matrix. The 
infiltrating macrophages stimulate the synthesis of TGF-β, which is a growth factor that 
increases tissue inhibitor of metalloproteinases (TIMP) production, thus reducing collagen 
turnover. Macrophages additionally produce other cytokines and growth factors, such as 
interleukin 2, interleukin 6, fibroblast growth factor, and platelet-derived growth factor 
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(PDGF), that seem to contribute to the process of inflammation and fibrosis (Sutaria et al., 
1998).   
The activated type 1 TGF-β receptor subsequently phosphorylates SMAD which are mobile 
transcription factors. A heteromeric complex of SMAD proteins translocates to the nucleus, 
where it interacts with transcription factors to regulate gene transcription (Wamsley-Davis et 
al., 2004) and stimulates tubulointerstitial fibrosis (Fukasawa et al., 2004). The events that 
lead to fibrosis are thought to be initiated by the rise in angiotensin II levels; also, other 
profibrotic factors seem to play a significant role because inhibition of angiotensin synthesis 
by ACE inhibitors or antagonism of the AT1 receptors reduces but does not completely 
eliminate the fibrotic process (Kaneto, Morrissey & Klahr, 1993; Ishidoya et al., 1995) 
In essence, obstruction of normal urine outflow results in biochemical, immunologic, 
hemodynamic, and functional changes. It stimulates a cascade of events in which elevated 
levels of angiotensin II, cytokines, and growth factors lead to tubular cell apoptosis and 
cellular inflammation, increased net matrix formation, and tubulointerstitial fibrosis. Many of 
the mediators are intrinsic to the renal tubular cells, and others are provided by fibroblasts 
and by migrating macrophages. 
 
4.1.5 Post-obstructive Diuresis. 
The resolution of bilateral ureteric obstruction results in increased urine flow 3 to 10 fold; this 
physiologic post-obstructive diuresis helps to excrete the salts retained during obstruction. 
However, there is pathologic diuresis that may occur when the kidneys excrete water and 
electrolytes that is more than that retained during the obstruction (Basile, Anderson & Sutton, 
2012).  
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During the period of significant polyuria, urine output of 200 mL/hr or higher may occur. 
Diuresis occurs mainly after relief of bilateral ureteric obstruction or obstruction of a solitary 
kidney, it rarely occurs when there is a healthy, contralateral kidney (Schlossberg & Vaughan, 
1984). 
Diuresis is typically a normal physiologic response to the volume expansion and solute 
accumulation that occurs during obstruction. Sodium, urea, and water are excreted, and 
diuresis subsides after solute, and fluid homeostasis is achieved (Loo et al., 1988). 
Though, a “pathologic” post-obstructive diuresis may ensue due to inappropriate renal 
handling of water or solutes or both. It is due to derangement of the medullary solute 
gradient and several altered signalling and transport pathways. The downregulation of 
sodium transporters with subsequent impaired sodium reabsorption in the thick ascending 
limb of the loop of Henle prevents maintenance of the medullary interstitial solute gradient, 
promoting a continued diuresis (Rokaw et al., 1996). 
 
The increased endogenous production and altered regulation of ANP induce saline diuresis 
(Soo Wan Kim et al., 2001). Also, other natriuretic peptides, such as the Dendroaspis 
natriuretic peptide, may contribute to the process. Pathologic post obstructive diuresis is 
characterised by the inadequate response of the collecting duct to antidiuretic hormone 
(ADH);  this is considered to be due to a downregulation of aquaporin water channels in this 
part of the nephron and perhaps in the proximal tubule, which has been shown in 
experimental models of unilateral and bilateral ureteric obstruction. (Nielsen & Agre, 1995; 
Gregersen et al., 1996; S W Kim et al., 2001).  
Several concepts have been proposed for the rare occurrence of post-obstructive diuresis 
with the release of unilateral ureteric obstruction and a normal contralateral Kidney. GFR may 
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be preserved in the setting of distal tubular damage such that the kidney filters a normal 
volume, but there is limited free water reabsorption. Occasionally,  a pronounced aquaporin 
channel defect may cause diminished free water absorption in this context (Schlossberg & 
Vaughan, 1984). 
An experimental study by Li et al., (2007) concluded that decreased Na+,K,+,2Cl− 
cotransporter type 2, the collapse of the inner medulla osmotic gradient, and suppressed 
phosphorylated renal aquaporins (AQP2) could be responsible for the impaired urine-
concentrating capacity in the chronic post-obstructive phase following the release of ureteric 
obstruction. The rarity of this condition has been ascribed to compensatory retention of salt 
and water by the contralateral kidney (Eskild-Jensen et al., 2007). 
4.1.6 Obstruction and kidney stones 
Obstruction has multiple consequences on the kidneys, ureters and the general well-being of 
the patient. In cases of obstruction associated with infection that can lead to sepsis, the 
consequences can be deleterious. Also, the pain caused by ureteric obstruction is significant 
and debilitating. The response of the ureter to obstruction by ureteric colic due to kidney 
stones is not well understood.  
The majority of kidney stones pass spontaneously, but this is dependent mainly on stone size 
and ureteric anatomy (Worcester & Coe, 2008). However, the passage of a kidney/ureteric 
stone can be painful due to the colicky nature of ureteric spasm which has a significant impact 
on the patient's quality of life, work responsibilities and predisposes them to ureteric 
obstruction and possible sepsis.  In cases of recurrent kidney stones, the condition becomes 
more debilitating for the patients. Hence, multiple medications have been advocated to 
enhance the process of stone passage. Ureteric stones can obstruct urine transport which 
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may cause some dynamic changes in ureteric contractility that are modulated by vasoactive 
substances (Paolo Santicioli & Maggi, 1998). Ureteric obstruction was tested in experimental 
animal models that have shown an increase in renal blood flow (RBF)  for an approximate 
period of 90 minutes which occurs immediately after obstruction, this phenomenon then 
decreases gradually after this initial response.  At the level of the collecting system, there is a 
rise in pressure in the initial five hours; then the pressure starts to decrease (Moody, Vaughn 
& Gillenwater, 1975). 
The mediation of the increase in the renal blood flow is mainly through the action of nitric 
oxide and eicosanoids such as prostaglandin E2 and I2. (Allen et al. 1978; Morrison et al. 1977; 
Chevalier et al. 1992). Prostaglandins are produced in the kidney and play an essential role in 
triggering the inflammatory response, contributing to the inception and progression of kidney 
diseases (Li et al., 2018). 
The action of angiotensin II and endothelin then decreases the renal blood flow (Pimentel et 
al., 1993). Due to the obstruction, there is an increase in intraluminal pressure proximal to 
the point of obstruction with an increase in ureteric  diameter. At this point of ureteric 
obstruction, there is a transient increase in the frequency and amplitude of smooth muscle 
contraction, which diminishes over a period. The urine flow is then dependant on the 
hydrostatic pressure of the urine made by the kidney (Rose & Gillenwater, 1973, 1978).   
During obstruction, there is a risk of infection which may cause an inflammatory response, 
further hindering the flow of urine. The effect of the stone on the intraluminal aspect of the 
ureter is also a factor that will impact urine flow as the ureteric mucosa can become inflamed 
and oedematous which will affect the ureteric compliance and the intraluminal diameter 
which will further inhibit the passage of the stone (Holmlund & Hassler, 1965). The 
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inflammation and oedema affecting the ureteric mucosa may cause inflammation and 
ischemia that leads to ureteric stricture (Fam et al., 2015). 
Ureteric stones 
The size and position of ureteric stones affect the passage rate, and the majority of the stones 
are small in size and pass spontaneously. In the prospective study by Miller and Kane, they 
investigated the time to spontaneous stone passage using plain radiography films. For stones 
<2mm wide - took 31 days to pass. 2-4mm wide - 40 days, and 4-6mm 39 days for the stones 
to clear from the ureter (Miller & Kane, 1999). The series by Coll et al. used non-contrast 
computed tomography (CT) which is the gold standard for detecting urinary tract stones; they 
show similar results (Coll, Varanelli & Smith, 2002). 
Tchey et al. have shown similar results of patients with ureteric stones in a series of 656 
ureteric stones, 86.3% (566) of patients passed the stone spontaneously. The mean time to 
stone passage was 6.8 days for stones less than 2mm in size, 12.6 days for stones 2 to 4mm, 
14.8 days for stones 4 to 6mm and 21.8 days for stones 6 to 8mm. The passage rate of stones 
was 55.3% in 7 days, 73.7% in 14 days, 88.5% in 28 days, and 97.7% in 60 days after the first 
episode of renal colic. Ninety (90) patients (13.7%) required intervention due to recurrence 
of symptoms or deterioration in renal function. The size and location of the ureteric stone are 
the most significant factors in predicting spontaneous passage. The more proximal the stone 
with a size of more than 6mm, the less chance of passing the stone (Tchey et al., 2011). Ueno 
et al. reported that 286 of 520 (53%) patients with ureteric stones were able to pass the 
stones spontaneously. As described earlier, size had a significant effect on the rate of stone 
passage. The stones that passed spontaneously had a mean size of 6.3 mm in length and 4.0 
mm in width; the stones that required intervention had a mean size of  11.7 mm in length and 
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7.1 mm in width. They reported that larger stones, more than 8mm were unlikely to pass 
(Ueno et al., 1977). The cohort investigated by Morse and Resnick show that ureteric calculi 
with smaller size and more distal in the ureter had higher chances of spontaneous passage. 
They calculated the stone width and position in the ureter and stratified the findings as 
follows:  
1 mm width, middle ureter 85%, distal ureter 100%. 
2 mm width, proximal ureter 100%, middle ureter 83%, distal ureter 93%. 
3 mm width, proximal  42%, middle 55%, distal 69 %. 
4 mm width, proximal 20%, middle 62%, distal 55%. 
5 mm width, proximal 6%, middle 57%, distal 45%. 
6 mm width, distal 25%. 
This cohort shows that patients with smaller stones located in the middle and distal ureter 
have a higher chance of spontaneous stone passage (Morse & Resnick, 1991). More than 80% 
of stones pass spontaneously, the size and location of the stone determines the likelihood of 
spontaneous passage (Jendeberg et al., 2017). 
4.1.7 Medical expulsive therapy for stone passage  
The passage of ureteric calculi may induce smooth muscle spasm that may affect the passage 
of stones and cause the classic symptoms of ureteric colic. There are multiple pharmacologic 
agents with different actions that have been used to facilitate stone passage. The ideal 
pharmacologic agent would have a spasmolytic action but still maintain peristalsis to aid in 
the passage of the stone.  
 95 
Calcium channel blockers 
This class of medication which inhibit the influx of extracellular calcium has been used to 
facilitate the passage of ureteric stones. Nifedipine, diltiazem and verapamil have been shown 
to inhibit ureteric contraction in humans and guinea pigs (Golenhofen & Lammel, 
1972)(Forman et al., 1978). The study by Hertle and Nawrath show that verapamil and 
nifedipine suppressed fast phasic contractions which are ureteric spasms without affecting 
slow tonic contractions, this suggests that calcium channel blockers can inhibit ureteric spasm 
without affecting peristalsis (L Hertle & Nawrath, 1984).      
 
Alpha blockers 
The autonomic nervous system modulates the contractile activity of the ureteric smooth 
muscles. The stimulation of  α-1 adrenergic receptors enhances the contractile amplitude and 
frequency of the ureteric smooth muscles. α1- adrenoceptors have been identified both in 
animal and human ureters. Activation of  α1- adrenoceptors can stimulate the PLC, IP3, DAG 
pathway and induce ureteric contraction. The density of α1 -adrenoceptors (α1A and α1D) in 
the ureteral smooth muscle is higher than other adrenoceptors (Morita et al., 1994; Scofield 
et al., 1995; Sigala et al., 2005).  
The rationale behind using a blocking agent that antagonises the activity of α-1 receptors may 
decrease the contractile activity associated with the ureteric spasm caused by the stone and 
subsequently facilitate stone passage.  
The study by Lindsey et al. show that the implantation of stones in canine ureters induced 
hyperperistaltic waves of contractions that created higher pressures than in the control 
group. The administration of the nonselective antagonist phenoxybenzamine decreased this 
spasmodic episode (Lindsey et al., 1979). 
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The investigation by Peters and Eckstein demonstrate that phentolamine which is a 
nonselective antagonist decreased the frequency of contraction in obstructed and partially 
obstructed canine ureters but without a significant effect on the amplitude of contraction, 
there is a significant increase in urinary flow in partially obstructed ureters (Peters & Eckstein, 
1975).  
Cervenakov et al. in a nonrandomized study administered 0.4 mg of Tamsulosin (a selective  
α-1 antagonist) daily to patients with ureteric stones n=51. The mean stone width was 4.0 
mm, and the mean length was 7.6 mm. This group were compared with a similar number of 
patients with ureteric stones of similar dimensions, the mean width was 3.8 mm, and the 
mean length was 7.5 mm. The latter group received standard supportive care. In the 
Tamsulosin group, 41 of the 51 patients (80.4%) passed the stones spontaneously in 
comparison with 32 (62.8%) in the conservative management group. The time to stone 
passage was also shortened in the treated group (Cervenàkov et al., 2002). There has been 
considerable debate about the use of expulsive medical therapy in the management of 
ureteric stones targeting the upper and lower segments of the ureter. The randomised 
controlled trial by Dellabella et al. demonstrate that Tamsulosin may be useful in facilitating 
the passage of distal ureteric stones (Dellabella et al. 2003). 
 
4.1.8 THE SUSPEND trial  
SUSPEND investigated the effectiveness of medical expulsive therapy in adults with ureteric 
colic in a multicentre, randomised, placebo-controlled trial.  
Patients between the age of 18–65 years who were expected to undergo expectant 
management of ureteric colic with a single stone confirmed on plain computed tomography 
(CT) scan were recruited in 24 UK hospitals. A remote randomisation system randomly 
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assigned participants to tamsulosin 400 μg, nifedipine 30 mg, or placebo was taken daily for 
up to 4 weeks, using an algorithm considering stone size (</=5 mm or >5 mm), and stone 
location (upper, mid, or lower ureter).  
The trial concluded that Tamsulosin 400 μg and nifedipine 30 mg are not effective at 
decreasing the need for further treatment to achieve stone clearance in 4 weeks for patients 
with expectantly managed ureteric colic (Pickard et al., 2015). 
Ye et al., (2018) conducted a double-blind, placebo-controlled study of 3296 patients with 
distal ureteric stones, across 30 centres in China, to evaluate the efficacy and safety of 
tamsulosin. The study concluded that the use of tamsulosin is beneficial in distal ureteric 
stones as it facilitates stone passage and relieves renal colic. The subgroup analyses found 
that tamsulosin provides a superior expulsion rate for stones >5mm, but no effect for stones 
</=5mm. 
The effectiveness of expulsive medical therapy is still under debate as large clinical trials have 
shown varying results in terms of stone passage, pain control during renal colic. Also, the 
reduction in the number of interventional procedures to clear the stones has both healthcare 
and financial implications; these mixed results may not be solely related to the type of medical 
therapy but due to our evolving understanding of ureteric physiology and the need to further 
understand the possible differences between the ureteric segments. 
 
Side effects of medical expulsive therapy 
The common side effects of calcium channel blockers are abdominal pain; dizziness; 
drowsiness; flushing; headache; nausea; palpitations; peripheral oedema; skin reactions; 
tachycardia and vomiting.  
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Uncommon side effects are angioedema; erectile dysfunction; gingival hyperplasia; myalgia; 
paraesthesia and syncope (BNF: NICE, 2019). 
The common side effects of alpha-blockers are dizziness and sexual dysfunction. The 
uncommon side effects are asthenia; constipation; diarrhoea; headache; nausea; 
palpitations; postural hypotension; rhinitis; skin reactions and vomiting. The rare side effects 
are angioedema; Stevens-Johnson syndrome; syncope. Dry mouth; epistaxis and vision 
disorders do occur but with unknown frequency (BNF:  NICE, 2019). 
 
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 
Non-steroidal anti-inflammatory drugs (NSAIDs)  have spasmolytic properties and commonly 
used in the management of ureteric colic. NSAIDs demonstrate various mechanisms that 
make them beneficial in kidney and ureteric stone disease with their effect on pain 
management and facilitation of stone passage. These benefits include the reduction in renal 
blood flow that decreases the pressure in the kidney collecting system. NSAIDs also relax the 
ureteric smooth muscle and reduce oedema caused by the stone impinging on the ureteric 
wall. In vitro studies demonstrate that prostaglandins increase the contractility of ureteric 
smooth muscle cells (Cole, Fry & Shuttleworth, 1988; Zwergel, Zwergel & Ziegler, 1991). 
NSAIDs inhibit cyclooxygenase (COX), which is an enzyme involved in prostaglandin synthesis 
from fatty acids.   
Diclofenac which is a non-selective COX inhibitor and NS-398 is a selective COX-2 inhibitor 
which has anti-inflammatory and analgesic properties (Futaki et al., 1994). Both agents 
diclofenac and NS-398 were shown to inhibit ureteric contractions (Mastrangelo et al., 2000). 
Furthermore, celecoxib (a selective COX-2 inhibitor) and indomethacin (non-selective COX 
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inhibitor) both inhibit PG release in the ureter even in the presence of COX-2 induction (Jerde 
et al., 2005). As a result, selective COX-2 inhibitors may be useful with fewer side effects in 
the management of patients with ureteral colic. 
The role of NSAIDs to facilitate ureteric stone passage has been tested in randomised 
controlled trials. The study by Laerum et al. show that oral diclofenac did not increase the 
rate of stone expulsion compared to placebo. However, diclofenac significantly decreased 
pain and the rate of hospital admissions (Laerum et al., 1995).  
Kapoor et al. demonstrate similar findings with indomethacin suppositories which is a 
nonselective COX inhibitor; patients with ureteric stones did not have an increased stone 
passage rates or decreased time to the stone passage in comparison with patients receiving 
placebo. Furthermore, the patients receiving indomethacin did require a statistically 
significant lower dose of narcotic analgesia (Kapoor et al., 1989).  
 
4.2 Hypothesis  
In this chapter, the effect of stones on ureteric contractility is investigated.  
In chapter 2 of this thesis, the nature of contraction of the different ureteric segments were 
investigated and behavioural differences between the pelvicalyceal system, renal pelvis, 
upper ureter, middle ureter and lower ureteric segments concerning frequency and 
amplitude of contraction were found. To further explore this concept, we hypothesise that: 
- The upper and lower ureteric segments respond differently to stone passage.  
4.3       Aims 
1- Develop an in vitro model of ureteric obstruction.  
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2- Compare the upper and lower ureteric segments basal contraction with and without 
obstruction.  
3- Measure the effect of a cholinergic agonist on stone passage.  
4.4       Methods 
The methods for this chapter are explained in chapter 2.  
 
4.5 Results:  
The upper ureteric (UU) segments n=14 and lower ureteric (LU) segments n= 18 both 
demonstrated basal spontaneous activity.  
The UU and LU segments were further divided into  
1- Upper ureteric segments with a stone (UU(+)Stone) n=7 - to investigate the effect of stone 
passage on the basal ureteric contractility of the upper ureteric segments and the effect of 
Carbachol on stone passage recording both amplitude and frequency of contraction.  
2- Upper ureteric segments without a stone (UU(-)Stone) n=7 - to investigate these segments 
as a control, recording both amplitude and frequency of basal and Carbachol-stimulated 
contraction.  
3- Lower ureteric segments with a stone (LU(+)stone) n=9 - to investigate the effect of stone 
passage on basal ureteric contractility of the lower ureteric segments and the effect of 
Carbachol on stone passage recording both amplitude and frequency of contraction.  
4- Lower ureteric segments without stone (LU(-)stone) n=9 - to investigate these segments 




Chapter 4. Fig 1- Comparison between the amplitude of basal contraction of the  
UU(-)stone and UU(+)stone. There is no significant increase in amplitude of contractility in the 
segments with an intraluminal stone.   
 
Chapter 4. Fig 2- Comparison between the frequency of basal contraction of the  
UU(-)stone with the frequency of UU(+)stone. There is no significant increase in contractile 
frequency of the upper ureteric segments with an intraluminal stone. 
Fig 1 and Fig 2. The UU(-)stone were compared with UU(+)stone; this showed a slight increase 
in amplitude from (0.00536±0.0027 g/mgT) to (0.00695±0.0026 g/mgT). There was also 
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increase in contractile frequency in the UU(+)stone (7.2±1.81E/5min) in comparison with the 
UU(-)stone (4.3±2.21 E/5min), both amplitude and frequency of contraction were not 
statistically significant (P=0.6830).  
 
Chapter 4. Fig.3- Comparison between the amplitude of basal contraction of the  
LU(-)stone with the amplitude of the LU(+)stone in the lumen.  
 
 
Chapter 4. Fig.4- Comparison between the frequency of basal contraction of the  LU(-)stone 
with the frequency of the LU(+)stone. 
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Fig 3 and Fig 4. The amplitude (0.02475 ± 0.0105 g/mgT) and frequency (5 ± 2.42 E/5min) of 
the lower ureteric basal contractility (LU(-)stone) was compared with the amplitude (0.04118 
± 0.0051 g/mgT) and frequency ( 5.57143 ± 1.67 E/5min) of the lower ureteric segment with 
a stone (LU(+)stone). There was no significant increase in amplitude  (P=0.2017) and 
frequency (P=0.5531) of contraction. 
 
 
Chapter 4. Fig.5- Comparison between the amplitude of basal contraction of the  




Chapter 4. Fig.6- Comparison between the frequency of basal contraction of the  
UU(-)stone with the LU(-)stone. Fig 5 shows the comparison between the amplitude of 
contraction of the basal contractility of the upper (0.00536±0.0027 g/mgT) and lower ureteric 
segments (0.02287 ± 0.00929 g/mgT) without a stone and Fig 6 shows the comparison 
between the basal contractile frequency of upper (4.28571 ± 2.21E/5min) and lower (4.625 ± 
2.13 E/5min) ureteric segments. The amplitude (P=0.1072) and frequency (P= 0.9137) of 





Chapter 4. Fig.7- Comparison between the amplitude of basal contraction of the  
UU(+)stone with the amplitude of the LU(+)stone. 
 
 
Chapter 4. Fig.8- Comparison between the frequency of basal contraction of the  
UU(+)stone with the frequency of the LU(+)stone. 
Fig 7 shows the comparison between the upper ureteric segments (+) stone and the lower 
ureteric segments (+) stone. The LU segment (0.03436 ± 0.0061 g/mgT) has shown a 
significant increase in amplitude (P=0.0018) in comparison with the amplitude (0.00695 ± 
0.0026 g/mgT) of the upper ureteric segment. Fig 8 shows the frequency of ureteric 
*** 
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contractility in the upper ureteric segment (7.28571 ± 1.81E/5min) in comparison with the 




Chapter 4. Fig.9 - Comparison between the amplitude of basal contraction of the  
UU(-)stone versus the UU(+)stone compared with the UU segments (-)stone that has been 
stimulated with CCh (Carbachol 10µmol) with the amplitude of the UU(+)stone that has also 







Chapter 4. Fig.10 - Comparison between the frequency of basal contractions of the UU(-)stone 
versus the UU(+)stone compared with the UU segments (-)stone that has been stimulated 
with CCh (Carbachol 10µmol); with the frequency of contraction of the UU segments (+)stone 
and CCh (Carbachol 10µmol). 
Fig 9 shows an increase in amplitude in the upper ureteric segment (+) stone (0.00695 ± 
0.0026 g/mgT) in comparison with the UU basal contraction (-) stone (0.00536±0.0027g/mgT), 
UU CCh stimulated segment without (-) stone (0.004963654±0.0022) and the ureteric 
segment with (+) stone and Carbachol did also have an increase in amplitude ( 
0.00614±0.0022 g/mgT) similar to the UU segment with a (+) stone.  
Fig 10 shows the comparison between the contractile frequency of the upper ureteric 
segments. The ureteric stone and Carbachol each had an impact on increasing the contractile 
frequency of the segments they were applied to.  
The contractile frequency of the UU segment with no (-) stone (4.29 ±2.21E/5min) has shown 
the lowest frequency of contraction in comparison with the basal contractility of the UU 
segment with a (+) stone (7.286±1.80 E/5min), UU segment with no (-) stone and stimulated 
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with CCh (7.5714±3.15 E/5min) and the UU segment (+) stone and stimulated with CCh 
(8.1429±1.7651E/5min).  
Both the stone in the ureter and Carbachol did increase the contractile frequency slightly 
higher than the previous segments but not statistically significant. Carbachol does not seem 
to affect the upper ureteric segments contractile amplitude but has an effect on the 




Chapter 4. Fig.11 – Comparison between the amplitude of basal contraction of the  
LU(-)stone versus the LU(+)stone and compared with LU(-)stone that has been stimulated 
with CCh 10µmol with the amplitude of the LU(+)stone and stimulated with CCh 10µmol.  
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Chapter 4. Fig 12 – Comparison between the frequency of basal contraction of the  
LU(-)stone versus the LU(+)stone and compared with LU segment (-)stone stimulated with 
CCh 10µmol and LU segment (+)stone that has also been stimulated with  
CCh 10µmol. 
 
Fig 11 shows a gradual rise in amplitude with the stone having a positive effect on increasing 
the amplitude of contractility in the lower ureteric segments. The amplitude (0.02033±0.0086 
g/mgT) of the non-stimulated LU segment without (-) a stone was the lowest among all 
segments. The non-stimulated LU segment with a (+) stone has shown a higher amplitude 
(0.03436±0.0061 g/mgT) in comparison with the previous segment but similar amplitude 
(0.03341±0.01081 g/mgT) to the CCh stimulated LU segment with (-) no stone. The LU 
segment with a (+) stone and stimulated with Carbachol demonstrated the highest amplitude 
(0.04708±0.0081 g/mgT) of contraction but not statistically significant (P=0.2019). 
Fig 12 demonstrates that the  frequency (5.44±1.44E/5min) of contraction of the non-
stimulated LU segments with a (+) stone was slightly higher than the frequency (4.11±1.95 
*** 
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E/5min) of the non-stimulated LU segment without a (+) stone. The LU segments that were 
stimulated with Carbachol demonstrated a statistically significant increase in ureteric 
contractile frequency. The LU segment with a (+) stone and stimulated with Carbachol 
demonstrated a statistically significant (p=0.0013)  increase in frequency (36.11±8.95 E/5min) 
in comparison with the non-stimulated segments with no (-) stone. There was no statistically 
significant difference between the LU segment stimulated with Carbachol, and the LU 
segment with a (+) stone stimulated with Carbachol (P=0.1895). There seems to be a 




Chapter 4. Fig.13 – Comparison between the amplitude of basal contraction of the UU 
segments (+) stone versus the UU(+)stone and stimulated with CCh 10µmol, compared with 
the basal contractions of LU segments (+) stone and the amplitude of the LU(+)stone that has 






Chapter 4 .Fig.14 – Comparison between the frequency of basal contraction of the UU 
segments (+) stone versus UU segments with (+) stone and stimulated with CCh 10µmol, 
compared with basal contractions of LU segments (+) stone and the frequency of the LU 
segments (+) stone that has been stimulated with CCh 10µmol. 
 
Fig 13 shows that the lower ureteric segments demonstrated statistically significant 
(P<0.0001) higher amplitude of contraction in both the non-stimulated (0.0344 ±0.006 g/mgT) 
and Carbachol-stimulated segments with a (+) stone (0.0471±0.0081 g/mgT) in comparison 
with both the stimulated (0.00614±0.0022 g/mgT) and non-stimulated (0.0069±0.0026 
g/mgT) upper ureteric segments with (+) stone, both these segments had a similar amplitude 
of contraction. In the Carbachol-stimulated LU segments with a (+) stone, there was higher 
amplitude than the non-stimulated segment.  
Fig 14 demonstrates that the frequency of contraction was similar between the basal 




The lower ureteric segment basal contractility with (+) stone has shown slightly lower 
frequency (5.44±1.44E/5min) in comparison with the upper ureteric segments. The 
Carbachol-stimulated segment with a (+) stone of the lower ureter has shown statistically 
significant higher (P=0.0004) frequency (36.11±8.95 E/5min) of contraction in comparison 
with the other segments.  
Traces of the upper and lower ureteric segments 
These traces show the difference between the upper and lower ureteric segments and the 
variety of contraction patters due to stone passage and Carbachol.  
  
Chapter 4 – Fig 15 – Upper ureter non-stimulated basal contraction without stone. 
 
 
Chapter 4 – Fig 16 – Upper ureter non-stimulated basal contraction with stone.  
 
 






Chapter 4 – Fig 18 – Upper ureter Carbachol stimulated contraction with stone.  
 
Chapter 4 – Fig 19 – Lower ureter non-stimulated basal contraction without stone.  
 
 
Chapter 4 – Fig 20 – Lower ureter non-stimulated basal contraction with stone. 
 
 








Chapter 4 – Fig 22- Lower ureter Carbachol stimulated contractions without stone.  
 
Chapter 4 – Fig 23 – Lower ureter Carbachol stimulated contractions without stone: another 
variety of contraction patterns.  
 
Ureteric contractility is similar in the upper and lower segments of the ureter, yet it exhibits 
a difference in the pattern of contraction. This difference in contractile activity which has 
been measured in terms of amplitude and frequency. Also the shape of the contractile waves 
is related to the nature of the ureteric segment itself. Both the upper and lower ureteric 
segments responded to the stimulation with Carbachol and stone passage or both but the 
type of response is different. This concept has a clinical relevance as during renal colic; the 
severity of the effect of the stone passage or obstruction on a specific ureteric segment may 
determine the degree of pain and discomfort. The traces shown above represents a 5 min 
interval of ureteric contractility at basal contraction or in response to drug stimulation and/or 




The upper ureteric segment basal contraction without a stone shows continuous and 
rhythmic contractions fig 15. The upper ureteric segment basal contraction with a (+) stone 
has shown spasmodic contractions with acontractile intervals fig 16.  
The upper ureteric segment stimulated with Carbachol and without a (-) stone fig 17 shows 
rhythmic contractions with seemingly spasmodic intervals. Comparing the pattern of 
contraction between the basal upper ureteric segment and the stimulated segment denotes 
that Carbachol enhances this spasmodic activity during contractions.  The upper ureteric 
segment with a (+) stone and stimulated with Carbachol, fig 18 the stone caused the upper 
ureter to go into spasmodic pattern of contraction with higher amplitude in comparison with 
basal contraction and also higher frequency in comparison with the other stimulated upper 
ureteric segments. The lower ureteric segment basal contraction fig 19, has shown 
continuous rhythmic contractions. The lower ureteric segment fig 20, with a (+) stone has 
shown low frequency of contraction but higher amplitude in comparison with the UU 
segments. 
The lower ureteric segment with a (+) stone and stimulated with Carbachol fig 21, shows an 
increase in amplitude and frequency, with spasmodic intervals similar to the Carbachol 
stimulated upper ureteric segment with a (+) stone fig 18. 
Fig 22 and fig 23 shows two types of contractile behaviour of the lower ureteric segments 
stimulated with Carbachol and without a (-) stone; this difference in behaviour was not seen 
in the upper ureter which could be due to the denser cholinergic innervation of the lower 
ureter (Prieto et al., 1994; Hernández, García-Sacristán & Orensanz, 1995). 
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4.6   Discussion  
Ureteric contractility remains interesting due to its consistency and variability at the same 
time. Various drugs and conditions affect ureteric contractility but also, the condition of the 
ureter itself affects the response to stimuli or obstruction. Nyirady et al. show that partial 
infravesical obstruction in foetal sheep ureters leads to diminished ureteric contractility due 
to the circumferential distention of the smooth muscles (Nyirády, Cuckow & Fry, 2008). The 
ability of the ureter to propel urine forward during peristalsis can diminish due to a period of 
obstruction. Biancani et al. show that there is an increase in contractile force in the rabbit 
ureter after two weeks of obstruction, there is no mechanical decompensation but rather the 
ureter undergoes changes that enhance its contractility by muscle hypertrophy and muscle 
fibre reorientation. Although, there are mechanical changes to overcome the obstruction; the 
obstructed ureter ability to generate intraluminal pressures required for urine transport 
decreases. This decrease in pressure results from the increase in ureteric diameter following 
obstruction according to Laplace’s law (Biancani, Hausman & Weiss, 1982b). 
Ureteric strictures and dilatation alter the electrical activity of the ureter (Shafik, 1996).  In 
long-standing conditions like megaureters, the contractile ability of the ureters in the 
presence of reflux and physical or functional obstruction has a suppressive effect on the 
rhythmic and tonic contractions of the ureter (Mudraya et al., 2004).  
In the clinical setting, the ureter undergoes periods of obstruction and irritation due to stone 
passage. The passage of the stone depends on the stone size and the internal diameter of the 
ureter which may have some variability between individuals. A 2 week period of ureteric 
obstruction may have a significant impact on stone passage and ureteric peristaltic function. 
The ureter seems to have an adaptive ability to overcome obstruction and hence, judging 
ureteric response to expulsive medical therapy based on previous clinical trials may not show 
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a complete picture of how ureteric conditions and especially obstruction. The metanalysis by 
Hollingsworth et al. advocates the use of expulsive medical therapy, but the recent clinical 
trial SUSPEND reported that Tamsulosin 400 μg and nifedipine 30 mg did not show efficacy in 
preventing further treatment for ureteric stone patients managed conservatively 
(Hollingsworth et al., 2006; Pickard et al., 2015). 
A recent trial investigated the efficacy and safety of Tamsulosin in Medical Expulsive Therapy 
for Distal Ureteric Stones reported that Tamsulosin had a significant effect on larger stones 
compared with smaller stones. The therapeutic benefit of Tamsulosin for large distal ureteral 
stones >5 mm (p < 0.01). The Tamsulosin group reported less recurrent renal colic (p < 0.001) 
and required less analgesia (p < 0.001) compared with placebo (Ye et al., 2018).  
In our current investigation, the ureter has shown behavioural variability due to 
pharmacological and physical stimulation. The ureteric response at different segments has 
been shown to be different. The relationship between ureteric obstruction, stone passage 
and the use of expulsive medical therapy is multifactorial and needs to take into consideration 
the ability of the ureter to adapt. Hence, pharmacological management of ureteric stones 
may target the upper and lower ureteric segments in order to facilitate stone passage but 








The aim of this thesis was to characterise the regional spontaneous contractile properties of 
the ureter, and their response to a contractile agonist, and how the presence of an 
intraluminal obstruction would affect contractile function. The hypothesis that was tested in 
this thesis was that the ureter exhibits an adaptive behaviour to obstruction. The ureter 
should not be regarded merely as a conduit of urine but rather an active and responsive organ 
to pathological changes.  
The ureter is a peristaltic organ with different segments contracting in a different way to fulfil 
its ability to conduct urine from the kidneys to the bladder. Different segments were 
hypothesised to have specific characteristics of function that would facilitate this process. 
These observations might then be used to develop novel approaches to manage more 
effectively ureteric stone passage and ureteric obstruction.  
Several aims, using an in vitro model of the pig ureter, tested this hypothesis:   
1. A description of the variation of spontaneous activity of the ureter in different 
segments 
2. The effect of a contractile agonist, carbachol, on different segments of the ureter 
3. The effect of obstruction on the contractile properties of the ureter.  
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The system begins from a high-frequency, low-amplitude contractile system on the upper part 
of the ureteric tract, to one of high-amplitude but low-frequency of contractions in the lower 
ureteric segments. 
All segments of the pelvicalyceal system (PCS) and the renal pelvis demonstrated basal 
spontaneous activity. The PCS showed a significantly (p<0.001) low mean amplitude of 
contraction compared to the renal pelvis, middle and upper ureter. However, the mean 
frequency was highest of any segment compared to those from the upper (p<0.05), middle 
(p<0.001) and lower (p<0.001) ureteric segments.  
Also, the renal pelvis showed a significantly (p<0.001) higher amplitude of contraction 
compared to the pelvicalyceal system (p<0.001) and the upper ureteric segments (p<0.001), 
similar to the middle ureter, but less than the lower ureteric segments (p<0.05). The 
contractile frequency of the renal pelvis was comparable to that of the pelvicalyceal system 
but significantly higher than that of the upper (p<0.05), middle (p<0.001) and lower (p<0.001) 
ureteric segments.  
The amplitude of the upper ureter spontaneous activity was significantly lower than the renal 
pelvis, middle and lower ureteric segments (p<0.001) but marginally  (p<0.05) higher than 
that in the pelvicalyceal system. The frequency of contraction was intermediate: it was higher 
than that in the middle and lower segments (p<0.001) but lower than that in the renal pelvis 
and pelvicalyceal system (p<0.05).  
Spontaneous activity was less well-organised in middle ureter segments compared to higher 
regions. Inter-contraction interval was varied and of significantly lower overall frequency.  
Contraction amplitude was similar to the lower ureter and renal pelvis but higher than that 
of the upper ureter and pelvicalyceal system. In the lower ureter, characteristics were similar 
to that of the middle ureter, as a high-amplitude but low-frequency system. 
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Carbachol had no significant impact on the amplitude or frequency of contraction in the UU 
segments. In the MU and LU segments; Carbachol significantly increased the amplitude & 
frequency of contraction. Ureteric contractility is similar in the upper and lower segments of 
the ureter, yet it exhibits a different contractile pattern in terms of amplitude and frequency. 
Furthermore, the shape of the contractile waves is relevant to the nature of the ureteric 
segment.  
 
The upper ureteric segments responded by slightly increased amplitude and frequency of 
contraction to stone passage but was not statistically significant. The lower ureteric segments 
responded to the stimulation with Carbachol, stone passage and both; it has shown a 
statistically significant increase in contractile frequency due to stone passage and carbachol. 
In the lower ureter there was no response to stone passage on its own and a slight increase 
in amplitude due to carbachol but was not statistically significant. This notion has clinical 
relevance as during renal colic; the severity of the effect of the stone passage or obstruction 
on a specific ureteric segment may determine the degree of pain and discomfort.  
 
The upper ureteric segment basal contraction with a stone has shown spasmodic contraction 
pattern with acontractile intervals and higher amplitude and frequency in comparison with 
basal contraction in contrast with the other stimulated upper ureteric segments. The lower 
ureteric segment basal contraction has shown continuous rhythmic contractions. The lower 
ureteric segment with a stone has shown a low frequency of contraction but higher amplitude 
in comparison with the UU segments. 
The lower ureteric segment with a stone and stimulated with Carbachol, shows an increase 
in amplitude and frequency, with spasmodic intervals similar to the Carbachol stimulated 
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upper ureteric segment with a stone. There appears to be a variation in contractile activity of 
the different segments of the ureter; as an integrated unit; these variations seems to facilitate 
the flow of urine from the kidneys to the bladder. 
 
An important purpose to characterise the pharmacological properties of the ureter is to 
formulate medical expulsive therapies (MET) to facilitate kidney and ureteric stone passage 
and also the alleviation of renal and ureteric colic.  MET is useful to facilitate the passage of 
ureteric stones less than 10 mm diameter and also as an adjunctive therapy with other 
modalities such as extracorporeal shockwave lithotripsy (ESWL) to clear ‘stone-streets’ 
(Steinstrasse).  Multiple clinical trials and meta-analysis have demonstrated to some degree 
conflicting evidence regarding the efficacy of medical expulsive therapy, but much of the 
evidence is conflicting (Hollingsworth et al., 2006; Pickard et al., 2015).  
 
Some of the inconsistency of these data may be due to the variability of contractile function 
of the ureter, or the physiological status of the patients when these studies were performed.   
For example, ureteric peristalsis can be affected by individual patient the state of hydration 
(Lang et al. 2002) and any previous obstruction or injury to the ureter. There can also be a 
difference between an acute presentation with a partially obstructing stone and a long-
standing obstruction or ureteric stricture (Hesketh et al., 2014).  These factors may also 
impact on the peristaltic contractile wave that progresses along the ureter.  
 
There are different types of medical expulsive therapy (MET) used for facilitating the passage 
of ureteric stones. Alpha-blockers, calcium channel blockers, Phosphodiesterase type 5 
inhibitors and corticosteroids. Each of these medications has shown varying degrees of 
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success in facilitating stone passage. The SUSPEND trial which is a multicentre UK clinical trial 
has become a cornerstone in the argument against the use MET have shown that tamsulosin, 
an alpha-blocker and nifedipine, a calcium channel blocker, both did not have a significant 
effect on stone passage (De Coninck et al., 2019).  Other metanalysis and clinical trials have 
shown a different result, and that MET can potentially improve stone passage and also, 
reduce pain during colic episodes as patients require less analgesia (Ye et al., 2018).  The 
pathophysiology of renal colic is not entirely understood, but it has been proposed that 
increased intraluminal pressure significantly increases pain (Rose & Gillenwater, 1973).  
 NSAIDs are excellent analgesics in renal colic as their predominant action is through inhibition 
of prostaglandin synthesis. The stone passage through the ureter causes local irritation and 
stimulates prostaglandin production. Prostaglandins (PGF2a) is involved in increasing evoked 
or spontaneous activity of the upper urinary tract (Zhang a Lang, 1994). Prostaglandins also 
increase glomerular afferent arteriolar vasodilatation and enhance vascular permeability 
which results in increased urine production and rise in renal pelvic pressure.   
NSAIDs decrease glomerular filtration by up to 35%, which subsequently lowers renal pelvic 
pressure and the stimulation of stretch receptors (Perlmutter et al., 1993). Furthermore, 
prostaglandin inhibition decreases ureteric oedema and inflammation, allowing better 
drainage; they also influence ureteric activity and reduce peristalsis. Moreover, NSAIDs may 
have a relaxing effect on ureteric smooth muscle. Indomethacin and diclofenac sodium 
abolished nearly the entire contractile response of ureteric muscle to electrical field 
stimulation (Cole et al., 1988). The role of NSAIDs and particularly diclofenac sodium is well 
described in the literature due to its effect in acute renal colic and the management of patient 
receiving shock wave lithotripsy (Cole & Fry, 1989). 
 123 
In the meta-analysis by Holdgate et al., (2004), patients receiving NSAIDs were less prone to 
need rescue analgesia, unlikely to experience vomiting (5.8% vs. 19.5%) and achieved more 
significant reductions in pain scores. As well as relieving acute pain, oral diclofenac and 
oral/rectal indomethacin have both been shown to be effective in reducing the number of 
new colic episodes and significantly reduce further hospital admissions by 28–57% (Kapoor et 
al., 1989; Laerum et al., 1995). 
 
5.2 The experimental Model 
The experimental setup used a number of ureteric segments for these experiments. Because 
human ureteric tissue is scarce a pig model was used in this thesis. For in vitro studies, porcine 
tissue is frequently used as an alternative model. Several studies have reported similarities 
between human and porcine tissue concerning the anatomy and physiology of the upper and 
lower urinary tract. These include similarity in urodynamic and morphological characteristics, 
and neural control (Sibley, 1984; Parsons et al., 2012).  The whole pig ureter was used with 
the aim of cataloguing the behaviour of the various segments by measuring contractile 
amplitude and frequency. The response of the ureter to obstruction at the upper and lower 
segments also provided a more comprehensive view of the ureteric response to stone 
passage. A comparison of the effect of obstruction in the upper ureter a lower ureteric 
segments was useful, as urinary calculi frequently obstruct the distal part of the ureter 
(Ahmed et al., 2015), although larger calculi will never progress along the ureter and obstruct 
the upper segments. 
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5.3 The relationship between structure and function of the ureter 
The ureter is often viewed as a single unit, but the delineation of individual ureteric segments 
has shown that there are functional differences and each contributes to the whole function 
through a coordinated response.  
There is a difference in the contractile behaviour between the pelvicalyceal system (PCS), 
renal pelvis and the upper ureter as these segments demonstrated higher contractile 
frequency. There was a gradual decrease in frequency at the middle and lower ureter. The 
PCS has a high-frequency rhythmic pattern of contraction and is consistent with the fact that 
this part of the upper urinary tract has an active role in the initiation of peristalsis.  
The renal pelvis also demonstrated high amplitude contractions followed by a low amplitude 
contractions in the upper ureter and a gradual increase in amplitude in the middle and lower 
ureteric segments. The renal pelvis contracts strongly to overcome the resistance offered by 
pelviureteric junction and initiate the propulsion of urine forward to the upper ureter (Morita, 
Ishizuka & Tsuchida, 1981). There was, except for the renal pelvis, an inverse relationship 
between the frequency and amplitude of contraction as the frequency gradually decreases 
from the pelvicalyceal system onwards. Thus, the overall contractile work to propel urine 
(amplitude * frequency) remained approximately constant along the ureter.  At the renal 
pelvis there were both large amplitude and high frequency contractions because, as noted 
above, this is where bulk flow of urine is initiated and so more work is required to provide 
this initial inertia.  The significance of these regional variations has not been fully elucidated, 
but a number of observations may be offered.  
The pelvicalyceal system showed the highest frequency, but with low amplitude contractions. 
The role of this segment is to transfer small volumes of urine continuously from the calyces 
and may have some role in initiating peristalsis.  
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As noted above, most contractile work is done by the renal pelvis to initiate bulk flow of urine. 
The upper ureter will augment the passage of the urine bolus to pass forward into the middle 
ureter.  It offers less fluid resistance due to its relatively large diameter and so flow may be 
continued with small amplitude contractions. 
The middle and lower ureteric segments have lower frequency and higher amplitude 
contractions. The lower ureteric segment has the highest amplitude of contraction and may 
be necessary to contract against the resistance to urine flow offered by the vesicoureteric 
junction. The pig ureteric dimensions and geometry seem to have an impact on the flow of 
urine bolus and also the passage of kidney stones (Nuss, et al. 2005). These dimensions were 
measured by the author of this thesis in a collaborative investigation to develop a ureteric 
model. The internal diameter of (n=8) pig ureters were measured. The average length of the 
ureters was 28.9±20 mm. The ureter was divided into three equal parts along its length; 
denoting the upper, middle and lower ureteric segments. The measurement was taken just 
distal to the renal pelvis. The measurement of the inner diameter of the ureter at the 
pelviureteric junction measures 6.5±1.3mm, the uppermost part of the upper ureter 
measures 6.0±1.3mm and tapers down to 3.0±0.6mm at the lower end of the upper ureter. 
The uppermost part of the middle ureter was 2.6±0.6mm, and the lower part of the middle 
ureter was 2.5±0.5mm. The uppermost part of the lower ureteric segment was 2.6±0.6, and 
the lowermost segment of the lower ureter was 2.4±0.5mm. The VUJ was slightly larger with 
2.9±0.2mm (Clavica et al., 2014). 
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Fig 5.1- Reconstruction of pig ureter geometry. Average pig ureter internal diameters (Di , in 
mm; N = 8), along the longitudinal coordinate i (i = 0 at UP; i = 15 at VUJ)  divided into Upper, 
Middle and Lower ureter (left). UPJ = ureteropelvic junction, VUJ = vesicoureteric junction. 
On the right; computer-aided design of the ureter. Adapted from Clavica et al (2014).  
 
5.4  Pharmacological manipulation of the ureter 
The action of carbachol on the ureter demonstrated differences between basal and agonist-
induced contractile behaviour. Carbachol (10 µM) had no impact on the amplitude or 
frequency of contraction in the upper ureteric segments. In the middle ureter segments, 
carbachol (10 µM) significantly increased the amplitude and frequency of contraction. The 
lower ureter segments have also shown a significant response to carbachol (10 µM) with a 
substantial rise in contractile amplitude and frequency. Atropine (1μM) had no effect on the 
amplitude and frequency of contraction on the upper ureteric, middle, and lower ureteric 
segments. 
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The three segments demonstrated a difference in contractile amplitude and frequency in 
response to both Carbachol but not to atropine. There is a relationship between the nature 
of modulated ureteric behaviour concerning the change in contractile frequency and 
amplitude and the density of cholinergic innervation of the ureteric segments.  
 
Muscarinic cholinergic receptors have been shown in the ureter and particularly in the distal 
and intravesical segments (Hernández et al., 1993). It has been reported that all five types of 
muscarinic receptors (M1–5) are immunohistochemically identified in the human ureter, 
although reverse transcriptase polymerase chain reaction confirms the presence of only M2, 
M3 and M5 (Sakamoto et al., 2006). More reliable radioligand binding studies have essentially 
identified M2 receptors in the porcine ureter (Hernández et al., 1995). The M3 receptor was 
found to mediate rhythmic contraction in a preparation of canine ureter, whereas relaxation 
was probably mediated mainly via the M4 receptor (Tomiyama et al., 2003b). In the study by 
Tomiyama et al., (2004), cholinergic receptor stimulation by the muscarinic agonist carbachol 
in anesthetized dogs had a suppressive effect on pressure and peristalsis in obstructed ureters 
in contrast to its activation of bladder smooth muscle. 
 
Anticholinergic medications may have a relaxing effect on the smooth muscle of the urinary 
tract and may reduce renal colic (Schneider et al., 2004). N-butylscopalamine did not reduce 
the opioid analgesia requirements in the management of renal colic in a randomised clinical 
trial (Holdgate et al., 2004b). Furthermore, in the literature, there is no evidence that 
anticholinergics facilitate stone expulsion. Only one randomised controlled trial investigated 
the efficacy of tolterodine in medical expulsion therapy. Erturhan et al., (2007) compared the 
efficacy of tamsulosin and tolterodine in 120 patients with distal ureteric stones. Patients 
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were divided into four groups. Group 1 patients received tamsulosin 0.4 mg/day, group 2 
patients received tamsulosin 0.4 mg/day plus tolterodine 2 mg (twice a day), group 3 patients 
received tolterodine 2 mg (twice a day) and group 4 was the control group. The study showed 
that the stone expulsion rate was 73.3% for group one, 70% for group two and 46.6% and 
40% for groups three and four, respectively. Tolterodine was not effective in improving the 
expulsion rate or reducing the expulsion time. Also, it did not contribute significantly in 
reducing the events of renal colic.  
Cholinergic receptor agonists have not been used as expulsive medical therapy; as most 
medical treatments investigated were mainly to relax the ureter and hence allow the stone 
to pass. There is still a degree of controversy regarding the benefit of medical expulsive 
therapy. This thesis investigated the effect of cholinergic receptor agonist (carbachol) and 
whether enhanced ureteric contractility may propel the stone through the ureter more 
effectively. There is evidence from the data presented in this thesis that the ureter responded 
differently to cholinergic-receptor manipulation which demonstrates that there is potential 
in pursuing a more targeted approach to expulsive medical therapy.  
5.5  The response to the pathological effect and the adaptation to change 
The ureter demonstrates altered contractile behaviour to adapt to physiological and 
pathological conditions.  Changes can occur after interventions that directly influence ureteric 
function, or secondary changes due to interventions that alter lower urinary tract function  
For example, after two weeks of obstruction there was an increase in contractile function of 
the rabbit ureter explained by muscle fibre reorientation and hypertrophy (Biancani et al., 
1982).  However, partial bladder outflow obstruction of foetal sheep was associated with 
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diminished ureteric contractility due to the circumferential distention of the smooth muscle 
layer (Nyirády, Cuckow & Fry, 2008). 
In addition to changes of muscle function in these conditions, there are also geometrical 
alterations that will diminish the contractile ability of the ureter.  An increase of ureter 
diameter can occur proximal to the site of an obstruction of the ureter; or by reflux to 
generate a megaureter due to an increase of lower urinary tract pressures, due say to outflow 
tract obstruction. These will decrease intraluminal pressure from the increase in ureteric 
diameter following obstruction according to Laplace’s law (Biancani, Hausman & Weiss, 
1982b). If these conditions are long-standing they may also have a suppressive effect on the 
rhythmic and tonic contractions of the ureter (Mudraya et al., 2004), in part by suppression 
of the electrical activity of the ureter (Shafik, 1996).  
In the clinical setting, the ureter undergoes periods of obstruction and irritation due to stone 
passage. The passage of the stone depends on the stone size and the internal diameter of the 
ureter which may have some variability between individuals. A two-week period of ureteric 
obstruction may have a significant impact on stone passage and ureteric peristaltic function. 
The ureter seems to have an adaptive ability to overcome obstruction and hence, judging 
ureteric response to expulsive medical therapy based on previous clinical trials may not show 
a complete picture of the ureteric response to obstruction. Clinical trials and metanalysis 
show a degree of contradictory evidence concerning the use of expulsive medical therapy 
(Hollingsworth et al., 2006; Pickard et al., 2015; Ye et al., 2018). The ureter has shown 
behavioural variability due to pharmacological and physical stimulation with a degree of 
variable response between the different segments. The relationship between ureteric 
obstruction, stone passage and the use of expulsive medical therapy is multifactorial and 
needs to take into consideration the adaptive characteristic of the ureter.  
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5.6 Limitations 
Although there is a similarity between the human and pig ureter, there are limitations 
associated with the animal model used here. The musculature of the pig ureter is similar to 
the human ureter, and the pig ureter propels approximately the same volume of urine. 
Anatomically the young pig ureter is comparable to the human ureter, but in the older pig, 
the calibre is proportionately larger. Cystograms and cystometrograms in the pig are very 
similar to those performed in humans. The peristaltic patterns and ureteric pressures are 
identical at all levels of the ureter in both the intact human and pig ureter. Normally the pig 
ureter does not show reflux as in humans (Melick & Schmidt, 1961) 
 The ureter was divided into segments to study it in a more detailed manner that gave 
considerable insight into its physiology. The investigation of the complete ureter may have 
given a different picture or insight due to the continuity of peristalsis, the interaction between 
the different parts and the integrity of the smooth muscle cells along the whole ureter.  
In addition, changes to ureteric blood flow will influence the ureteric response to either 
medications or obstruction are not represented in an in vitro model.  
Another limitation is the viability of the retrieved porcine tissue which limits the duration of 
the experiments.  
5.7 Insights, recommendations for future research and practical applications 
To achieve a whole picture of the nature of the upper urinary tract, various parts of its 
function were investigated. The upper urinary tract was divided into five segments, and 
the behaviour of each segment was investigated, along with the effect of cholinergic 
receptor modulation. The effect of obstruction was catalogued for segments of the upper 
and lower ureter.  
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The investigations of this thesis have shown that there is a functional difference in the 
nature of the contraction; i.e. there is a difference between the frequency and amplitude 
of contraction between different segments. There is also a difference between the upper 
and the lower ureteric segments in responding to obstruction and stone passage. The 
change in ureteric structure due to obstruction can alter the contractile behaviour 
(Nyirády, Cuckow & Fry, 2008).  
Other conditions like pregnancy pose physiological and mechanical changes on the ureter 
due to the pressure of the uterus on the ureter and the effect of progesterone (Hickling, 
Sun & Wu, 2015). The functional nature of the ureter can be understood regarding a 
general behaviour and a changing specific and adaptable behaviour. The general 
behaviour is peristalsis, and the specific set of behaviours is the response of each part of 
the upper urinary tract to change; the adaptability to pathological conditions and the 
continuous drive of the general and specific behaviours towards the continuity of a single 
focused function which is peristalsis. Therefore a methodological approach has been 
adopted to develop a conceptual understanding to delineate the observations and 
insights gained from the investigations for this thesis.  
 
• Medical expulsive therapy (MET) is a useful management strategy to remove ureteric 
stones and manage renal colic. Further investigations to catalogue the effect of MET 
medications on the different segments of the ureter would be useful as a step towards 
developing clinical trials that would test combination therapy of drugs to target the 
upper and lower ureteric segments either separately or simultaneously.  
• Carbachol which is a cholinergic antagonist increased ureteric amplitude and 
frequency of contraction significantly in the middle and lower ureteric segments and 
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also in the presence of a stone. Bethanechol is a muscarinic agonist that has been used 
for the management of urinary retention and may have a similar effect to Carbachol 
on the ureter. Although, theoretically it may increase ureteric contractility and hence 
colic, combination of this drug with nonsteroidal anti-inflammatory drugs may 
facilitate stone passage.  This may be further studied in vitro and also in a randomised 






















- Ahmed A. et al. Factors predicting the spontaneous passage of a ureteric calculus of 
⩽10 mm, Arab Journal of Urology 2015: 13: 84–90.  
 
- Allen JT. et al. The effect of indomethacin on renal blood flow and uretral pressure in 
unilateral ureteral obstruction in a awake dogs. Investigative urology 1978:15: 324–7.  
 
- Allen, TD. Congenital ureteral strictures. Journal of urology 1970: 104: 196–204. 
 
- Anderson JK, Kabalin JN, C. J. (2007) Campbell-Walsh Urology. 9th ed. Edited by Wein 
AJ. Philadelphia. 
 
- Aragona F. et al.The morphological basis of ureteral peristalsis - An ultrastructural 
study of the rat ureter’, International Urology and Nephrology 1988: 20:239–250.  
 
- Aslam M. Unilateral multicystic dysplastic kidney: long term outcomes, Archives of 




- Bagley DH. et al. Endoluminal sonography in evaluation of the obstructed 
ureteropelvic junction. Journal of endourology 1994: 8: 287–292.  
 
- Barnes PJ. How corticosteroids control inflammation. British Journal of Pharmacology 
2006: 245–254. 
 
- Basile, DP.et al. Pathophysiology of acute kidney injury. Comprehensive Physiology 
2012: 2: 1303–53.  
 134 
 
- Becker AJ. et al. The effect of the specific phosphodiesterase-IV-inhibitor rolipram on 
the ureteral peristalsis of the rabbit in vitro and in vivo, Journal of Urology 1998: 160: 
920–925.  
 
- Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. The 
Biochemical journal 1984: 220: 345–60.  
 
- Biancani P. et al.Effect of obstruction on ureteral circumferential force-length 
relations. American Journal of Physiology-Renal Physiology 1982 :243: 204–210.  
 
- Blok C. et al. Dynamics of the Ureterovesical Junction: Its Fluid Transport Mechanism 
in the Pig’, The Journal of Urology 1985: 134: 175–178. 
 
- BNF: British National Formulary - NICE (2019).  
 
- Boyarsky S. & Labay, PC. Urodynamics 1971. 
 
- Brading AF. et al. The effects of papaverine on the electrical and mechanical activity 
of the guinea-pig ureter. The Journal of physiology 1983: 334: 79–89.  
 
- Burdyga TV. et al. The mechanism of Ca2+ release from the SR of permeabilised 
guinea-pig and rat ureteric smooth muscle. Bioch et Biophys Acta 1998: 1402: 109–
114.  
 
- Burdyga TV & Magura IS. Paradoxical effects of La3+ on the Na+-loaded ureter and 
taenia coli smooth muscles of the guinea pig. General physiology and biophysics 1988: 
7: 313–6.  
 
- Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacology 
and Therapeutics 2006: 433–454.  
 
- Burnstock G. Purinergic signalling in the lower urinary tract’, Acta Physiologica 2013: 




- Canda AE.et al. Physiology and pharmacology of the human ureter: basis for current 
and future treatments. Urologia internationalis 2007: 78: 289–98.  
 
- Caravati EM. et al. Nifedipine for the relief of renal colic: a double-blind, placebo-
controlled clinical trial. Annals of emergency medicine 1989: 18: 352–354.  
 135 
- Carey MP. et al. Ureteric Obstruction by the Gravid Uterus’, The Australian and New 
Zealand Journal of Obstetrics and Gynaecology 1989: 29: 308–313. 
 
- Carl A. et al. Regulation of ion channels in smooth muscles by calcium: American 
Journal of Physiology 1996. 
 
- Carl P. & Stark L. Indications for surgical management of genitourinary tuberculosis. 
World Journal of Surgery 1997: 21: 505–510. 
 
- Carugo D. et al. An artificial model for studying fluid dynamics in the obstructed and 
stented ureter.  Annual International Conference of the IEEE Engineering in Medicine 
and Biology Society 2013 . 
 
- Cauchi JA. & Chandran H. Congenital ureteric strictures: An uncommon cause of 
antenatally detected hydronephrosis. Pediatric Surgery International 2005: 21: 566–
568. 
 
- Caughey AB. and Parer JT. Tocolysis with beta-adrenergic receptor agonists’, Seminars 
in Perinatology 2001: 25: 248–255.  
 
- Cervenàkov I. et al. Speedy elimination of ureterolithiasis in lower part of ureters with 
the alpha 1-blocker-Tamsulosin.’, International urology and nephrology 2001: 4: 25–
9.  
 
- Chaignat V. et al. Effects of a non-selective COX inhibitor and selective COX-2 inhibitors 
on contractility of human and porcine ureters in vitro and in vivo’, British Journal of 
Pharmacology 2008: 154: 1297–1307.  
 
- Chaudhary P. et al. Primary adenocarcinoma of ureter: A rare histopathological 
variant. Urology Annals 2016: 8: 357–359.  
 
- Chevalier RL. et al. EDRF modulates renal hemodynamics during unilateral ureteral 
obstruction in the rat. Kidney international 1992, 42: 400–6.  
 
- Cholkeri-Singh A. et al. Laparoscopic ureteral injury and repair: Case reviews and 
clinical update. Journal of Minimally Invasive Gynecology 2007: 356–361.  
 
- Chung SD. et al. Increased risk of diabetes in patients with urinary calculi: a 5-year 
followup study. The Journal of urology 2007: 186: 1888–1893.  
 
- Clavica, F. et al. Investigating the flow dynamics in the obstructed and stented ureter 
by means of a biomimetic artificial model. PLoS ONE 2014. 
 136 
 
- Cogan P. Atrial natriuretic peptide. Kidney International 1990: 37:1148–1160.  
 
- Cole RS. & Fry CH. Can Prostaglandins Facilitate the Passage of Ureteric Stone Streets? 
in Shock Wave Lithotripsy 1989: 2: 61–66.  
 
- Cole RS., Fry, CH & Shuttleworth, KE. The action of the prostaglandins on isolated 
human ureteric smooth muscle.’, British journal of urology 1988: 61: 19–26.  
 
- Coll DM et al. Relationship of Spontaneous Passage of Ureteral Calculi to Stone Size 
and Location as Revealed by Unenhanced Helical CT. American Journal of 
Roentgenology 2002: 178: 101–103.  
 
- De Coninck V. et al. Medical Expulsive Therapy for Urinary Stones: Future Trends and 
Knowledge Gaps. European Urology 2019: 658–666.  
 
- Constantinou CE. Renal pelvic pacemaker control of ureteral peristaltic rate. American 
Journal of Physiology 1974: 226. 
 
- Constantinou CE. & Djurhuus JC. Pyeloureteral dynamics in the intact and chronically 
obstructed multicalyceal kidney. The American journal of physiology 1981: 241: 398-
411.  
 
- Constantinou CE. & Hrynczuk JR. Urodynamics of the upper urinary tract. Investigative 
Urology 1976: 14. 
 
- Cunat L. et al. The effects of aluminum, iron, chromium, and yttrium on rat intestinal 




- Danuser H. et al. Systemic and topical drug administration in the pig ureter: Effect of 
phosphodiesterase inhibitors α1, β and β2-adrenergic receptor agonists and 
antagonists on the frequency and amplitude of ureteral contractions’, J Urol 2001. 
166: 714–720.  
 
- Daune B. et al. Hydronephrosis after aortofemoral bypass graft. A prospective study.’, 
europepmc.org 1991.  
 
- Davenport K. et al. The Role of Non-Steroidal Anti-Inflammatory Drugs in Renal Colic’, 
Pharmaceuticals 2010: 3: 1304–1310.  
 
 137 
- Davidson ME & Lang RJ. Effects of selective inhibitors of cyclo-oxygenase-1 (COX-1) 
and cyclo-oxygenase-2 (COX-2) on the spontaneous myogenic contractions in the 
upper urinary tract of the guinea-pig and rat. British journal of pharmacology 2000: 
129: 661–670. 
 
- Dawson-Edwards O. Role of ureter in renal transplantation: I. Studies of denervated 
ureter with particular reference to ureteroureteral anastomosis. The Journal of 
Urology 1959: 82: 566–72. 
 
- Deane RF. Functional studies of the ureter: its behaviour in the domestic pig (Sus 
scrofa domestica) as recorded by the technique of Trendelenburg. British journal of 
urology 1967. 39: 31–37. 
 
 
- Dellabella M. et al. Medical-expulsive therapy for distal ureterolithiasis: Randomized 
prospective study on role of corticosteroids used in combination with tamsulosin - 
Simplified treatment regimen and health-related quality of life. Urology 2005: 66: 
712–715. 
 
- Dellabella M. et al. Efficacy of Tamsulosin in the Medical Management of Juxtavesical 
Ureteral Stones. The Journal of Urology 2003: 170: 2202–2205.  
 
- Dellabella M. et al. Randomized Trial of the Efficacy of Tamsulosin, Nifedipine and 
Phloroglucinol in Medical Expulsive Therapy for Distal Ureteral Calculi. The Journal of 
Urology 2005: 174:167–172. 
 
- Dewan PA. et al. Upper pole pelviureteric function obstruction’, Pediatric Surgery 
International 1998: 13: 290–292.  
 
- Duyl Van WA. et al. Potassium-induced contractions in pig ureter strips. Consequences 
for Helical Muscle-Fiber Model of Ureter. Urology 1982: 20: 53–58.  
 
- De Conink V. et al. Medical expulsive therapy for urinary stones: future trends and 




- Schick E. & Tanagho EA. The effect of gravity on ureterl peristalsis’, Journal of Urology 
1973: 187–191.  
 
- Edvardsson VO.et al. Hereditary Causes of Kidney Stones and Chronic Kidney Disease. 
Pediatric nephrology 2013: 28: 1923–1942.  
 138 
 
- Elkoushy, Mohamed & Andonian, S. Surgical, Radiographic, and Endoscopic Anatomy 
of the Kidney and Ureter. Campbell-Walsh Urology. 11th edn 2015: 170–172.  
 
- Emamian SA. et al. Kidney dimensions at sonography: correlation with age, sex, and 
habitus in 665 adult volunteers. American journal of roentgenology 1993: 160: 83–6.  
 
- Eskild-Jensen A. et al. AT1 receptor blockade prevents interstitial and glomerular 
apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral 




- Fam XI. et al. Ureteral stricture formation after ureteroscope treatment of impacted 
calculi: A prospective study’, Korean Journal of Urology 2015: 56: 63.  
 
- Fernbach SK. et al. Ureteral duplication and its complications. Radiographics : a review 
publication of the Radiological Society of North America 1997: 17: 109–127.  
 
- Finberg JPM. & Peart WS. Function of smooth muscle of the rat renal pelvis response 
of the isolated pelvis muscle to angiotensin and some other substances. British Journal 
of Pharmacology 1970: 39: 373–381.  
 
- Floyd RV. et al. Morphology, Calcium Signaling and Mechanical Activity in Human 
Ureter. Journal of Urology 2008: 180: 398–405.  
 
- Foote JW. et al. Observations on the ureteropelvic junction’, J Urol 1970: 104: 252–
257. 
 
- Forman A. et al. Effects of nifedipine on the smooth muscle of the human urinary tract 
in vitro and in vivo. Acta pharmacologica et toxicologica 1978: 43: 111–8.  
 
- Fried T. Atrial Natriuretic Factor: A Historic Perspective. The American Journal of the 
Medical Sciences 1987: 294: 134–138. 
 
- Fröber R. Surgical anatomy of the ureter. BJU International 2007, 100: 949–965.  
 
- Fukasawa H. et al. Down-regulation of Smad7 expression by ubiquitin-dependent 
degradation contributes to renal fibrosis in obstructive nephropathy in mice.’, 
Proceedings of the National Academy of Sciences of the United States of America 
2004: 101: 8687–92.  
 
 139 
- Futaki, N. et al. NS-398, a new anti-inflammatory agent, selectively inhibits 
prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 




- Golenhofen K. & Lammel E. Selective suppression of some components of 
spontaneous activity in various types of smooth muscle by iproveratril (Verapamil).’, 
Pflugers Archiv 1972 : European journal of physiology 1972: 331: 233–43.  
 
- Gosling JA. and Dixon JS. Functional Obstruction of the Ureter and Renal Pelvis. A 
Histological and Electron Microscopic Study’, British Journal of Urology 1978: 50: 145–
152.  
 
- Gravina GL. et al. Tamsulosin treatment increases clinical success rate of single 
extracorporeal shock wave lithotripsy of renal stones.’, Urology 2005: 66: 24–28.  
 
- Gregersen H. et al. Regional differences exist in elastic wall properties in the ureter. 
Scandinavian journal of urology and nephrology 1996: 30: 343–348.  
 
- Griffiths DJ. & Notschaele C. The mechanics of urine transport in the upper urinary 





- Hanna MK. Some observations on congenital ureteropelvic junction obstruction. 
Urology 1978: 151–159.  
 
- Hannappel J. et al. Pacemaker Process of Ureteral Peristalsis in Multicalyceal Kidneys. 
Urologia Internationalis 1982: 240–246.  
 
- Harish J. et al. Pelviureteric junction obstruction: how much is the extent of the upper 
ureter with defective innervation needing resection?’, Journal of pediatric surgery 
2003: 38: 1194–1198. 
 
- Hashim H. & Woodhouse CRJ. Ureteropelvic junction obstruction’, European Urology, 
Supplements 2012: 11: 25–32.  
 
- Hava M. & Hurwitz A. The relaxing effect of aluminum and lanthanum on rat and 




- Hawthorn MH. et al. Urothelium-derived inhibitory factor(s) influences on detrusor 
muscle contractility in vitro. British Journal of Pharmacology 2000: 129: 416–419.  
 
- Hernández M. et al. Different muscarinic receptor subtypes mediating the phasic 
activity and basal tone of pig isolated intravesical ureter. British journal of 
pharmacology 1993: 110: 1413–20.  
 
- Hernández M. et al. Muscarinic binding sites of the pig intravesical ureter. Journal of 
autonomic pharmacology 1995: 15: 351–9.  
 
- Hertle L. & Nawrath H. Calcium channel blockade in smooth muscle of the human 
upper urinary tract. I. Effects on depolarization-induced activation. J Urol 1984: 132: 
1270–1274. 
 
- Hertle L. & Nawrath H. Stimulation of voltage-dependent contractions by calcium 
channel activator Bay K 8644 in the human upper urinary tract in vitro. The Journal of 
urology 1989: 141: 1014–8.  
 
- Hesketh EE. et al. A murine model of irreversible and reversible unilateral ureteric 
obstruction. Journal of visualized experiments 2014. 
 
- Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. American 
Journal of Physiology 2009: 296: 1239–1244.  
 
- Hickling DR. et al. Anatomy and Physiology of the Urinary Tract: Relation to Host 
Defense and Microbial Infection. Microbiology spectrum 2015.  
 
- Hieble JP. et al. International Union of Pharmacology. X. Recommendation for 
nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacological reviews 
1995: 47: 267–70.  
 
- Hindryckx A. & De Catte L. Prenatal diagnosis of congenital renal and urinary tract 
malformations. Facts, views & vision in ObGyn 2011: 3: 165–74.  
 
- Holden D. et al. Renal pelvic pressures in human chronic obstructive uropathy.British 
journal of urology 1984: 56: 565–70.  
 
- Holdgate A. & Pollock T. Systematic review of the relative efficacy of non-steroidal 
anti-inflammatory drugs and opioids in the treatment of acute renal colic. British 
Medical Journal 2004: 1401–1404.  
 
 141 
- Hollingsworth JM. et al. Medical therapy to facilitate urinary stone passage: a meta-
analysis’, Lancet 2006: 368: 1171–1179.  
 
- Holmlund D. & Hassler O. A method of studying the ureteral reaction to artificial 
concrements.’, Acta chirurgica Scandinavica 1965: 130: 335–43.  
 
- Hörl WH. Nonsteroidal Anti-Inflammatory Drugs and the Kidney’, Pharmaceuticals 
2010: 3: 2291–2321.  
 
- Hutch JA. et al. The bladder musculature with special reference to the ureterovesical 





- Imaizumi Y. et al. Ionic currents in single smooth muscle cells from the ureter of the 
guinea-pig. The Journal of physiology 1989: 411: 131–59.  
 
- Iselin CE. et al. Localization of nitric oxide synthase and haemoxygenase, and 
functional effects of nitric oxide and carbon monoxide in the pig and human 
intravesical ureter. Neurourology and Urodynamics 1997: 16: 209–227.  
 
- Ishidoya S. et al. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial 
fibrosis caused by unilateral ureteral obstruction. Kidney internationa 1995l: 47:1285–
94.  
 





- Jendeberg J. et al. Size matters: The width and location of a ureteral stone accurately 
predict the chance of spontaneous passage. European radiology 2017 :27:4775–4785.  
 
- Jerde TJ. et al. Celecoxib inhibits ureteral contractility and prostanoid release. Urology 
2005: 65: 185–190. 
 
- Jung H. et al. Endoluminal Isoproterenol Irrigation Decreases Renal Pelvic Pressure 
During Flexible Ureterorenoscopy: A Clinical Randomized, Controlled Study’, 
European Urology 2008: 54: 1404–1413.  
 






- Kajbafzadeh AM. et al. Smooth muscle cell apoptosis and defective neural 
development in congenital ureteropelvic junction obstruction. The Journal of urology 
2006: 176: 718–23. 
 
- Kaneto H. et al. Three-D muscular arrangement at the ureteropelvic junction and its 
changes in congenital hydronephrosis: a stereo-morphometric study. The Journal of 
urology 1991: 146: 909–914. 
 
- Kaneto H. et al. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of 
rats with unilateral ureteral ligation. Kidney international 1993: 44: 313–21.  
 
- Kapoor DA. et al. Use of indomethacin suppositories in the prophylaxis of recurrent 
ureteral colic. The Journal of urology 1989: 142: 1428–30. 
 
- Karaca I. et al. Ureteral fibroepithelial polyps in children. Pediatric Surgery 
Internationa 1997: 12: 603–604.  
 
- Kennedy C. ATP as a cotransmitter in the autonomic nervous system’, Autonomic 
Neuroscience 2015: 2–15.  
 
- Kiil F. Urinary Flow and Ureteral Peristalsis in Urodynamics.1973 (eds) Springer, Berlin, 
Heidelberg. 
 
- Kim SW et al. Diminished renal expression of aquaporin water channels in rats with 
experimental bilateral ureteral obstruction. Journal of the American Society of 
Nephrology 2001: 12: 2019–28.  
 
- Kim, Soo Wan et al. Increased expression of atrial natriuretic peptide in the kidney of 
rats with bilateral ureteral obstruction. Kidney International 2001: 59: 1274–1282.  
 
- King LR. Megaloureter: definition, diagnosis and management. The Journal of urology 
1980: 222–3. 
 
- Klahr S. & Morrissey J. Obstructive nephropathy and renal fibrosis. Kidney Intl. 
supplement 2003: 105-112. 
 
- Knight GE. et al. ATP is released from guinea pig ureter epithelium on distension. 
 143 
American Journal of Physiology 2002: 282: 281- 288.  
 
 
- Kondo A. The contraction of the ureter. I. Observations in normal human and dog 
ureters.’, Nagoya journal of medical science 1970: 32: 387–394. 
 
- Kubo M. et al. Hydronephrosis as a complication of appendicitis: a case report. 
Hinyokika kiyo. Acta urologica Japonica 1996: 42: 679–681. 
 
 
- Kuntz A. et al. Fiber components of the splanchnic nerves.’, The Anatomical record 
1957: 128: 139–146. 
 
- Kuvel M. et al. Distribution of Cajal like cells and innervation in intrinsic ureteropelvic 




- Laerum E. et al. Oral diclofenac in the prophylactic treatment of recurrent renal colic. 
A double-blind comparison with placebo. European urology 1995: 28: 108–11.  
 
- Laird JM et al. Effects of artificial calculosis on rat ureter motility: peripheral 
contribution to the pain of ureteric colic.  A J physiol 1997 :272: 1409-16.  
 
- Lam JS et al. Ureteropelvic junction obstruction. J urol 2007: 177: 1652–1658.  
 
- Lamont C. et al. Intracellular Na+ measurements in smooth muscle using SBFI - 
changes in [Na+], Ca2+ and force in normal and Na+-loaded ureter. Eur J Physiol 1998: 
435: 523–527.  
 
- Lang RJ et al. Pyeloureteric peristalsis: role of atypical smooth muscle cells and 
interstitial cells of Cajal-like cells as pacemakers. J physiol 2006: 576: 695–705.  
 
- Lang RJ. & Zoltkowski BZ. et al. Electrical characterization of interstitial cells of Cajal-
like cells and smooth muscle cells isolated from the mouse ureteropelvic junction. J 
urol 2007: 177: 1573–80.  
 
- Lang RJ & Hashitani H. et al. Spontaneous electrical and Ca2+ signals in typical and 
atypical smooth muscle cells and interstitial cell of Cajal-like cells of mouse renal 
pelvis. J physiol 2007: 583: 1049–68.  
 
- Lang RJ et al. Pyeloureteral motility and ureteral peristalsis: essential role of sensory 
 144 




- Langley JN & Anderson HK. The Constituents of the Hypogastric Nerves. J physiol 1894: 
17: 177–191. 
 
- Langley & Anderson HK. The Innervation of the Pelvic and adjoining Viscera: Part VII. 
Anatomical Observations.’, The Journal of physiology 1896: 20: 372–406. 
 
- Latifpour J. et al. Characterization of autonomic receptors in neonatal urinary tract 
smooth muscle. Developmental pharmacology and therapeutics 1989: 13: 1–10. 
 
- Lee BR et al. A quantitative histologic analysis of collagen subtypes: The primary 
obstructed and refluxing megaureter of childhood. Urology 1998: 51: 820–823. 
 
- Lenaghan D. Bifid ureters: an anatomical physiological and clinical study. In: Webster 
R, ed. Congenital Malformations of the Rectum, Anus and Genitourinary Tracts 1963. 
 
- Lepor H. Evaluating men with benign prostatic hyperplasia.Reviews in urology 2004: 
6: 8–15.  
- Lescay HA & Tuma F. Anatomy, Abdomen and Pelvis, Ureter, StatPearls 2019.  
 
- Leung VYF et al. Doppler waveforms of the ureteric jet: An overview and implications 
for the presence of a functional sphincter at the vesicoureteric junction. Pediatric 
Radiology 2007: 417–425.  
 
- Leung VYF. et al. The ureteric jet Doppler waveform as an indicator of vesicoureteric 
sphincter function in adults and children. An observational study. Ultrasound in 
Medicine and Biology 2002: 28: 865–872.  
 
- Li C. et al. Altered expression of epithelial sodium channel in rats with bilateral or 
unilateral ureteral obstruction. American Journal of Physiology 2007: 293: 333–341.  
 
- Li Y. et al. Prostaglandins in the pathogenesis of kidney diseases.Oncotarget 2018. 9: 
26586–26602.  
 
- Lindsey D. et al. Modification by dipyrone (noramidopyrine methanesulphonate) of 
stone-induced ureteric hyperperistalsis in the dog. Urological research 1979: 7: 13–7.  
 
- Londos C. et al. Receptor-mediated stimulation and inhibition of adenylate cyclases: 
 145 
the fat cell as a model system. Advances in cyclic nucleotide research 1981: 14: 163–
71. 
 
- Loo MH. et al. Pathophysiology of obstructive nephropathy. World Journal of Urology 




- Magee C. et al. A new embryologic classification for uro-gynecologic malformations: 
the syndromes of mesonephric duct induced mullerian deformities. The Journal of 
urology 1979: 121: 265–267. 
 
- Maggi CA. et al. Effect of Bay K 8644 and ryanodine on the refractory period, action 
potential and mechanical response of the guinea-pig ureter to electrical stimulation. 
Naunyn-Schmiedeberg’s archives of pharmacology 1994: 349: 510–22.  
 
- Maizels M. et al. Valves of the ureter as a cause of primary obstruction of the ureter: 
anatomic, embryologic and clinical aspects. The Journal of urology 1980: 123: 742–7. 
 
- Marchini GS. et al. Gout, stone composition and urinary stone risk: a matched case 
comparative study. The Journal of urology 2013: 189: 1334–1339.  
 
- Mastrangelo, D. et al. Diclofenac and NS-398, a selective cyclooxygenase-2 inhibitor, 
decrease agonist-induced contractions of the pig isolated ureter. Urological research 
2000: 28: 376–82.  
 
- Mastrangelo, D et al. Nitric Oxide Production Within Rat Urothelial Cells’, The Journal 
of Urology 2003: 170: 1409–1414. 
 
- Mastrangelo, D. & Iselin CE. Urothelium dependent inhibition of rat ureter contractile 
activity. Journal of Urology 2007: 178: 702-709.  
 
- Van Mastrigt R. The Propagation Velocity of Contractions of the Pig Ureter in Vitro BT  
- Urodynamics: Upper and Lower Urinary Tract II’, 1985 (eds): 126–138.  
 
- Matsumoto R. et al. Expression and functional role of β3 -adrenoceptors in the human 
ureter. International journal of urology 2013 : 20: 1007–14.  
 
- Melick WF. et al. Experimental Studies of Ureteral Peristaltic Patterns in the Pig:I. 




- Melick WF et al. Experimental Studies of Ureteral Peristaltic Patterns in the Pig. II. 
Myogenic Activity of the Pig Ureter. The Journal of Urology 1961: 86: 46–50. 
 
- Mendez Probst CE. et al. Preoperative indications for percutaneous nephrolithotripsy 
in 2009. Journal of endourology 2009: 23: 1557–1561.  
 
- Metzger R. et al. Cajal-like cells in the human upper urinary tract. The Journal of 
Urology 2004: 172: 769–772.  
 
- Miller OF & Kane CJ. Time to stone passage for observed ureteral calculi: a guide for 
patient education. The Journal of urology 1999: 162: 688–90. 
 
- Mitchell GA. The Innervation of the Kidney, Ureter, Testicle and Epididymis.’, Journal 
of anatomy 1935: 70: 10-32. 
 
- Modi P. & Goel R. Synchronous endoscopic management of bilateral kidney and ureter 
fungal bezoar.’, Urologia internationalis 2007: 78: 374–376.  
 
- Moody TE. et al. Relationship between renal blood flow and ureteral pressure during 
18 hours of total unilateral uretheral occlusion. Implications for changing sites of 
increased renal resistance.’, Investigative urology 1975: 13: 246–51.  
 
- Morita T et al. Characterization of alpha-adrenoceptor subtypes involved in regulation 
of ureteral fluid transport.The Tohoku journal of experimental medicine 1987: 152: 
111–118. 
 
- Morita T et al. Ureteral urine transport: changes in bolus volume, peristaltic 
frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. 
The Journal of urology 1987: 137: 132–5.  
 
- Morita T. et al.  Function and distribution of autonomic receptors in canine ureteral 
smooth muscle. Neurourology and Urodynamics 1994: 13: 315–321.  
 
- Morita T. Initiation and propagation of stimulus from the renal pelvic pacemaker in 
pig kidney.’, Investigative urology 1981: 19: 157–60.  
 
- Morrison AR. et al. Unmasking of thromboxane A2 synthesis by ureteral obstruction 
in the rabbit kidney’, Nature 1977: 267: 259–260.  
 
- Morse R. M. & Resnick M. I. Ureteral calculi: natural history and treatment in an era 
of advanced technology. The Journal of urology 1991: 145: 263–5.  
 
 147 
- Mudraya I. S. et al. Contractile function of the smooth-muscle wall and its adrenergic 
regulation in megaureter. Bulletin of experimental biology and medicine 2004: 138: 
298–300.  
 





- Nasu T. & Suzuki N. Effects of aluminum ions on K(+)-induced contraction in ileal 
longitudinal smooth muscle. Comparative biochemistry and physiology1998: 120: 
137–43.  
 
- National Center for Biotechnology Information. PubChem Comp. Database; 
CID=174174. 
 
- Nielsen S. & Agre P. The aquaporin family of water channels in kidney. Kidney 
International 1995: 48: 1057–1068.  
 
- Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour 
promotion. Nature 1984: 308: 693–8.  
 
- Noordzij JW & Dabhoiwala NF. A view on the anatomy of the ureterovesical junction’, 
Scandinavian Journal of Urology and Nephrology 1993: 27: 371–380.  
 
- Nuss GR. et al. Adjunctive therapy to promote stone passage. Rev in urol 2005: 7: 67-
74.  
 
- Nyirády P. et al. Changes to the contractile function of ureter smooth muscle after 




- Duarte-Escalante O. et al. The Neurohistochemistry of Mammalian Ureter: A New 
Combination of Histochemical Procedures to Demonstrate Adrenergic, Cholinergic 
and Chromaffin Structures in Ureter. J Urol 1969: 101: 803–811. 
 
- O’Conor VJ. Role of ureter in renal transplantation: Studies of denervated ureter with 
particular reference to ureteroureteral anastomosis. J Urol 1959: 82: 566–72. 
 








- Paquin AJ. Ureterovesical anastomosis: the description and evaluation of a technique. 
The Journal of urology 1959: 82: 573–583.  
 
- Parsons BA. et al. The validation of a functional, isolated pig bladder model for 
physiological experimentation.’, Frontiers in pharmacology 2012: 3: 52.  
 
- Perlmutter A. et al. Toradol, an NSAID used for renal colic, decreases renal perfusion 
and ureteral pressure in a canine model of unilateral obstruction’, Journal of Urology 
1993: 149: 926–930.  
 
- Peters HJ & Eckstein W. Possible pharmacological means of treating renal colic. 
Urological research 1975: 3: 55–9.  
 
- Pickard R. et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, 
randomised, placebo-controlled trial. The Lancet 2015: 386: 341–349.  
 
- Pickering JW and Endre ZH. The definition and detection of acute kidney injury. Journal 
of renal injury prevention 2014: 3: 21–5.  
 
- Pimentel JL. et al. Regulation of renin-angiotensin system in unilateral ureteral 
obstruction. Kidney international 1993: 44: 390–400.  
 
- Pontincasa P et al. Defective in vitro contractility of ureteropelvic junction in children 
with functional and obstructive urine flow impairment. Journal of Pediatric Surgery 
2006: 41:1594–1597.  
 
- Pope JC et al. How they begin and how they end: classic and new theories for the 
development and deterioration of congenital anomalies of the kidney and urinary 
tract .Journal of the American Society of Nephrology 1999 : 10: 2018–2028. 
 
- Prieto D. et al. Histochemical and functional evidence for a cholinergic innervation of 
the equine ureter. Journal of the Autonomic Nervous System 1994: 47. 
 
- Purkerson ML et al. Role of atrial peptide in the natriuresis and diuresis that follows 





- Radmayr C. et al. Embryology and anatomy of the vesicoureteric junction with special 
reference to the etiology of vesicoureteral reflux’, T Adv in Urology 2009: 1: 243–250.  
- Rank WB et al. Ureteral diverticula: etiologic considerations.’, The Journal of urology 
1960: 83: 566–569. 
 
- Resim S. Role of tamsulosin in treatment of patients with steinstrasse developing after 
extracorporeal shock wave lithotripsy. Urology 2005: 66: 945–948.  
 
- Rickwood AM et al. Current management of duplex-system ureteroceles: experience 
with 41 patients. British journal of urology 1992: 70: 196–200. 
 
- Rogers, A. & Hasan, T. Management of secondary pelviureteric junction obstruction. 
Indian Journal of Urology 2013: 294–302.  
 
- Rokaw MD et al. Regulation of a Sodium Channel-associated G-protein by 
Aldosterone. Journal of Biological Chemistry 1996: 271: 4491–4496.  
 
- Romero VDG et al. Kidney stones: a global picture of prevalence, incidence, and 
associated risk factors. Reviews in urology 2010: 12: 86-96.  
 
- Rose JG & Gillenwater JY. The effect of adrenergic and cholinergic agents and their 
blockers upon ureteral  activity. Investigative urology 1974: 11: 439–451. 
 
- Rose JG & Gillenwater JY. Effects of obstruction on ureteral function. Urology 1978: 
139–145.  
 
- Rose JG & Gillenwater JY. Pathophysiology of ureteral obstruction. American Journal 
of Physiology 1973: 225: 830–837. 
 
- Roshani H. et al. An electro-myographic study of the distal porcine ureter. Journal of 
Urology 2000: 163: 1570–1576.  
 
- Roshani H. An in vivo endoluminal ultrasonographic study of peristaltic activity in the 
distal porcine ureter. Journal of Urology 2000: 163: 602–606.  
 
- Roshani H. et al. Pharmacological modulation of ureteral peristalsis in a chronically 
instrumented conscious pig model: Effect of cholinergic stimulation and inhibition.’, 
The Journal of urology 2003: 170: 264–267. 
 
- Ross JA et al. Observations on the physiology of the human renal pelvis and ureter. J 
Urol 1967: 97: 449–54. 
 150 
 
- Ruano-Gil D. & Tejedo-Mateu A. Human embryo (12 mm) with mesohydronephrosis 
and ureterohydronephrosis. Acta anatomica 1975: 93: 135–140. 
S 
 
- Sakamoto K. et al. Characterization of muscarinic receptor subtypes in human ureter. 
Journal of endourology 2006: 20: 939–42.  
 
- Sampaio FJ & Mandarim-de-Lacerda CA. Morphometry of the kidney. Applied study in 
urology and imaging. Journal d’urologie 1989: 95: 77–80. 
 
- Sampaio FJ et al. The pig kidney as an endourologic model: anatomic contribution. 
Journal of endourology 1998: 45–50.  
 
- Santicioli P & Maggi CA. Myogenic and neurogenic factors in the control of 
pyeloureteral motility and ureteral peristalsis. Pharmacological reviews 1998: 50: 
683–722.  
 
- Scarcello NS and Kumar S. Multiple ureteral diverticula. The Journal of urology 1971: 
106: 36–37. 
 
- Scheuerlein H. et al. Wilhelm von Waldeyer-Hartz—A Great Forefather: His 
Contributions to Anatomy with Particular Attention to “His” Fascia’, Frontiers in 
Surgery 2017: 4: 74.  
 
- Schlossberg SM & Vaughan ED. The mechanism of unilateral post-obstructive diuresis. 
The Journal of urology 1984: 131: 534–6.  
 
- Schnaper HW. The Tubulointerstitial Pathophysiology of Progressive Kidney Disease. 
Advances in chronic kidney disease 2017: 24: 107–116.  
 
- Schneider T. et al. Signal transduction underlying carbachol-induced contraction of 
human urinary bladder. The Journal of pharmacology and experimental therapeutics 
2004: 309: 1148–53.  
 
- Schulman CC. Ultrastructural evidence for adrenergic and cholinergic innervation of 
the human ureter.  J Urol 1975 : 113: 765–771.  
 
- Scofield MA. et al. Quantification of steady state expression of mRNA for alpha-1 
adrenergic receptor subtypes using reverse transcription and a competitive 
polymerase chain reaction. The Journal of pharmacology and experimental 
therapeutics 1995: 275: 1035–42.  
 151 
 
- Shafik A. Electroureterogram in the Obstructed Ureter and Vesicoureteral Reflux 
Journal of Surgical Research 1996: 65: 145–148.  
 
- Shalaby-Rana, E. et al. Imaging in Pediatric urology. Pediatric clinics of north America 
1997: 1065-1089. 
 
- Sheih CP et al. Cystic dilatations within the pelvis in patients with ipsilateral renal 
agenesis or dysplasia. The Journal of urology 1990: 144: 324–7. 
 
 
- Shen H. et al. Expression of β-adrenergic receptor subtypes in human normal and 
dilated ureter. International Urology and Nephrology2017: 49: 1771–1778.  
 
- Sibley GN. A comparison of spontaneous and nerve-mediated activity in bladder 
muscle from man, pig and rabbit. The Journal of physiology 1984. 354: 431–43.  
 
- Sigala S. et al. Evidence for the presence of α1 adrenoceptor subtypes in the human 
ureter. Neurourology and Urodynamics 2005: 24: 142–148. 
 
- Sisson and Grossman’s The anatomy of the domestic animals 1975: 479. 
 
- Somlyo AP & Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 
1994: 231–236.  
 
- SorianoRM & Leslie SW. Anatomy, Abdomen and Pelvis, Kidneys, StatPearls 2019.  
 
- Spronck B. et al. Ureter Smooth Muscle Cell Orientation in Rat Is Predominantly 
Longitudinal. PLoS ONE 2014: 9. 
 
- Srisubat A. et al. Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous 
nephrolithotomy  (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. The 
Cochrane database of systematic reviews 2009. 
 
- Stamm WE & Hooton TM. Management of urinary tract infections in adults. The New 
England journal of medicine 1993: 329: 1328–1334.  
 
- Starr NT et al. Microanatomy and morphometry of the hydronephrotic & obstructed 
renal pelvis in asymptomatic infants.The Journal of urology 1992: 148: 519–24. 
 
- Stief CG. et al. Phosphodiesterase isoenzymes in human ureteral smooth muscle: 
Identification, characterization, and functional effects of various phosphodiesterase 
 152 
inhibitors in vitro’, Urologia Internationalis 1995: 55: 183–189. 
 
- Stief CG. et al. A possible role for nitric oxide in the regulation of human ureteral 
smooth muscle tone in vitro. Urological research 1996: 24: 333–337. 
 
- Straub M et al. Pediatric urolithiasis: the current surgical management. Pediatric 
nephrology 2010: 25: 1239–1244.  
 
- Streb H. et al. Release of Ca2+ from a nonmitochondrial intracellular store in 
pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983: 306: 67–9. 
 
- Summers JL et al. Multiple ureteral diverticula. Case report with a discussion of 
etiology. The Ohio State medical journal 1972: 68: 1027–1028. 
 
- Sutaria PM et al. Transforming growth factor-beta receptor types I and II are expressed 
in renal tubules and are increased after chronic unilateral ureteral obstruction. Life 
sciences 1998: 62: 1965–72.  
 
- Swenson O et al. A New Concept of the Etiology of Megaloureters. New England 




- Del Tacca M. Acetylcholine content of and release from isolated pelviureteral tract. 
Naunyn-Schmiedeberg’s archives of pharmacology 1978: 302: 293–297. 
 
- Takeyama J & Sakai K. Mucosal abnormalities in congenital ureteropelvic junction 
obstruction. Histopathology 2007: 51: 716–717.  
 
- Tanagho EA et al. The trigone: anatomical and physiological considerations. In relation 
to the ureterovesical junction. J Urol 1968: 100. 
 
- Tchey DU. et al. Expectant Management of Ureter Stones: Outcome and Clinical 
Factors of Spontaneous Passage in a Single Institution’s Experience. Korean journal of 
urology 2011: 52: 847–51.  
 
- Theobald RJ. Changes in ureteral peristaltic activity induced by various stimuli. 
Neurourology and Urodynamics 1986: 5: 493–504.  
 
- Tillig B. et al. Effects of artificial obstruction on the function of the upper urinary tract 
of guinea pigs, rats and pigs. European Journal of Pediatric Surgery 2004: 14: 303–315.  
 
 153 
- Tomiyama Y. et al. Functional muscarinic cholinoceptors in the isolated canine ureter. 
Naunyn-Schmiedeberg’s archives of pharmacology 2003: 367: 348–52.  
 
- Tomiyama Y. et al. Effects of cholinergic drugs on ureteral function in anesthetized 
dogs. The Journal of urology 2004: 172: 1520–3.  
 
- Tsuchida S. et al. Initiation and Propagation of Canine Renal Pelvic Peristalsis. Urologia 




- Uchiyama T & Chess-Williams R. Muscarinic receptor subtypes of the bladder and 
gastrointestinal tract, J. Smooth Muscle Res. 2004: 40: 237-47. 
 
- Uehara Y. & Burnstock G Demonstration of "GAP junctions" between smooth muscle 
cells. The Journal of Cell Biology 1970: 44: 215–217.  
 
- Ueno A. et al. Relation of spontaneous passage of ureteral calculi to size. Urology 




- Venkatesh R. et al. Impact of a double-pigtail stent on ureteral peristalsis in the 
porcine model: initial studies using a novel implantable magnetic sensor. Journal of 




- Wamsley-Davis A. et al. AT1A-mediated activation of kidney JNK1 and SMAD2 in 
obstructive uropathy: preservation of kidney tissue mass using candesartan. A j 
physiol 2004: 87:474-80.  
 
- Wein AJ et al. Campbell-Walsh Urology 11th Edition, Campbell-Walsh Urology 2016. 
 
- Weinberg S. Ureteral function.I. Simultaneous monitoring of ureteral peristalsis. 
Invest. Urol. 1974: 12: 103:107. 
 
- Weiner DM et al. Expression of muscarinic acetylcholine and dopamine receptor 
mRNAs in rat basal ganglia. National Academy of Sciences USA. 1990: 7050.  
 
- Weiss RM et al. Dynamic length-tension curves of cat ureter.The American journal of 
physiology 1972: 222: 388–393.  
 154 
 
- Weiss RM et al. Adrenergic innervation of the ureter. Investigative urology 1978: 16: 
123–7.  
 
- Weiss RM & Biancani, P. Characteristics of normal and refluxing ureterovesical 
junctions. Journal of urology 1983: 129: 858–61. 
 
- Whitaker RH. Diagnosis of obstruction in dilated ureters. Annals of the Royal College 
of Surgeons of England 1973: 53:153–166. 
 
- Wise GJ et al. Fungal infections of the genitourinary system: manifestations, diagnosis, 
and treatment. The Urologic clinics of North America 1999: 26: 701–18. 
 
- Wolf JSJ et al. Comparative ureteral microanatomy. J endourol 1996: 10: 527–531. 
 
- Woodburne RT & Lapides J. The ureteral lumen during peristalsis. American Journal of 
Anatomy 1972: 133: 255–258.  
 
- Woodward M. & Frank D. Postnatal management of antenatal hydronephrosis. BJU 
International. 2002: 149–156.  
 




- Yamaguchi OA & Constantinou CE. Renal calyceal and pelvic contraction rhythms. 
American Journal of Physiology1989: 257. 
 
- Yamamoto KK. The effects of beta-adrenoceptor agonists on KCl-induced rhythmic 
contraction in the ureter of guinea pig.’, J Smooth Muscle Res 2000: 36: 13–9. 
 
- Yang Y. et al. The expression of epidermal growth factor and transforming growth 
factor-beta1 in the stenotic tissue of congenital pelvi-ureteric junction obstruction in 
children. Journal of pediatric surgery 2003: 38: 1656–1660. 
 
- Yano S et al. Actions of some autonomic drugs on spontaneous contractions of 
isolated dog ureter. Urologia internationalis 1984: 39: 100–104. 
 
- Ye Z. et al. Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal 
Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-
controlled Trial. European Urology 2018: 73: 385–391. 
 155 
 
- Yilmaz E. et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers 
for distal  ureteral stones. The Journal of urology 2005: 173: 2010–2012.  
 
- Yin FC & Fung YC. Mechanical properties of isolated mammalian ureteral segments. 
American Journal of Physiology 1971: 221: 1484 – 1493.  
 
- Ylinen E. et al. Outcome of patients with antenatally detected pelviureteric junction 
obstruction. Pediatric nephrology 2004: 19: 880–887.  
 
- Yoshimura Y. & Yamaguchi O. Calcium independent contraction of bladder smooth 
muscle. International Journal of Urology 1997: 4: 62–67.  
 
- Yucel S & Baskin LS. Neuroanatomy of the ureterovesical junction: clinical 




- Zelenko N. et al. Normal Ureter Size on Unenhanced Helical CT. American Journal of 
Roentgenology 2004: 1039–1041.  
 
- Zhang Y & Lang RJ. Effects of intrinsic prostaglandins on the spontaneous contractile 
and electrical activity of the proximal renal pelvis of the guinea-pig. B J Phar 1994: 113: 
431–438. 
 
- Zwergel U. et al. Effects of Prostaglandins and Prostaglandin Synthetase Inhibitors on 
Acutely Obstructed Kidneys in the Dog. Urologia Internationalis 1991: 47: 64–69. 
 
 
 
 
 
 
